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Overview 
The portfolio has three parts.   
 
Part one is a systematic literature review, in which the theoretical, conceptual and 
empirical literature relating to the relationship between illness perceptions, mood and 
quality of life in coronary heart disease populations is reviewed.   
 
Part two is divided into two empirical papers:   
1. Paper one utilises a qualitative methodology to explore refractory angina 
patients' experiences of undergoing EECP, and their lives before and after the 
treatment.   
2. Paper two utilises a quantitative methodology to explore the relationship 
between illness perceptions, mood and quality of life in chronic refractory 
angina patients that have undergone EECP treatment.      
 
Part three comprises the appendices. This includes a reflective statement and 
supplementary information relevant to all three papers.   
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Illness Perceptions, Mood and Quality of Life:  A Systematic Review of 
Coronary Heart Disease Patients 
 
Abstract 
Objective: To examine published literature investigating the relationship between 
illness perceptions, mood and quality of life (QoL) in coronary heart disease (CHD) 
populations.   
Methods: Key databases were systematically searched (CINAHL, Medline, 
PsycINFO, Scopus and Web of Science) for studies matching the inclusion criteria.  
References of included studies were examined and key authors contacted.  Studies 
were subject to a quality control check. 
Results: 21 studies met the inclusion criteria.  A synthesis of the results found that 
illness perceptions were correlated to and predicted QoL and mood across CHD 
diagnoses.  Specific illness perceptions (control, coherence and timeline) were found 
to be important for patients that had experienced an unexpected medical event, such 
as myocardial infarction.   
Conclusion: The results of this study provide support that illness perceptions are 
related to outcomes across CHD populations and disease progression, however the 
results do not selectively support one particular model.  Recommendations are 
consistent with cardiac rehabilitation guidelines.  Further research should focus on 
the systemic impact of illness perceptions.       
 
Keywords: anxiety; coronary heart disease; depression; illness perceptions; quality 
of life.   
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Coronary heart disease (CHD) occurs due to an accumulation of fatty plaque in the 
arterial walls of the heart; a process known as atherosclerosis. This plaque narrows 
the arteries and reduces the blood flow to and from the heart, which can lead to 
myocardial infarction
i
 (MI) and angina
ii
.   
CHD accounted for over 7.3 million deaths worldwide in 2008 [1], and is the 
most common cause of death in the UK, with approximately one in five male and 
one in eight female deaths due to CHD [2].  The prevalence of CHD is increasing 
annually [3], creating a large societal burden [4].  The total cost to the UK 
Government, including healthcare, informal care and production loss due to 
morbidity and mortality was approximately £9 billion in 2006, and is increasing 
annually [5].   
There are a variety of physical, demographic and social factors that increase 
both the risk of developing CHD and subsequent morbidity and mortality, such as 
obesity, smoking, genetics, hypertension and diabetes [3, 6, 7].  However, research 
has found that the degree of physical recovery is not directly linked to illness 
severity [8, 9] and that psychological factors are also important determinants of CHD 
outcome.  Various psychosocial factors have been found to be key in CHD recovery, 
including locus of control (LoC) [10], self-efficacy [11], coping strategies [12], 
social support [13], mood [14] and illness perceptions [15].  Research even suggests 
that illness perceptions may be more important than medical factors in recovery [16, 
17].  This has been found across various chronic health conditions, including chronic 
fatigue syndrome (CFS) [18], diabetes [19] and CHD [15].  Illness perceptions is a 
                                                          
i
 A heart attack 
ii
 Chest pain due to a lack of blood supply and oxygen to the heart.  Stable = Pain 
precipitated by activity with minimal pain at rest. Unstable = Can occur more unpredictably 
at rest.  
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pertinent research area for CHD, as studies have shown that many CHD patients (up 
to 83%) hold misconceptions about their illness [20, 21, 22].  Therefore, it is 
important to further understand the impact on CHD outcomes of holding 
maladaptive illness perceptions.    
Illness perceptions are beliefs and expectations regarding one's own or others' 
illness and develop from a variety of sources, including experience and environment.  
The most widely applied model for explaining the relationship between illness 
perceptions and emotional and behavioural responses is the self-regulatory model 
[23].  This model describes a parallel processing framework, in which patients 
employ illness-related cognitive and emotional representations to make sense of their 
illness.  These representations guide decisions regarding coping strategies, which are 
subsequently evaluated based on outcome (see Figure 1).  Although coping appears 
to mediate the relationship between illness perceptions and outcome, research also 
indicates that there is a direct relationship independent of coping [24]. 
 
 
 
 
 
 
 
 
 
Figure 1. The self-regulatory model [23]  
14 
 
Leventhal, Meyer and Nerenz (1980) [23] proposed 5 core dimensions to illness 
perceptions.  These were beliefs about illness symptoms (identity), expected duration 
(timeline), causal factors (cause), illness effects (consequences) and the extent to 
which the illness could be controlled or cured (control/cure).  Subsequent research 
highlighted the importance of patients' beliefs that their illness makes sense (illness 
coherence), which has been added as a sixth core dimensions [25]. 
These constructs were supported by a meta-analytic review of the self-
regulatory model [24], which examined various chronic illnesses, including diabetes 
[26] and asthma [27].  A range of outcomes were also investigated, including 
psychological wellbeing [26] and quality of life (QoL) [28].  The meta-analytic 
review provided evidence that the relationship between illness perceptions and 
outcomes is not disease-specific.  However, most of the studies utilised a cross-
sectional design, leading to difficulties concluding the direction of causality.  Since 
this review, more studies have employed a longitudinal design, demonstrating illness 
perceptions impacting on outcomes.   Furthermore, the meta-analytic review only 
included two studies of patients that had experienced MI [29, 17].  Since this review, 
research using CHD patients has found illness perceptions to be important 
determinants in a variety of outcome measures, including medication adherence [30], 
cardiac rehabilitation attendance [31], mood [32] and QoL [33].   Mood and QoL are 
strong psychosocial predictors of CHD [34] and are independently associated with 
morbidity and mortality [35], highlighting the importance of these outcomes in 
research.   
A systematic literature review was previously undertaken to investigate the 
effectiveness of interventions to change illness perceptions in CHD patients [36].  
The review included a heterogeneous sample of CHD patients, including angina, MI, 
15 
 
CHD and patients that recently received coronary artery bypass graft
iii
 (CABG) or 
percutaneous transluminal coronary angioplasty
iv
 (PTCA).  Cognitive-behavioural 
interventions were found to be the most effective to dispel misconceptions, 
irrespective of CHD patient population.  The review also investigated whether these 
interventions would affect secondary outcomes, such as changes in QoL, health 
behaviour and psychological wellbeing.  However, there was a shortage of consistent 
secondary outcomes investigated in the intervention studies, which led to a lack of 
clear evidence that changing illness perceptions influenced QoL and mood.  As 
illness perceptions have been shown to be changeable through health-care 
interventions, it is important to focus on the specific relationship with secondary 
outcomes, such as mood and QoL, as these have been shown to be independently 
associated with morbidity and mortality [35]. Greater clarity of the relationship 
between these factors could potentially inform health-care interventions for CHD 
patients and build on the lack of intervention research that has focused on these 
secondary outcomes.  Furthermore, it is important to review this relationship across a 
heterogeneous sample of CHD patients, as this will enable similarities and 
differences in this relationship to be highlighted across the whole disease course.     
The aim of the current review was to examine published literature 
investigating the relationship between illness perceptions, QoL and mood in CHD 
populations.  The following research questions were identified: 
 
                                                          
iii
 A surgical intervention that involves removing arteries or veins from other parts of the 
body and using them to bypass blocked arteries.  This increases blood supply to and from the 
heart. 
iv
 A surgical intervention that involves inflating a balloon within the coronary artery to 
increase blood supply to the heart. 
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1) How do overall illness perceptions relate to mood and QoL in CHD populations? 
 
2) Are there differences in the strength of illness perceptions
v
 in relation to QoL and 
mood in CHD populations? 
 
3) Are there differences in these relationships dependent on the stage of CHD 
disease course and progression?  
 
Method 
Data Sources 
A systematic electronic search of the literature was performed, searching the 
databases: Cumulative Index to Nursing and Allied Health Literature (CINAHL), 
Medline, PsycINFO, Scopus and Web of Science.  Databases were selected to enable 
a comprehensive search of psychological, medical and sociological factors. 
References from selected articles were searched by hand to ensure additional 
relevant studies were also included.  Prominent researchers in the field were also 
contacted to acquire further research in the process of publication
vi
.   
 
Search Strategy 
The electronic search was performed in November 2011.  The following search 
terms in Table 1 were selected to optimise likelihood of identifying relevant studies 
in order to answer the research questions.  Search terms were chosen through initial 
checks of key studies and the relevant key words used in these studies.  
                                                          
v
 Identity, timeline, cause, consequences, control/cure and illness coherence 
vi
 Professor Moss-Morris (Head of Health Psychology at the Institute of Psychiatry) and 
Professor Furze(Professor of Adult Nursing and Health Care at Coventry University) 
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Table 1. Search Strategy 
 
Selection Criteria 
Studies were included for selection if participants were adults with a diagnosis of at 
least one of the following: 1) angina 2) myocardial infarction 3) CHD 4) eligible for 
or recently received revascularisation via PTCA or CABG.  These CHD patient 
populations have been researched in a previous systematic literature review [36].  
                                                          
vii
 One of three cardiac diseases: ST elevation myocardial infarction, Non-ST elevation 
myocardial infarction and unstable angina. 
Search Criteria Search Terms 
Abstract 
 
Abstract 
 
 
 
Title 
 
 
 
 
 
 
 
 
 
 
Abstract 
illness* OR health* (AND) 
 
percep* OR expect* OR belie* OR 
represent* OR cognit* OR attitud* 
(AND) 
 
"coronary heart disease*" OR "coronary 
artery disease*" OR "CHD" OR "CAD" 
OR "angina" OR "angina pectoris" OR 
"myocardial infarction*" OR "MI" OR 
"heart attack*" OR "angioplasty" OR 
"PCI"  OR "percutaneous coronary 
intervention*" OR "coronary artery 
bypass surger*" OR "CABG" OR "ACS" 
OR "acute coronary syndrome
vii
*" 
(AND) 
  
"quality of life" OR "QoL" OR 
"well#being" OR emotion* OR psycho* 
OR distress* OR affect* OR depress* 
OR mood* or anxi* 
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The studies selected included a measure of illness perceptions and at least one 
secondary outcome measure: either QoL (physical and/or emotional) or mood 
(anxiety and/or depression).  The studies also needed to employ a quantitative 
design, to ensure statistically justified relationships.  Only peer reviewed full-text 
studies were included to increase scientific rigour. 
Intervention studies were excluded due to a previous review investigating 
these studies [36].  Furthermore, intervention studies did not specifically investigate 
the relationship between illness perceptions, mood and QoL.  Studies were also 
excluded if they were not published in the English language due to the potential loss 
of meaning through translation.    It was also beyond the scope of the review to 
extend to systemic issues, such as family illness perceptions.  Therefore these were 
excluded at the study selection stage.   
 
Quality Assessment 
The quality of each included study was assessed using a modified version of Downs 
and Black's (1998) [37] checklist.  This was originally developed to assess healthcare 
intervention studies, which have been specifically excluded from the current review.  
Therefore, the checklist incorporated questions from the CONSORT 2010 statement 
[38], which provided a checklist that covered the essential information to judge the 
relevance and reliability of the study (Appendix 4.1).  The quality of each study was 
rated by two researchers to check for inter-rater reliability.   
 
Data Extraction 
A data extraction form was designed to obtain information from each included study 
to specifically address the research questions (Appendix 4.2).  Extracted data 
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included participant characteristics, study design, method, results, conclusions and 
implications.  
 
Data Synthesis 
A narrative method of data synthesis was chosen due to the anticipated heterogeneity 
of the included studies, in terms of participant characteristics, outcome measures and 
study design.   
 
Results 
Details of Included and Excluded Studies  
Figure 1 shows the article selection process.  Of the 1672 articles identified from 
initial database searches, 1611 were not relevant based on reviewing abstracts and 
titles.  Removal of duplicates and application of stated inclusion and exclusion 
criteria left 16 studies.  Five further articles were identified through searching the 
reference sections of included studies.  In total, 21 studies were included in the final 
review.  
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Figure 2. Article selection process 
 
Quality Assessment 
Included studies varied in quality from 12 to 19 out of a total possible 19 points, 
using the selected quality assessment tool.  Although all studies were included in the 
review independent of quality, scores were considered in formulating results.  There 
were three items on the quality checklist that were noticed to be particularly low in 
the majority of studies.  Eight studies did not report the differences between 
respondents and non-respondents, 13 studies did not provide estimates of the random 
variability of the data, and 15 studies did not report whether subjects were 
representative of the entire population from which they were recruited.  An 
Eligible studies 
16 
Identified via 
references (5) 
Studies included 
in the review 
21 
Researchers 
contacted in field 
(0) 
Removal of 
duplicates 
Inclusion and 
exclusion criteria 
 
CINAHL 
231 
Total 
1672 
Relevant studies 
61 
Medline 
436 
 
 
PsycINFO 
216 
 
Scopus 
329 
 
Web of 
Science 
460 
 
Exclusion based on 
title and abstract 
21 
 
independent reviewer also rated the included articles to examine inter-rater 
reliability, which was found to be strong using a Pearson correlation (r = 0.889, p 
<0.001). 
Overview of Results  
An overview of the 21 included studies can be found in Table 1.  The proportion of 
males and females in the studies ranged from 50% to 100% male, with an average of 
72.72% for males and 27.28% for females.  Research supports a higher prevalence of 
CHD in males [2] in western cultures, suggesting that the studies are representative.  
The mean age across all studies was 62.43 years.  In western cultures, CHD 
prevalence is highest for men and women over 55 and 65 years, respectively [2].  
These results suggest that the studies are representative of CHD population regarding 
age and gender.   
 A range of CHD populations were investigated, including MI (n=13), angina 
(n=2), acute coronary syndrome (n=1) and planned surgical procedures (n=9).  
Ethnicity was not reported in 15 studies.  However, 5 studies reported a high 
percentage of white Caucasian participants.  Only one study recruited participants 
from India (study 19).           
  Studies utilised cross-sectional (n=7) and longitudinal (n=14) designs, with 
equal proportions of studies recruiting outpatients and inpatients.  Studies used 
correlational analysis (n=10) and regression (n=14) to analyse results.  The majority 
used hierarchical regression (n=8), with a minority of studies using linear regression 
(n=2), logistic regression (n=3) and structured equation modelling (n=1).  
  The studies utilised a variety of measures to assess illness perceptions, mood 
and QoL.  The majority of studies either used the Illness Perceptions Questionnaire 
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(IPQ) [29] (n=6) or the Illness Perceptions Questionnaire Revised (IPQ-R) [25] 
(n=7).  A minority of studies used the Sense of Coherence Questionnaire [39] (n=4), 
York Angina Beliefs Questionnaire (YABQ) [20] (n=1) and the Health Perceptions 
Questionnaire [40] (n=1).  Eight studies measured physical QoL (PQoL), 7 measured 
emotional QoL (EQoL) and 2 measured social QoL (SQoL).  The majority of studies 
measuring distress used the Hospital Anxiety and Depression Scale (HADS) [41] 
(n=10).  A minority of studies used the Profile of Mood States (POMS) [42] (n=2), 
Physical Health Questionnaire (PHQ-9) [43] (n=1) and Beck Depression Inventory 
(BDI) [44] (n=1).  
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Study 
No. [Ref 
No.] 
Authors/ 
Country 
Design Response Rate Participants CHD 
Classification 
Illness Perception 
Measure 
QoL and/or 
Distress 
Measures  
Key Findings Quality 
Rating 
(/19) 
1 
[45] 
 
 
 
 
 
 
 
 
 
2 
[46] 
 
 
 
 
 
 
 
 
3 
[47] 
Aalto, Aro, 
Weinman, 
Heijmans, 
Manderbacka 
& Elovainio 
(2006) 
Finland 
 
 
 
 
Alsen, Brink, 
Brandstrom, 
Kansson & 
Persson 
(2010) 
Sweden 
 
 
 
 
Arnold, 
Herrick, 
L 
(T2 1 year) 
 
 
 
 
 
 
 
 
 
L  
(T1 in 
hospital, T2 
4 months) 
 
 
 
 
 
 
C-S 
 
62.5% of original 
sample participated. 
84% retention at T2 
 
 
 
 
 
 
 
 
Not reported 
 
 
 
 
 
 
 
 
 
63.3% of original 
sample 
N = 3130 
Age = 45-74 (64.38, 
SD = 7.04) 
50% Male 
50% Female 
Finnish speaking 
 
 
 
 
 
N = 204 
Age = 64 (SD=10) 
71% Male 
29% Female 
Ethnicity not 
reported 
 
 
 
 
N = 124 
Age = 64 
34% MI 
36% re-
vascularisation 
20% use nitrates 
weekly 
 
 
 
 
 
 
MI 
76% first MI 
 
 
 
 
 
 
 
 
First MI 
 
IPQ-R 
 
 
 
 
 
 
 
 
 
 
IPQ 
 
 
 
 
 
 
 
 
 
Health 
Perceptions 
QoL: 
Visual 
Analogue 
Scale 
 
 
 
 
 
 
 
Distress: 
HADS 
QoL: 
SF36 
 
 
 
 
 
 
Distress: 
POMS 
QoL significantly correlated 
with all IPQ subscales. 
Identity, consequences and 
cure/control added 
significantly to QoL 
(p<0.001). 
Illness perceptions predicted 
changes in QoL even when 
baseline status was 
accounted for. 
 
Timeline (chronic & cyclic) 
& consequences were 
associated with worse QoL. 
Personal control was 
associated with better 
physical QoL. 
Treatment control was 
associated with both 
physical and emotional QoL. 
 
Significant weak 
correlations between health 
17 
 
 
 
 
 
 
 
 
 
 
18 
 
 
 
 
 
 
 
 
 
17 
 
24 
 
 
 
 
 
 
 
4 
[48] 
 
 
 
 
 
 
 
 
 
 
 
 
5 
[49] 
 
 
 
 
Pankratz & 
Mueller 
(2007) 
USA 
 
 
Bergman, 
Malm, 
Karlsson & 
Berterö 
(2008) 
Sweden 
 
 
 
 
 
 
 
 
Blair, 
Leakey, Rust, 
Shaw, 
Benison & 
Sandler 
(1999) 
 
 
 
 
 
 
L 
(T1 before 
hospital 
discharge, T2 
2 weeks post, 
T3 4 weeks 
post) 
 
 
 
 
 
 
 
L 
(T1 6 weeks 
post MI, T2 3 
months post, 
T3 6 months 
post) 
 
 
 
 
 
 
100% 
 
 
 
 
 
 
 
 
 
 
 
 
 
81.6% completed T1, 
T2 & T3 
 
 
 
 
62.1% Male 
37.9% Female 
Ethnicity not 
reported 
 
 
N = 100 
Age = 36-70 
Median = 57 
79% Male 
21% Female 
Ethnicity not 
reported 
 
 
 
 
 
 
 
N = 62 
Age, gender and 
ethnicity not 
reported 
 
 
 
 
 
 
 
 
First MI 
 
 
 
 
 
 
 
 
 
 
 
 
 
MI 
 
 
 
 
 
Questionnaire 
 
 
 
 
 
A Swedish 
Version of the 13-
Item Sense of 
Coherence Scale 
(SOC) 
 
 
 
 
 
 
 
 
 
 MHLC 
(Chance, 
Internality,  
Powerful others) 
 
 
QoL: 
SWB 
 
 
 
 
QoL: 
SF-12 
 
 
 
 
 
 
 
 
 
 
 
 
Distress: 
HADS  
 
 
 
 
perception and anxiety & 
depression. When 
controlling confounding 
variables, only anxiety 
significantly correlated.  
 
Significant positive 
correlation between SWB 
health outlook.  
High vs Low SOC: High 
had better mental health, 
less angina, greater 
treatment satisfaction & 
more physical activity. 
High vs Medium SOC: Only 
difference was in lifestyle. 
Medium vs Low: Only 
differences were in mental 
health and lifestyle. 
 
Chance significantly 
positively associated with 
depression & anxiety at T1, 
T2 & T3. 
Internality significantly 
negatively correlated with 
 
 
 
 
 
 
16 
 
 
 
 
 
 
 
 
 
 
 
 
 
14 
 
 
 
 
 
25 
 
 
 
 
 
 
6 
[50] 
 
 
 
 
 
 
 
 
7 
[51] 
 
 
 
 
 
 
 
 
 
UK 
 
 
 
 
Cherrington, 
Moser, 
Lennie & 
Kennedy  
(2004) 
USA 
 
 
 
 
Dickens et al 
(2008) 
UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
C-S 
 
 
 
 
 
 
 
 
 
L 
(T1 in 
hospital, T2 
6 months, T3 
12 months) 
 
 
 
 
 
 
 
 
 
 
 
94% completed 
questionnaires 6% 
excluded. 
 
 
 
 
 
 
 
269 (91%) 
completed T2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
N = 49 
Age = 60.8 (SD=-
13.32) 
50% Male 
50% Female 
White 
 
 
 
 
N = 313 
Age = 57.7 
(SD=11.2) 
63% Male 
37% Female 
Ethnicity not 
reported 
 
 
 
 
 
 
 
 
 
MI treated by 
angioplasty 
 
 
 
 
 
 
 
 
First MI 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
IPQ 
 
 
 
 
 
 
 
 
 
IPQ  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Distress: 
STAI. 
BDI. 
 
 
 
 
 
 
 
Distress: 
HADS 
 
 
 
 
 
 
 
 
 
depression & anxiety at T2 
& T3. 
No differences on powerful 
others. 
 
Anxiety and depression 
were moderately correlated 
with illness perceptions. 
IPQ scores were predictive 
of the likelihood of 
occurrence of complications. 
No mediating effect of 
anxiety and depression 
between illness perceptions. 
 
IPQ at baseline was 
significantly associated with 
new depression, even after 
controlling for confounding 
variables, particularly 
thoughts that heart disease 
would last a long time. 
Participants that thought 
their CHD could be 
cured/controlled were half as 
likely to develop depression. 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
17 
 
 
 
 
 
 
 
 
 
 
26 
 
 
8 
[52] 
 
 
 
 
 
 
 
 
9 
[33] 
 
 
 
 
 
 
 
 
 
 
10 
[53] 
 
 
Dunkel, 
Kendel, 
Lehmkuhl, 
Hetzer & 
Regitz-
Zagrosek 
(2011). 
Germany 
 
 
French, 
Lewin, 
Watson & 
Thompson 
(2005) 
UK 
 
 
 
 
 
 
Furze, Lewin, 
Murberg, 
Bull & 
 
L 
(T1 3 days 
before 
surgery, T2 1 
year post) 
 
 
 
 
 
L  
(T1 in 
hospital. T2 
6 months) 
 
 
 
 
 
 
 
 
L 
(T2 1year) 
 
 
97% of sample 
completed T1 
63.3% of T1 sample 
completed T2 
 
 
 
 
 
 
83% of those eligible 
took part. 
 
 
 
 
 
 
 
 
 
 
 94% of original 
sample approached 
participated. 
 
N = 1587 
Age = 66.81 
(SD=9.03) 
79.1% Male 
19.9% Female 
99.2% Caucasian 
 
 
 
 
N = 194 
Age = 63.3 
(SD=10.6) 
75% Male 
25% Female 
Ethnicity not 
reported 
 
 
 
 
 
N = 141 
Age = 67.99 
(SD=8.96) 
 
Planned CABG  
 
 
 
 
 
 
 
 
 
MI 
81% First MI 
 
 
 
 
 
 
 
 
 
 
Chronic stable 
angina 
 
 
IPQ  
(Causal subscale) 
 
 
 
 
 
 
 
 
IPQ  
 
 
 
 
 
 
 
 
 
 
 
YABQ 
 
 
 
Distress: 
PHQ-9 
 
 
 
 
 
 
 
 
Distress: 
HADS 
QoL: 
QLMI 
 
 
 
 
 
 
 
 
Distress: 
HADS  
Physical 
 
Causal attributions of 
personality and stress/mental 
load led to worsening of 
depressive symptoms 1 year 
post-surgery. 
Attributions to stress, 
personality and destiny were 
associated with higher 
depressive scores. 
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Study Design: C-S: Cross-sectional; L: Longitudinal; T1= Time point 1, T2= Time point 2, T3=Time point 3, T4=Time point 4, T5=Time point 5. 
Classification: CABG: Coronary Artery Bypass Graft; CHD; Coronary Heart Disease; HRQoL: Health-related quality of life; MI: Myocardial Infarction; 
EQoL; Emotional quality of life; PQoL; Physical quality of life; PTCA: Percutaneous Transluminal Coronary Angioplasty QoL: Quality of life.  
Measures: BDI; Beck Depression Inventory; CAS; Control Attitudes Scale;  HADS; Hospital Anxiety and Depression Scale; MCHLC; the Multi-
Dimensional Health Locus of Control Scale; POMS; Profile of Mood States; PHQ-9; Patient Health Questionnaire; QLMI; Quality of Life after MI 
Questionnaire; SAQ-PL; Seattle Angina Questionnaire – Physical Limitation Scale; SF12; Short-Form-12; SF36; Short-Form-36; SF36v2: Short-Form-36 
Version 2; STAI; State-Trait Anxiety Inventory; SWB; Spiritual Wellbeing Scale; YABG; York Angina Beliefs Questionnaire.   
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Illness Perceptions, Mood and QoL 
Studies 3, 6, 10 and 14 examined illness perceptions as a whole construct.  Negative 
illness perceptions were significantly correlated to and predicted worsened PQoL.  
Study 3 also found a significant correlation with spiritual wellbeing (existential, 
religious and spiritual).  It was consistently reported that negative illness perceptions 
correlated with elevated anxiety and depression (studies 3, 6, 10).  However, only 
study 14 reported illness perceptions to be a significant predictor of changes in 
depression.   
Identity, Mood and QoL 
Four studies excluded the identity subscale from analysis.  Study 9 excluded identity 
to reduce questionnaire burden and study 13 reported that previous research had 
suggested that identifying with symptoms was not a good indicator of illness 
identity.  Studies 2 and 12 did not give a reason for the exclusion. 
  Mixed findings were observed in the five studies that examined the 
relationship between identity and QoL (studies 1, 14, 17, 19, 20).  Studies 1 and 19 
found significant correlations between identity, EQoL and PQoL.  However, study 
14 found no significant relationship between these variables.  Only study 19 
investigated SQoL, reporting no significant relationship.  However, there was a 
consistent finding that identity significantly predicted changes in PQoL and EQoL at 
baseline assessment and follow-up.  Only study 19 found identity to not predict 
PQoL.  However, this study had the lowest quality rating (12/19).   
  Identity was consistently not significantly related to depression (studies 7, 14, 
20).  Only study 18 investigated the relationship between identity and anxiety and 
found a significant positive correlation and significant differences in identity scores 
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for anxious and non-anxious patients.  Study 18 had a high quality score, 
demonstrating clinical validity.  
Consequences, Mood and QoL 
Perceived consequences was significantly correlated with poorer PQoL (studies 2, 9, 
14, 17, 19) and EQoL (studies 2, 9, 17, 19).  However, only study 19 found 
consequences to significantly predict changes in PQoL and EQoL.  This study had a 
lower quality score compared to the studies that found no significance (studies 2, 9, 
17, 20).   
  Studies 9 and 19 found a significant relationship between consequences and 
SQoL.  Although these studies differ greatly in their quality rating (17/19 & 12/19), 
they both recruited inpatients that had experienced an MI. 
  The majority of studies reported increased negative consequences were 
significantly correlated with elevated depression (studies 1, 6, 12).  Although study 
13 found no significant relationship, it had a lower quality rating compared to the 
other studies.  Only study 20 used regression analysis and found consequences to 
significantly predict changes in depression. Study 18 found a significant difference 
in consequence scores between anxious and non-anxious participants, whereas study 
13 found no significant correlation.  The quality ratings were similar for both studies 
(16/19 &15/19).      
 Illness Coherence, Mood and QoL 
Studies 2 and 19 found a significant positive correlation between coherence and 
PQoL.  Study 14 found no significant association.  Although there is little difference 
in quality ratings, studies 2 and 19 recruited inpatients after an unexpected MI, 
whereas study 14 recruited patients before a planned operation.     
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  Studies 4 and 19 found a significant positive correlation between coherence 
and EQoL, whereas studies 2 and 14 found no significant association.  Studies 2 and 
14 had higher quality ratings (18/19 & 16/19) compared to studies 4 and 19 (16/19 & 
12/19).  Only study 19 examined the relationship between coherence and SQoL and 
found a significant positive relationship.  However, study 19 had the lowest quality 
rating (12/19).   
  Lower illness coherence was consistently significantly correlated with 
elevated depression (studies 4, 13, 14, 16).  Studies 15 and 18 found lower coherence 
was also significantly correlated with elevated anxiety, whereas study 13 found no 
significance.  However, study 15 also found that when coherence worsened, there 
was no increase in depression and anxiety levels, raising questions regarding 
causality and highlighting that other factors could have affected depression and 
anxiety levels. No studies investigated this using regression analysis.  
Control, Mood and QoL 
Studies 1 and 17 found a significant correlation between perceived low CHD control 
and worsened PQoL and EQoL.  Although study 9 found no relationship between 
control and QoL, the quality ratings were similar for all three studies (17/19, 18/19 
& 17/19).  
  Study 2 reported that decreased personal control was significantly correlated 
with worsened PQoL, whereas study 14 did not.  However, personal control 
consistently predicted changes in PQoL (studies 19, 20).   The three studies that 
found a significant relationship had recruited patients that had experienced an 
unexpected medical event, whereas study 14 had recruited patients undergoing a 
planned operation.  Studies 2 and 14 found no significant relationship between 
personal control and EQoL.  However, studies 19 and 20 reported a significant 
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relationship.  Although study 19 had the lowest quality rating, study 20 scored the 
highest possible rating (19/19).       
  Decreased treatment control was consistently significantly correlated with 
poorer PQoL and EQoL (studies 2, 19).  Study 20 found treatment control to 
significantly predict changes in PQoL and EQoL, whereas study 19 did not.   
  Perceptions of CHD control consistently predicted changes in anxiety and 
depression levels (studies 5, 7, 11).  Study 5 reported that patients who viewed their 
health as due to luck, fate or chance showed the strongest relationship with 
depression and anxiety.  
  Lower perceived personal control was consistently significantly correlated 
with elevated depression (studies 12, 13, 14, 20) and anxiety (studies 12, 13, 20).  
Study 18 found significant differences between anxious and non-anxious patients for 
both personal and treatment control, whereas study 13 found no significant 
relationship with anxiety.  The quality ratings for these two studies were similar 
(16/19 & 15/19). 
Timeline, Mood and QoL 
Negative perceived CHD timeline was significantly correlated with worsened QoL at 
baseline (studies 1, 9) and follow-up (studies 17, 20).  Timeline was consistently 
found to not relate to, nor predict EQoL (studies 9, 17, 20). 
  It was consistently found that perceived increased CHD chronicity and 
variability was significantly correlated with worsened QoL (studies 2, 14, 19).  
Studies 2 and 14 found this relationship to be weaker in EQoL compared to PQoL, 
whereas study 19 reported equal strength.  Only study 19 examined the predictors of 
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QoL using regression analysis and found cyclical to be a significant predictor of 
PQoL and SQoL, but not EQoL.   However, study 19 had the weakest quality rating.  
  Study 7 reported that negative perceived CHD timeline was significantly 
correlated with elevated depression, whereas study 20 did not.  Study 7 recruited 
inpatients experiencing an initial MI, whereas study 20 recruited outpatients with a 
diagnosis of CHD.    
  An increased perception of CHD chronicity was significantly correlated to 
elevated depression (studies 12, 14) and anxiety (study 18).  However, study 13 
found both relationships to be non-significant.  Study 14 found that increased 
perception of CHD variability was significantly correlated to elevated depression, 
whereas study 12 found no significance.  Study 12 recruited ACS inpatients, whereas 
study 14 followed inpatients through to discharge with planned cardiac surgery.   
Perceived Cause, Mood and QoL 
Six studies excluded the causal attribution subscale.  Four studies did not give a 
reason for this (studies 2, 7, 18, 20), but the remaining two stated that their sample 
size was smaller than the 81 recommended to analyse the subscale (studies 13, 14). 
  Various causes were related to QoL outcome, including epidemiological 
(study 1), stress (studies 1, 9, 19), internal (studies 1, 3, 17) and external causes 
(studies 9, 17).  Stress was the most consistent cause related to QoL, with studies 1, 
3 and 17 reporting a significant relationship with EQoL and PQoL.  Although study 
17 found internal causes to significantly predict changes in EQoL, the majority of 
studies did not find any perceived causes to predict changes in QoL (studies 1, 9, 
19).  
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  Studies 8 and 12 found that stress and personality were significantly related 
to depression.  Personality was defined as ambitious, impatient and short-tempered 
in study 8, whereas it was not specified in study 12.  No studies examined the 
relationship between patients' perceived causes of CHD and anxiety.  
 
Discussion 
Summary and Conclusions 
This study aimed to undertake a systematic literature review examining the 
relationship between illness perceptions, QoL and mood in a heterogeneous sample 
of CHD patients.   There was a consistent finding across CHD populations of a 
significant relationship between increased severity of illness perceptions, poorer QoL 
and elevated depression and anxiety.  The results of this study suggest that illness 
perceptions are important determinants of outcome throughout CHD disease course 
and progression.  This finding adds to existing literature [24] by suggesting that the 
relationship between illness perceptions and outcome is not only universal across 
illnesses, but can also be found throughout a specific disease course and progression.   
The present review found that attributing more symptoms to CHD, 
perceiving greater negative consequences and perceiving CHD to be more chronic 
and variable had the strongest relationship with poorer QoL across CHD 
populations.  Furthermore, poorer illness understanding, perceiving greater negative 
consequences and low personal and treatment control had the strongest relationship 
with elevated anxiety and depression across CHD populations.     
Illness perceptions impact on outcomes, such as QoL and mood, by 
influencing patients' decisions to undergo positive health-behaviour changes, such as 
improvement in diet and increased exercise.  Illness perceptions can influence 
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decision-making abilities regarding medication adherence, treatment decisions and 
attendance at cardiac rehabilitation programmes [64, 65].  An increased 
understanding of CHD can act as a mediator between adverse experiences and 
psychological wellbeing [66, 67].  Patients with more positive illness perceptions are 
able to conceptualise the nature of CHD and believe in their ability to choose 
appropriate coping strategies [40].  Illness perceptions can also influence motivation 
and self-efficacy to adopt positive health-behaviours.  Lewin (1997) [68] proposed 
that negative illness beliefs, such as "angina is a mini heart attack" and "if you get 
angina you should rest as much as possible", lead to a reduction in activity, due to 
fear of further heart damage.  This reduction can result in physical de-conditioning 
and lead to poorer outcomes (see Figure 3).  
 
 
 
 
 
 
Figure 3. The relationship between illness perceptions and outcome (Lewin, 1997) 
[68]. 
Although the present review found a relationship between illness perceptions and 
outcome, the self-regulatory model [23] is not unique in highlighting this 
relationship.  For example, perceived consequences is similar to the ‘severity of 
illness’ construct described in the health beliefs model [69].  Furthermore, the link 
Angina at lower 
level of activity 
Reduce activity to 
prevent angina and 
further heart damage 
De-conditioning, less 
efficient use of 
oxygen in 
myocardium 
Negative illness 
perceptions 
"Angina is a mini heart 
attack" 
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between perceived levels of control, self-efficacy and health-related behaviours is 
one component of the theory of planned behaviour [70].  This theory posits that 
perceived behavioural control and motivation can influence behavioural change and 
achievement through choice, preparation and effort during activities [71].  The 
results of this study, therefore, provide support that illness perceptions are related to 
outcomes across CHD populations, but does not selectively support one particular 
model.  
 
Differences throughout Disease Progression. 
Although the present study found illness perceptions to influence outcome 
throughout CHD progression, differences in the strength of specific illness 
perceptions dependent on disease stage were also observed.   
Lower perceived control over CHD symptoms and poorer understanding of 
the disease was significantly related to poorer QoL in patients that had experienced 
an unexpected medical event, such as an MI.  The present review also found that 
perceiving CHD to be more chronic and variable was significantly related to elevated 
anxiety and depression in patients that had experienced an unexpected MI.  These 
relationships were not found to be significant in studies that had recruited 
outpatients. 
The results of this study suggest that specific illness perceptions may have 
greater consequences on outcomes dependent on whether patients had recently 
experienced an unexpected medical event.  Any unexpected medical event can be 
disruptive and traumatic, requiring patients to quickly adapt to the emotional, 
behavioural and social demands involved in treatment and recovery [72].  If, during 
this time, patients lack an understanding of their illness, confidence in their ability to 
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control symptoms, and view CHD as chronic, they may be less likely to engage in 
immediate health-behaviour changes, such as improved diet, increased exercise and 
attendance at cardiac-rehabilitation, which are essential for recovery [64].  It is, 
therefore, necessary to provide sufficient information regarding management of 
symptoms and disease course for patients that have experienced a sudden medical 
event.  Patients should be encouraged to attend cardiac-rehabilitation, which can 
increase perceived control and confidence in ability to change behaviours [73].  
Interventions aimed at altering maladaptive beliefs during cardiac rehabilitation after 
MI can result in improved QoL [74] and psychological wellbeing [73].    
 
Limitations 
The current review is subject to several limitations.  Although the quality control 
checklist was combined from two valid checklists, the combination has not been 
tested for its psychometric properties.  However, there was strong inter-rater 
reliability, supporting the checklist validity.  It should also be noted that the quality 
checklist highlighted that the majority of studies did not state whether subjects were 
representative of the entire population from which they were recruited, making it 
difficult to fully generalise the findings.  The review also only included peer-
reviewed studies.  This could have resulted in publication bias.   
There were a variety of self-report questionnaires used to measure illness 
perceptions, QoL and mood.  This could have created difficulty as different measures 
may define constructs differently.  For example, the relationship between mood, 
consequences and timeline was reported to be significant when using the HADS 
[41], but not significant using the POMS [42].    
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The present review included a heterogeneous CHD sample, which led to a 
large variation in CHD disease course.   For example some studies recruited patients 
that had recently experienced their first MI, whereas other studies recruited 
outpatients that had a diagnosis of chronic angina.  There are potential confounding 
effects of acute illnesses and the results of the review have found differences in the 
significance of illness perceptions dependent on disease course. 
A further limitation is the possibility of sample bias.  The recruitment process 
in many studies enabled the possibility of a self-selecting sample bias, as patients 
with higher levels of distress or critical ill states may have refused or been unable to 
participate.  
 
Strengths 
The present paper reviewed all studies that met inclusion criteria.  There were no 
studies identified that were not available to review, allowing a thorough investigation 
of the research questions.   
Overall, the studies had good quality ratings, with thorough descriptions of 
aims, research questions, results and discussion.  Many also acknowledged their 
limitations.  There were also generally large sample sizes which enabled sufficient 
power for statistical analysis.  Many studies used multiple hierarchical regressions, 
which enabled a degree of control over potential confounding demographic factors, 
such as age (study 11), gender (6) and disability (14).  
 
Clinical Implications 
This review found illness perceptions to significantly influence mood and QoL 
across a range of CHD diagnoses.  The results of the review suggest that screening 
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and identifying illness perceptions is important and relevant for all CHD patients, 
and should not be dependent on disease state.   Illness perceptions could be assessed 
by a short form questionnaire and/or clinical interview by any healthcare 
professional involved in patient care, which could inform care planning and support.   
  Interventions for this patient population should focus on identifying and 
modifying maladaptive beliefs during rehabilitation and recovery, as recommended 
by Sign (2002) [75].  A review concluded that cognitive-behavioural interventions 
were the most effective in altering maladaptive illness perceptions in CHD patients 
[36].  Interventions, such as cardiac rehabilitation programmes, should be regularly 
offered to patients throughout CHD progression.  In the present review, a range of 
illness perceptions were related to mood and QoL.  Therefore, cardiac rehabilitation 
should address any identified maladaptive illness perceptions, as recommended by 
the British Association for Cardiovascular Prevention and Rehabilitation (BACPR) 
[76].     
 The present review found specific illness perceptions that were significantly 
related to mood and QoL in patients that had experienced an unexpected medical 
event, such as MI.  Healthcare professionals should be aware that illness coherence, 
perceived control and perceptions of disease timeline are important determinants of 
mood and QoL in patients, and should provide sufficient information regarding 
management of symptoms and CHD disease course after an MI.  The BACPR [76] 
reported that increasing education of this patient population can restore confidence 
and increase sense of perceived personal control.  However, it seems that 
rehabilitation should not just be about increasing education, but also targeting 
specific illness perceptions and facilitating change in these beliefs.    
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Future Directions 
It was beyond the scope of this review to investigate systemic issues, such as the 
impact of family members' illness perceptions on outcomes.  However, this is an 
important area to investigate in the future, as a mismatch between patients and 
family members' illness perceptions and subsequent coping strategies can impact on 
recovery, particularly through health-behaviour changes [78].  Future research could 
provide further support for the BACPR [76] recommendations that cardiac 
rehabilitation programmes adopt a multidisciplinary bio-psychosocial approach that 
is available for individuals and family members.     
The review solely focused on QoL and mood as outcomes for CHD patients.  
Further reviews could investigate differing outcomes to assess whether illness 
perceptions have stronger relationships with these, for example rehospitalisation, 
mortality and objective health outcomes.  An investigation into the cost-effectiveness 
of interventions to alter illness perceptions may also be useful.  Although the review 
was designed to include only quantitative research, there were no qualitative research 
papers available within searched databases that investigated the specific research 
questions.  It may be useful to investigate the breadth of concerns CHD patients have 
regarding their illness perceptions, QoL and experiences of mood using a qualitative 
design.  Work has begun to use qualitative research to investigate this regarding 
uptake of cardiac rehabilitation [79], however, more research is needed.  
The review found large variability in the measures used to assess illness 
perceptions, QoL and mood.  Constructs need to be clearly and consistently defined 
to enable comparisons between studies.  The HADS could be used across studies to 
measure mood, as it has already been widely used in cardiac patients, and has been 
recommended as a screening tool in CHD patients by the NSF Clinical Guidelines 
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[77].  A QoL measure should at least include physical and emotional QoL as 
separate constructs, such as the SF12 or SF36.   
 
 Conclusions 
This systematic literature review aimed to examine the relationship between illness 
perceptions, QoL and mood in a heterogeneous CHD population.  Illness perceptions 
were found to predict QoL and mood across CHD diagnoses.  Specific illness 
perceptions (control, coherence and timeline) were found to be important for patients 
that had experienced an unexpected medical event, such as MI.  The results of this 
study provide support that illness perceptions are related to outcomes across CHD 
populations, but the results do not selectively support one particular model.  
Recommendations are consistent with the BACPR [76] guidelines on cardiac 
rehabilitation.  Further research should focus on the systemic impact of illness 
perceptions.       
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Abstract 
Background: Previous qualitative research investigating patients' experiences of 
living with coronary heart disease (CHD) and undergoing various treatments has 
enabled increased understanding of patients' experiences and perceptions of their 
illness.   However, there has been no qualitative research into refractory angina 
patients' experiences of enhanced external counterpulsation treatment (EECP) or 
changes in their lives before and after the treatment.   
Objectives: To explore refractory angina patients' experiences of undergoing EECP, 
and to gain insight into their lives before and after the treatment.    
Methods:  Ten male refractory angina participants completed a semi-structured 
interview about their experiences of EECP and their lives before and after the 
treatment.  Interviews were transcribed and analysed using interpretive 
phenomenological analysis (IPA). 
Results: Five themes emerged; the impact of angina; fear experienced by the 
individual and family as a limiting factor; attitudes towards EECP treatment; 
response from others; and the impact of EECP.   
Conclusions: The study adds to existing literature by proposing that the process of 
undergoing EECP treatment not only leads to physiological improvement, but also 
effects psychological pathways, through providing hope, establishing a therapeutic 
relationship and increasing confidence and self-efficacy to confront positive and 
challenging health-behaviour changes.     
 
 
Keywords: chronic refractory angina; enhanced external counterpulsation treatment; 
experiences   
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Angina pectoris is the most common indicator of coronary heart disease (CHD), with 
symptoms including pain across the chest, shoulders, back, arms and jaw.  This pain 
is temporary and can be relieved following rest or medication.
1
 Angina is caused by 
a build up of fatty plaque in the arteries, leading to a restriction of blood flow around 
the heart, and can be triggered during increased metabolic demand, such as exercise, 
emotional stress and cold weather.
1
 Although the prevalence of CHD is increasing 
annually,
2
 mortality rates are decreasing
3
 due to advancements in treatment and 
medication.  Therefore, more people are living with angina symptoms, with 
approximately 95,000 new cases per year.
2
 Furthermore, the prevalence of angina 
increases with age, and as life expectancy is increasing, the frequency of angina will 
continue to rise.
4
 This has led to an increase in societal burden and cost to the NHS.
5
 
Allender, Scarborough, Peto and Rayner (2008)
6
 estimated that the cost of CHD to 
the UK in 2006 was approximately £9 billion.  It is, therefore, important to continue 
to develop strategies to improve the treatment and management of angina symptoms.  
 The two main surgical treatments for angina are coronary artery bypass grafts 
(CABG) and percutaneous transluminal coronary angioplasty (PTCA).  CABG is an 
invasive procedure involving open heart surgery, where new routes are created 
around the narrowed arteries using veins taken from other areas of the body.  PTCA 
is also an invasive treatment that involves inflating a small balloon on the tip of a 
catheter in narrow sections of the artery.  A small tube of stainless steel mesh, called 
a stent, is left in situ to keep the artery open.  Both interventions aim to increase 
blood flow to and from the heart. 
 Although there are many benefits from these treatments, there are risks 
involved due to the invasive nature of the procedures.  Increased life expectancy and 
prevalence of CHD has led to many patients experiencing multiple unsuccessful 
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surgical treatments.
7
  Mukherjee, Bhatt and Roe (1999)
8
 estimated that there are over 
100,000 patients in this situation every year.  Many CHD patients can reach a stage 
where it is medically unadvisable to undergo further surgical procedures and have 
difficulty controlling angina symptoms through medication management.  This 
condition is known as chronic refractory angina.
9
  Approximately 10-15% of patients 
with angina meet the criteria for this condition.
9
  Refractory angina can lead to 
reduced quality of life (QoL) and increased disability due to recurrent pain attacks, 
lack of energy and poor sleep.  Furthermore, patients can develop symptoms of 
anxiety and depression, which can lead to reduced interest in previously enjoyed 
activities and increased dependence on relatives and health professionals.
10, 11
 
There have been a variety of treatments developed for refractory angina 
patients that are less invasive and have fewer contraindications,
9, 12
 such as spinal 
cord stimulation and enhanced external counterpulsation treatment (EECP).  EECP 
involves wrapping paired compressible cuffs around the calves, lower and upper 
thighs, which are attached to an EEG machine and subsequently inflate and deflate in 
synchrony with the cardiac cycle.  Both the inflation and deflation of the cuffs 
reduces cardiac load on the heart.  The inflation of the cuffs during diastoleviii 
increases the volume of blood pumped back to the heart, and deflation during 
systoleix decreases the resistance and cardiac workload.  EECP occurs over 35 
sessions, each lasting one hour, usually over a seven week period.
13
  
 Research has predominantly focused on the medical benefits of EECP, such 
as measurable reductions in frequency and intensity of angina pain.
14
 However, 
research has demonstrated that the level of physical recovery is not directly linked to 
                                                          
viii The period of time when the heart refills with blood after systole 
ix Contraction of the heart 
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degree of illness severity
15
 and that psychosocial factors are also important 
determinants of CHD outcome.  Quantitative research studies have demonstrated the 
importance of psychosocial as well as physical determinants in CHD outcome.
16
  For 
example, Lett et al (2004)
17
 and Arnold (2009)
18
 found positive correlations between 
mood and frequency and severity of self-report angina, independent of CHD 
severity.  Furthermore, Petrie, Weinman, Sharpe and Buckley (1996)
19
 found illness 
perceptions after myocardial infarction (MI)x to predict future disability and return to 
work.  It is, therefore, important to understand patients' psychosocial experiences of 
CHD, in addition to physical determinants of recovery.  
There is limited quantitative research into psychosocial outcomes after EECP 
treatment.  In a pilot study, Fricchione et al (1995)
20
 found an improvement in 
overall wellbeing, whilst Springer, Fife and Lawson (2001)
21
 found an improvement 
in psychological distress, depression and anxiety.  Both studies found these 
improvements unrelated to physical recovery, suggesting an independent 
psychosocial benefit of EECP.  Further research using refractory angina patients 
found this improvement to be sustained for up to two years
22
 and five years.
23
       
Whilst quantitative research is important, it does not seek to understand 
patients' experiences of illness.  Qualitative research can increase understanding of 
these experiences and how they impact on health, wellbeing and outcome.  The use 
of less structured research methods enables development of an understanding of 
patients' experiences and perceptions of their illness.  Qualitative research, using 
methods such as interpretative phenomenological analysis (IPA)
 24
 has been used in 
health settings to investigate patients' experiences of CHD treatments, such as 
CABG
25, 26
 and PTCA.
27
 These studies have predominantly focused on hospital 
                                                          
x  A heart attack 
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patient-care experiences, and few studies have examined the effects of treatment on 
health and wellbeing.  To date, there is no qualitative research in relation to EECP 
treatment.  It is important to gain an insight into patients' experiences of this 
treatment and perceptions of the impact this treatment has on their lives. 
  Qualitative research has also been used in health settings to investigate 
patients' experiences of living with chronic illnesses, such as back pain
28
 and 
multiple sclerosis.
29
  Only one study has explored patients' experiences of living with 
angina symptoms.
30
   It was reported that angina patients developed a negative spiral 
of reduced activity and functional ability, which seemed to be partly caused by fear 
of the consequences of undertaking certain activities, such as causing further heart 
damage.   The relationship between beliefs regarding refractory angina, coping 
strategies and behaviour change has been demonstrated in the self-regulatory 
model
31
 (Figure 1), which posits that patients attempt to make sense of an illness 
threat by developing parallel cognitive and emotional representations.   
 
 
 
 
 
       
 
Figure 1. The self-regulatory model
31
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A review of the relationship between illness perceptions, mood and QoL in CHD 
patients (R. Foxwell, unpublished data, 2012) provided support for this model.  It 
seemed that in the long-term it was important to develop coping strategies and 
evaluate the effectiveness of these strategies based on psychosocial outcomes, such 
as mood and QoL.  There is limited qualitative research investigating experiences of 
living with chronic refractory angina and illness perceptions, and no research in 
relation to EECP treatment.  It is important to understand patients' perceptions of 
their illness and their experiences of living with refractory angina to improve ways 
that health professionals can help to increase QoL and recovery.   
 
Therefore, the aims of this study were to explore refractory angina patients' 
experiences of undergoing EECP, and to gain insight into their lives before and after 
the treatment.    
 
Method 
Design 
Qualitative methodology, specifically interpretative phenomenological analysis 
(IPA), was employed for the analysis and interpretation of semi-structured interview 
data.  Please see epistemological statement (Appendix 1.2).    
 
Participants 
The study used a convenience sample of participants from the Bradford Teaching 
Hospitals NHS Foundation Trust (BTHFT) Cardiology Department's EECP service.  
All patients completing the full course of EECP treatment between January and 
December 2011 were approached to participate.  All participants must have had the 
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ability to provide informed consent.  As EECP is a treatment for refractory angina 
patients, all met the inclusion criteria of having a diagnosis of refractory angina.  A 
consecutive series of eligible patients were approached by the EECP nurses as they 
neared the end of their treatment.  In total, twelve participants were approached and 
ten agreed to take part in the study.  One patient declined and the other was willing 
but subsequently could not find an appropriate time to be interviewed. 
 
Measures 
Semi-structured interviews were undertaken with ten participants.  The interview 
schedule allowed for open-ended questions to elicit information around three main 
issues (Appendix 5.1 for interview schedule).  Firstly, patient's experiences of the 
EECP treatment, which was informed by previous research investigating patient's 
experiences of cardiac treatment.
 26
  The second two areas (patient's perceptions and 
experiences of living with refractory angina both before and after the EECP 
treatment) were based on constructs of the self-regulatory model.
31
  The interview 
schedule was piloted on two people of a similar age to the average patient age in the 
service (67.7 years).  The aim of the pilot was to ensure the suitability of the semi-
structured interview questions; ensuring that the questions were open-ended enough 
to enable participants to talk about their experiences and to ensure that the questions 
were understandable.  The pilot found that the questions were suitable for the main 
research study.   Interviews lasted between 35 and 75 minutes.  All interviews were 
conducted, tape-recorded and transcribed by the researcher.  
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Procedure 
Ethical approval was obtained from County Durham and Tees Valley Research 
Ethics Committee (Appendix 2.1).   Research and Development (R&D) approval 
was obtained from Bradford Teaching Hospitals NHS Foundation Trust (BTHFT) 
(Appendix 2.2).  Patients completing EECP treatment between January and 
December 2011 were approached by the EECP nurses as they neared the end of their 
treatment.  The nurses described the study and provided information sheets 
(Appendix 5.2).  If the patient was interested in participating, and verbally agreed 
with the clinic nurses, they were contacted by the researcher via telephone to further 
discuss the study and to arrange a meeting at a time and place that was convenient 
for them.  During this discussion with the researcher it was made clear that this 
meeting would involve the completion of written consent and undertaking of an 
interview.  At the point of meeting, participants were given the opportunity to 
discuss the study further before completing the consent form (Appendix 5.3).  
Participants were informed that their interviews would be made anonymous.  At this 
stage all participants agreed to continue with the study.  At the end of the interview, 
participants were given the opportunity to be contacted by the researcher for 
feedback on the main findings via post or email.  
 
Analysis Procedure 
Ten audio-taped interviews were transcribed verbatim and allocated pseudonyms to 
anonymise.  Transcriptions were then printed out with line numbers and read over 
several times by the researcher to increase familiarity with content.  The researcher 
then analysed the data following guidelines outlined in Smith, Flowers and Larkin 
(2009).
24
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Stage one.  The transcripts were re-read and anything of significance and interest 
noted in the left hand margin.  At this stage comments were separated into 
descriptive, linguistic and conceptual comments.  Descriptive comments focused on 
the content of the participants' comments, linguistic comments explored the specific 
use of language used and conceptual comments were at a further interrogative level.  
At this stage three other independent researchers read extracts of interview 
transcripts and made initial comments according to descriptive, linguistic and 
conceptual domains.  Discussion between researchers took place to facilitate and 
formulate a consensus of main themes emerging from transcripts. 
Stage two.  Transcripts were re-read and emerging themes were documented on the 
transcripts.  Emerging themes were discussed with three other independent 
researchers.  
Stage three.  The researcher then looked for patterns in these themes and across 
different participant's themes.  Quotes from the transcripts were extracted to support 
identified themes. 
Stage four. The most relevant themes from across all 10 participants were 
synthesised and re-organised to form super-ordinate and subordinate themes.  
Discussions with a co-analyst occurred throughout the process.  
 
Results 
Descriptive Statistics 
Participants' age ranged from 50 to 80 years, with a mean of 64.2 (SD = 10.11).  All 
participants were male.  Out of the ten interviews that were undertaken, eight of the 
participants had completed the EECP treatment once (participants 1, 2, 3, 4, 5, 6, 7, 
10).  One participant had completed the treatment twice (participant 9) and one had 
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completed it four times (participant 8).  Five participants were interviewed alone 
(participants 3, 4, 5, 7, 10), whereas the remaining five were interviewed with a 
family member present (participants 1, 2, 6, 8, 9). 
 One participant did not return the demographic information sheet.  Therefore 
information about 9 of the interviewed participants is presented.  Participants were 
asked whether they have visited their GP more, less or the same amount since the 
EECP treatment.  Four participants visited their GP less than before the treatment 
and four visited the same amount.  There was only one participant that visited their 
GP more frequently.  Participants were also asked whether they take more, less or 
the same amount of medication since the EECP treatment.  Five participants took 
less medication and four took the same amount since the treatment.  
 
Themes 
Results of the analysis revealed 5 super-ordinate themes and 10 subordinate themes 
of patients' experiences of refractory angina and the EECP treatment.  A summary of 
the themes is presented in Table 1.  
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Table 1. Super-ordinate themes with corresponding sub-ordinate themes. 
Super-ordinate Themes Subordinate Themes 
Impact of angina  Different ways of coping.  
Identity 
Fear  "You just associate heart attacks, angina, 
and people die" 
Restricted  
Attitudes towards EECP  "Last chance saloon"  
Special and novel experience 
Response from others  Supported; "You're not on your own" 
Hidden disease 
Impact of EECP  "I feel now that I can do it" 
Change of focus 
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Super-ordinate theme one: Impact of angina 
Different ways of Coping 
The majority of participants interviewed used a variety of strategies that enabled 
them to cope with having refractory angina.    
 
All participants commented on how important it was to them just to keep going, and 
persevering with living with angina symptoms.   
"This is the way, you have to keep going going going" (participant 9; 392) 
 
"Some things in life where you can't stop, no matter what happens" 
(participant 4; 346) 
 
Some participants attempted to distance themselves from the angina pain by 
perceiving the angina as having a separate, alive identity of its own (personification). 
"It's got a life of its own, it flicks on and off" (participant 5; 214) 
 
"...and to me it's like, don't forget me, I'm still here, sort of thing" (participant 
4; 187-188) 
This strategy went even further with some participants, by viewing the angina pain 
as an 'enemy' and having to fight a battle against the pain.  
"I try to give fight, to make a happy self" (participant 9; 352-353) 
 
"As long as I live to fight, that's good enough" (participant 10; 218-219) 
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The majority of participants commented that they used humour as a way of coping 
with their angina.  
"Well, we can make a joke out of it, so to laugh over it, and I think it releases 
everybody's feelings being able to talk like that" (participant 2; 490-491) 
 
"Found something to laugh about... yeah, not take it too seriously.  I mean, 
it's a serious thing, I realise that, but we, we made the best of it" (participant 
3; 505-506) 
 
When directly questioned about the emotional impact of angina, many participants 
commented that they did not experience any difficult feelings. 
"Well, I never think about this, I never think about whether I have to have the 
treatment again" (participant 9; 374-375) 
 
"I'm not that sort of person, so I've never been depressed about it, I'm, I'm a 
realist" (participant 5; 384-385) 
 
Other participants focused on their difficulties mainly being around practical issues. 
"I can't go abroad because insurance is more than the flight" (participant 4; 
273-274) 
 
"Suppose I went out there and started trying to dig this garden..." 
(participant 2; 435-436) 
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However, two participants did try and verbalise the emotional impact of angina and 
the treatment and found this difficult.  
"I've been told I've got the breaking strain of a Kitkat when it comes to... and 
um... and I find it hard to explain, but it's just...within myself I feel.... better... 
than... I just... I don't know... the correct word for it..." (participant 4; 363-
364) 
 
"That was definitely... that attitude had been swept aside, no question about 
that.  There's no question about that.  And you can't put a price on that...you 
can't put it into words...this is what I'm trying to do now" (participant 7; 735-
736) 
 
Identity 
Many participants talked about what they were like before they developed heart 
disease and angina.  This was normally a portrayal of a fit and healthy person. 
"I've always been a fit person; this is what's more uh...kind of anxiety with 
me.  If I have an anxiety problem on one level with it, is I've always been fit. 
Superfit.  And I've kept full time employment with it as well" (participant 6; 
844-846) 
 
Most participants described holding stereotypical male occupations, such as 
mechanic, builder and fireman, when they were fit and healthy.  Participants 
acknowledged the difficulties of having to give up these roles since developing 
angina.  
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"I mean, I'm disappointed that uh, I lost me job through it all.  A long time 
ago I were a fireman.  I loved me job" (participant 8; 382-383) 
 
"It's the only thing I've been actually good at is working, because I enjoyed 
it" (participant 4; 616) 
 
Participants 6 and 7 seemed to be indicating that the process of developing angina 
and not working felt de-masculinising.   
"I'm just a monkey wrench now" (participant 6, 968) 
 
"So therefore, you tend to become a little bit of a couch monkey" (Participant 
7, 85-86) 
 
Super-ordinate theme two: Fear 
Participants described that prior to the EECP treatment they experienced a lot of fear 
around angina pain. 
 
"You just associate heart attacks, angina, and people die" 
Many participants commented on the significance of experiencing pain in their heart 
instead of pain in another part of their body.   
"...and it's not going to kill me, it's just pain.  And if you felt it in your leg you 
wouldn't think twice about it.  The fact that it's in your heart, you have to get 
used to the fact that each time you get it, it's not going to kill you" 
(participant 5; 109-112) 
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"cause you just associate heart attacks, angina, and people die, you know.  
Um... you don't associate with people learning to live with it, um... you just 
associate people end up dying from it, you know.  Uh... as I said, if it were 
your foot or your ankle or your knee or whatever, yeah painful, problematic 
and all the rest of it, but you don't think it's gonna kill you" (participant 5; 
249-252) 
 
Participants reported that even after being told by medical professionals that angina 
pain was not dangerous, when they got the pain, they immediately thought that it 
would develop into a heart attack and they would die.  
"... and you're sitting, waiting, and no matter what anybody tells you, like 
angina won't kill you, I could have a doctor, consultant, all the nurses, all the 
machines round me, but when you get angina, nothing, nothing stops you 
from... thinking..." (participant 4; 170-173) 
 
Restricted 
Many participants commented that their lives had become very restricted since 
developing refractory angina and that there was a barrier between themselves and the 
outside world. 
"But there is a link between angina and depression because you really do feel as 
though your life is, has become a box.  There's no way of getting out of that box, 
because to get out of it is too much, it's gonna cause pain" (participant 7; 625-629) 
 
"If you can imagine, like a bud that's closed tight, like I'm in a cocoon, I can't 
do anything"(participant 8; 346-347) 
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Participants described that the angina pain was not the cause of this restriction and 
that it was more the fear of getting the pain which they thought could lead to further 
heart damage or death.  
"I can't go somewhere if I'm thinking 'I can't go outside I'll have a heart 
attack' cause of the suffering pain you see.  And it's scary" (participant 9; 
286-288) 
 
"Well, when it restricts you, whatever you're doing, you know, if you try to 
push yourself, how far could you push yourself before you did any damage? 
You know, there's always that in your mind" (participant 8; 92-94) 
 
Participants commented that refractory angina not only had an impact on themselves, 
but also on their families.  Participants said that their family were worried about 
them. 
"They worry about me.  I know they worry about me, but I don't want them 
to" (participant 3; 772-773) 
 
This worry that was described by participants led to overprotectiveness by family 
members and further restrictions and barriers on the participants' life.  Participants 
described this as frustrating. 
"I don't need other people to do things for you.  It's very annoying for you 
when other people are trying to mollycoddle you" (participant 5; 427-428) 
 
"they want to wrap you up in cotton wool" (participant 5; 415-416) 
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Super-ordinate theme three: Attitudes towards EECP  
Participants talked at length about the time they spent with the nurses during the 
EECP treatment and what it meant to them.  
 
Last chance saloon  
Many participants commented on the number of different treatments that were now 
not available to them.   
"He suggested trying...as other options seemed to have expired, they didn't 
feel they could do any more surgery, so this was virtually the only option 
available" (participant 1; 5-6) 
 
Participants described how the EECP treatment was the only option left to them and 
that it was their last hope for improving their symptoms.   
"They all hope that it's going to be a successful treatment.  It's a bit like the 
last chance saloon really, there's not much else they can do" (participant 3; 
768-769) 
 
"So EECP were the last thing for me to go for really" (participant 8; 269-
270) 
 
Special and novel experience 
Participants described that over the course of EECP treatment, they developed a 
relationship with the nurses.  There were various aspects of this relationship that 
seemed important to participants.   
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Participants commented that they had conversations with nurses and talked with 
them during the whole process. 
"I was really impressed with them, I was.  They talk to you all the time, one of 
them talks all the time, cause to try and take your mind off the noise" 
(participant 3; 456-457) 
 
Not only did it seem important that the nurses talked to them and provided 
distraction, but they also listened to the participant in a non-judgmental, empathic 
way.   
"They talked, they'd have a laugh, you could share your life experiences.  
They were really quite understanding" (participant 4; 100-101) 
 
"Very good personal relationships... they made us... although as I said, it 
wasn't a painful experience, you still have trepidation, and uh... they just help 
you relax" (participant 1; 79-80) 
 
During the treatment, the EECP nurses provided participants with information about 
angina and treatment, which enabled them to hold realistic expectations of the 
outcome. 
"They explained uh... as to what people will gain and what wouldn't gain. It 
wasn't a, it wasn't a cure.  So they didn't give you any kind of false hope.  It 
was how they explained it, it was left up to the individual how they accepted 
it, and I accepted that it wasn't a cure" (participant 6; 381-386) 
 
76 
 
The majority of participants highlighted that the treatment was a very different 
experience to other medical treatments they had undergone, due to the relationship 
with the EECP nurses. 
"You're not just lying on a bed receiving treatment, like you are invariably if 
you go into hospital for anything else, nine times out of ten they've got some 
other, other things to do and so forth" (participant 7; 70-73) 
 
Participants were keen to emphasise the EECP treatment as being unique and only 
available to a small number of refractory angina patients every year.   
"Even now, many people they are travelling abroad to have this sort of 
treatment, you know, at their own cost" (participant 10; 79) 
 
(Talking about a local pharmacist): "He's been doing the job for the best part 
of 30 years and he'd never heard of EECP" (participant 7; 286-287) 
 
This made participants feel special and important to the team and to the nurses. 
"Well, when you see her will you tell her that cold hands sends his regards, 
she'll know who it is.  She says she's been working for eight and half years 
and this is the first time she's ever come across this" (participant 2; 95) 
 
Due to experiencing a special relationship with the team, nurses and treatment, 
participants commented that they felt some responsibility to 'spread the word' about 
EECP to ensure more people have the treatment.  
"It's a great shame, cause there's so few people that can have the treatment in 
any one year, it's a great shame more people aren't made aware of it, or are 
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becoming aware of it.  But that having been said, I, you know, as I've been 
saying we try to spread it around.  If we who've had it can try to spread it 
around" (participant 7; 203-207) 
 
Super-ordinate theme four: Response from others 
Participants frequently commented on the significance of other people and their 
views of angina.  There were positive and negative aspects that were commented on. 
 
Supported; "You're not on your own" 
The majority of participants highlighted that they underwent EECP treatment and 
lived with refractory angina with the help of family members.  Participants 
commented that family members went through the whole process with them.  
"I suppose they've come through the process with me, day by day" 
(participant 5; 449) 
 
Many participants described the importance of meeting other people that were in a 
similar situation to themselves.  Participants found it helpful to speak to other 
patients that had undergone EECP treatment. 
"He reassured, he, he did assure me that it was a good treatment, you know, 
and that kinda gave me uh... nudge further" (participant 6; 280) 
 
This made participants feel that they would like to give some reassurance and 
support to patients that were going to have the EECP treatment.   
"If you could talk to people that are going to have it done, put 'em at ease, 
like, it would be quite a good thing really" (participant 8; 197-199) 
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More widely, participants found it helpful to get support from other people living 
with refractory angina.  
"The positive side is, well not sure there's a positive side, but for all the 
people out there just the same as you that are carrying on with their lives, 
and, you know, managing it and living with it" (participant 5; 280-283) 
 
"It's been a good thing, that heart group.  A lot of people have benefitted 
from it, they've all got the same, they're all in the same boat" (participant 3; 
934-935) 
 
Participant 4 commented that hearing about people living with refractory angina 
provided a source of inspiration and motivation.   
"...you hear different stories about Ranulph Fiennes, having a heart bypass, 
running seven marathons and climbing up Mount Everest.  So I thought, well 
if he can do that, I can get back to work" (participant 4; 17-19) 
 
Support from other people was also commented to be of importance to participants.  
For example, most participants described at least one incident where other people 
had noticed a physical improvement and commented on it after the EECP treatment. 
"But certainly the people in the club have noticed, and I can't remember who 
is was now, but somebody three weeks ago said that he thought I was looking 
better as well" (participant 7; 478-480) 
 
This acknowledgement of an outwardly physical improvement made participants feel 
more confident and more positive of the effects of the treatment.  
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"Yeah they say oh you look better, your appearance is different, and you look 
more happier, and things like that.  And it also gives you positive feedback, 
which is good, you know, you feel good inside" (participant 10; 253-255) 
 
"Which made me feel better as well, when people say oh you look alright 
today, you know what I mean? (yeah) Not as grey, not as...couple of people 
have said that, especially my friends, you know what I mean?" (participant 4; 
401-405) 
 
Hidden Disease 
Participants described angina pain as a hidden disease that is not physically obvious 
to other people in comparison to other illnesses.   
"And again it's difficult, if you could see a swelling, or you could see a gash, 
or you could see a rash, you can't actually see it.  To nobody else, you know, 
nobody else can see that you've physically got it.  You know what I'm saying? 
It's not like a broken leg, people can physically see it.  You can't see it, 
there's nothing to see" (participant 5; 272-274) 
 
This led to participants feeling uneasy about being judged by other people. 
"I often feel a bit, I don't know, not uneasy about it, but people get the wrong 
impression, they don't know you, do they?  (participant 3, 327) 
 
"If they see you on a scooter, and you park it up and then get off it and go for 
a walk, they think 'what's he need a scooter for?'" (participant 3; 320-322) 
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Super-ordinate theme five: Impact of EECP 
"I feel now that I can do it" 
Many participants commented that their confidence to confront and accomplish more 
physical activities had improved since the EECP treatment.   
"Not only did it push me to do it, but also by doing it, it showed me that I 
don't need to worry so much about it for the future, so since I've come back 
I'm pushing myself that much more all the time, which is good!" and "Now 
there's no need for me to be worried, I tend to feel now that I can do it, 
whereas before, I thought I don't want to try and do it because it will hurt" 
(participant 7; 92-97) 
 
Participants also described feeling less fear surrounding developing angina pain.    
The fear factor has been removed completely from, from all of my actions, 
that relates to everything (participant 7, 400-401) 
 
These improvements in confidence enabled participants to do more activities. 
"Before, I think if somebody had asked me to go to corner shop, I'd think I 
can't manage, I can't go.  Very hard to go there.  It's not far away.  Now I can 
go 200 times now" (participant 9; 147-150) 
 
"I'm not sure that if I hadn't had the EECP, I'm not sure I would have 
undertaken to go camping with the boys" (participant 7; 567-569) 
 
These improvements also made participants feel less restricted in their lives. 
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"If you can imagine, like a bud that's closed tight, like I'm in a cocoon, I can't 
do anything, but then, I've had the...uh...EECP and I feel as though it's open 
and there's daylight there, and I feel as though it helps so much.  I feel as 
though I could do anything" (participant 8; 346-349) 
 
Change of focus 
Participants commented that since the treatment they viewed their lives differently.  
There seemed to be a shift in focus from the fear of angina pain restricting their lives 
to other factors being taken into consideration. For example, participants 
acknowledged the restrictions they have due to their age. 
"And of course, you've got to take your age into account haven't you" 
(participant 3; 280-281) 
 
"I'm not a young man anymore, and your body does have a tendency to break 
down in its energy and its health" (participant 6; 555-556) 
 
Participants also commented on other illnesses that still limited their quality of life. 
"It's the angina that has improved, yeah.  But the breathing hasn't improved a 
lot" (participant 3; 272-273) 
 
"It's me leg that I came off the machine with, not me breathing.  I could have 
gone on for a bit longer, but my leg wouldn't let me" (participant 2; 313-315) 
 
The majority of participants focused on the short-term future: 
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"But I won't give them a date, because until like the week before I'll say I'll be 
coming next week or whatever.  But I won't plan long term purely because 
it'll depend how I feel" (participant 5; 408-410) 
 
"I just take it as it...every day as it comes" (participant 3; 725-726) 
 
However, it seems that for participant 7 the treatment gave him the opportunity to 
think about the long-term future:  
"Just basically there is potentially a future ahead of me and that I need to be 
planning for it, whereas before I was thinking 'what the hell' " (participant 7; 
717-718) 
 
Although most participants focused on the short-term and conveyed an uncertainty 
of the future, they did not seem distressed by this, and were quite accepting and 
positive.  
"I know as time goes by there will be some other things which will crop up in 
the body and there will be other sort of illnesses, but I'll see, I'll wait and 
see" (participant 10; 499-501) 
 
"Well, what can we say about the future? If we knew, if we knew, if we knew 
the idea, thing, we could look forward to it" (participant 6; 860-861) 
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Discussion  
Summary of main findings 
The study sought to understand patients' experiences of living with chronic 
refractory angina before and after EECP treatment.  A further aim of the study was to 
understand patients' experiences of the process of undergoing EECP treatment.  
Some themes developed new concepts in relation to the process and outcome of 
EECP.  However, some themes provided support for existing literature in relation to 
patients with CHD and angina.  Themes will be discussed in relation to the research 
questions.    
 
1. What is life like living with chronic refractory angina pectoris? 
Impact of angina 
Participants adopted a variety of coping strategies to cope with the emotional and 
practical difficulties associated with angina.  Some participants adopted strategies 
such as stoicism and perceived the angina pain as something to fight against.  
Participants even personified the angina pain to view it as a separate identity with its 
own agenda, instead of adapting and integrating it into their own identity.  Two 
participants attempted to describe the emotional impact of angina, but found this 
difficult to verbalise, suggesting that participants rarely tried to put their emotional 
experiences into words. 
 Coping has been defined as the thoughts and actions used to manage external 
and internal demands that are perceived as challenging.
32
 Participants appeared to be 
utilising an emotion-focused coping strategy,
32
 which involves managing emotions 
associated with stress.  This coping style has been associated with poorer outcomes 
compared to problem-focused coping, which involves adopting practical strategies to 
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change stressful situations.
33
 However, research has found that emotion-focused 
coping strategies, such as emotional-distancing, are often adopted and are more 
appropriate if a situation cannot be controlled or changed, and this approach can 
specifically assist in developing and sustaining a sense of psychological wellbeing.
34
     
 Participants also used humour throughout the interviews.  This could be a 
further strategy to cope with the negative experiences and emotional reactions to 
threatening situations.
35
 However, research also suggests that humour can be a 
positive coping strategy, as it has a buffering effect on negative life events and 
reduces the experience of negative emotions.
36
 Humour has been found to facilitate 
coping and adjustment, particularly in an older male population.
37
 
 Although emotional-distancing may be an adaptive coping strategy in the 
short-term, adjustment research suggests that this may not be favourable in the long-
term.  Refractory angina is diagnosed when patients are ineligible for further 
revascularisation and angina cannot be improved through medication.
9
  This 
diagnosis will trigger a process of physical and emotional adjustment, due to poor 
control of angina symptoms and uncertainty regarding the future.
30
  Hopson and 
Adams (1976)
38
 proposed a model for successful adjustment, which included seven 
key stagesxi.  Most participants could be described as being at the minimisation stage, 
where people avoid experiencing difficult emotional reactions, such as depression 
and hopelessness, and are impeded in reaching the final adjustment stage of 
internalisation of angina into one's identity and behaviours.
38
  Participants appeared 
to be trying to hold on to their old identities.  Most described themselves as always 
being fit and healthy, holding masculine, hard-working jobs.  This contrasts to their 
                                                          
xi
  1.Immobilisation  2.Minimisation  3.Depression 4. Acceptance 5.Testing 6.Searching for 
meaning 7.Internalisation   
85 
 
chronic illness identity and may be hard to integrate and accept.
39
  Defending against 
emotional reactions and new identities are barriers to the uptake of health services 
and health behaviour change.
40
  A dual, interacting process between identity shift 
and behaviour change has been found.
41
  This highlights the importance of working 
with patients in a flexible and dynamic way to enable the process of adjustment. 
Type D (distressed) personality is associated with negative affectivity and 
social inhibition.
42
  People who have this personality trait are more likely to keep 
their negative feelings to themselves and not express them to others due to fear of 
being judged.  The present study found refractory angina patients had difficulty 
expressing their emotions and feared being judged by others.  Pedersen and Denollet 
(2006)
43
 found that Type D personality can increase risk of morbidity and mortality 
in CHD populations.  It is, therefore, important that interventions focus on 
encouraging refractory angina patients to share their negative feelings.  However, it 
should be noted that there would be a need for further research to demonstrate the 
beneficial effects of refractory angina patients expressing their negative feelings, 
perhaps through a study where half of participants were encouraged to express their 
feelings and half were discouraged. 
 
Fear 
Participants described that the fear of experiencing angina pain was a greater 
limitation than the pain itself.  Although participants knew that angina was not 
dangerous, when experiencing the pain there was an overriding cognitive focus on 
angina leading to a heart attack and death.  This has also been found in chronic pain 
populations
44
 and similar results were found by MacDermott (2002)
30
 in a study of 
patients with stable angina.  Patients displayed caution regarding physical exertion 
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due to a fear of negative consequences.  This process seems to support the fear-
avoidance model of chronic pain (FAM).
45
   This model posits that the fear of 
physical activity increasing pain, along with catastrophic misinterpretations, will 
lead to avoidance, hyper vigilance, disuse and eventually increased pain and 
disability.  In the short-term, this coping strategy of escape and avoidance is 
effective.  However, the avoidance and withdrawal from activities in anticipation of 
pain, instead of as a response to pain, can lead to increased irritability, frustration 
and depression, along with a decrease in muscular and cardiovascular usage, known 
as the 'disuse syndrome'.
46
  These factors are associated with decreased pain 
tolerance and increased pain intensity and disability.
44, 47
      
 
 
 
 
 
 
 
Figure 2. The Fear-Avoidance Model by Lethem, Slade, Troup and Bentley (1983)
45
 
Participants also described that their families experienced the same fears, which was 
causing further limitations in their lives.  Developing a chronic illness can affect the 
whole family system and can lead to a period of adjustment to maintain family 
homeostasis.
48
  Participants found that families became overprotective to cope with 
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the threat of loss of their significant other.
49
  Studies have found that perceived 
overprotection is associated with worsened psychological wellbeing,
50
 QoL
51
 and 
decreased self-efficacy.
52, 53
  Therefore, perceived overprotectiveness may lower 
patients' levels of self-efficacy for controlling symptoms and overcoming their own 
fears.  A mismatch between patients and family members' reactions and coping 
strategies can impact on recovery, particularly through health-behaviour changes.
54
  
It is, therefore, important that information given with the aim of dispelling 
maladaptive illness beliefs is shared and understood with the whole family.  
Cognitive-behavioural interventions to address the FAM
45
 should include identifying 
negative automatic thoughts, behavioural experiments to confront pain-related fear 
and relaxation techniques.     
 As all participants were male, this perception of overprotectiveness is 
consistent with existing literature on gender differences in support and adjustment,
55
 
with females more likely to be overprotective of their spouse than males. 
 
2. What are the experiences of patients undergoing EECP treatment? 
"Last chance saloon" 
Participants reported that the EECP treatment provided a last hope to improve their 
angina symptoms.  Refractory angina patients are ineligible for further 
revascularisation and medication management is already at the limit.  This can 
initiate feelings of hopelessness regarding the future.  However, there are very few 
contraindications for EECP treatmentxii, which enables most refractory angina 
patients to undergo the treatment.  Furthermore, the enthusiasm and positive 
                                                          
xii
 Severe peripheral vascular disease; arrhythmias that intervene with machine triggering; 
pregnancy; bleeding diathesis; significant aortic insufficiency 
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approach from the EECP nurses appeared to re-instil hope for the future for patients 
and their families.  Hope is a dynamic state of existential coping among patients with 
a life-threatening disease.
56
  Hope focuses on the future
57
 and has positive effects on 
outcome and recovery.
58
  Patients with renewed hope are more likely to undergo 
health behaviour change by modifying how they perceive and respond to a threat or a 
transition.
59
  Hope can also increase optimism, which has also been linked to 
improved outcomes.
60
  Although it seems crucial to renew hope in this patient 
population, participants commented that the nurses provided realistic expectations, 
which enabled them not to be disappointed when their angina was not 'cured' by the 
EECP.  Developing realistic illness beliefs can improve recovery and outcomes in 
CHD patients.
61
 This could be through boosting self-efficacy and confidence through 
the EECP treatment. 
 
Special and novel experience  
Providing realistic hope and developing a strong therapeutic alliance are strongly 
correlated, suggesting that the clinician-patient relationship is a key factor in 
fostering or diminishing hope.
62
  
Participants described developing a strong and special relationship with the 
EECP nurses that delivered the treatment.  This relationship was identified as 
different to the usual medical model clinician-patient relationship.  There were a 
variety of different aspects that seemed to contribute to this relationship, which 
seemed to be based on Rogerian core conditions
63
 of empathy, unconditional 
positive regard and congruence.  The nurses also spend 35 hours over a seven week 
period delivering the treatment, which likely also contributes to development of a 
strong therapeutic relationship.   
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 Participants described that the nurses listened, reassured, and were 
understanding and non-judgemental.  Empathic engagement in patient care has been 
found to contribute to treatment satisfaction,
64
 better compliance
65
 and clinical 
outcomes.
66
  This could be because empathy enhances mutual understanding and 
trust, which promotes honesty and a stronger congruence between patient needs and 
care plans. 
 It appears that the EECP nurses have adopted a relationship-centred model of 
care compared to the more common medical or biopsychosocial model.
67
  This 
model suggests that diagnosis is only one aspect of the relationship, and that it is 
equally important to give the patient space to articulate their concerns, discuss 
expectations, and for clinicians to show their human side.
68
  During the 35 hours of 
treatment, the nurses and patients spend time talking to each other about many 
topics, including their angina symptoms.   This space to talk enables a creation and 
recreation of reality and identity through dialogue, known as the dialogic model.
69
       
 
3. What is life like for patients after the EECP treatment? 
"I feel now that I can do it" 
After the EECP treatment, participants experienced an increase in confidence and 
self-efficacy regarding physical activity.  Participants also described that the fear of 
experiencing angina pain had reduced.  Before the treatment, participants would not 
try to push themselves physically, for fear of further heart damage.  As proposed by 
the FAM
45
 this can lead to a vicious cycle of maladaptive behaviours, including 
avoidance, disuse, depression and disability that delays recovery.
70, 71
 However, after 
the EECP treatment, participants had less fear of experiencing angina, and were 
more likely to confront activities, and not become stuck in the vicious cycle.   
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 One hypothesis for this could be participants' increase in self-efficacy.  Self-
efficacy is the belief that one can successfully perform new or difficult tasks to 
achieve a desired outcome.
72
  Chronic pain literature has found self-efficacy to 
mediate the relationship between pain-related fear and pain intensity and disability.
73
  
Woby, Urmston and Watson (2007)
74
 suggested that self-efficacy was an important 
addition to the FAM and that patients with high self-efficacy engage in more 
adaptive behaviours that aid recovery, such as exercise,
75
 with the opposite found for 
low-self efficacy.
76
  Angina is a chronic pain condition, and it appears that after the 
EECP treatment participants have managed to break free from the vicious cycle and 
engage in more adaptive behaviours through a reduction in pain-related fear and 
increased self-efficacy.  Figure 3 depicts the adaptations to the FAM.      
 
  
 
 
 
 
 
 
 
 
 
Figure 3. The Fear-Avoidance Model adapted by Woby, Urmston and Watson 
(2007)
74
 to include self-efficacy. 
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The present study adds to existing literature by proposing that the process of 
undergoing EECP treatment not only leads to physiological improvement, but also 
effects psychological pathways, through providing hope, establishing a therapeutic 
relationship and increasing confidence and self-efficacy to confront challenging 
behaviour changes.  It seems that participants gain confidence to confront 
challenging activities through a similar process to Kolb's learning cycle.
77
 Kolb 
proposed 4 learning stages, which involved experiencing an activity, reviewing the 
experience, concluding and learning from the experience and planning further goals 
from what has been learnt.  By establishing a therapeutic relationship, the EECP 
nurses seem to have provided a containing space for refractory angina patients.  This 
containment leads to an increase in functioning by reviewing patients' day-to-day 
activities during the EECP treatment and developing the confidence to set further 
goals and learn from them.  The present study suggests that EECP treatment should 
be viewed as a holistic therapeutic intervention as it impacts on both physiological 
and psychological pathways. 
 
Clinical Implications  
Refractory angina impacts on the whole family system, not just the individual.  A 
mismatch between patients' and families' reactions, adjustment and illness 
perceptions can impede recovery.
78
  Services need to ensure patients and family 
members are provided with the same information, to enable congruence between 
their illness beliefs.  A family intervention approach instead of focusing on the 
individual would be recommended.  Services should invite family members to 
undergo interventions with the patient, such as self-management programmes.  This 
could improve maintenance of health behaviour change and recovery. 
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 Instilling hope in this patient population was important and has been found to 
facilitate adaptive coping strategies.
79
 Services need to be aware of the importance of 
hope in refractory angina patients and identify, acknowledge, and participate in 
developing hope.  Providing treatments that have fewer contraindications, such as 
EECP, maintains hope and improves recovery.   
 The approach adopted by the EECP nurses allowed for a strong therapeutic 
relationship to develop with the patient, which was acknowledged as important to 
participants.  Health-care professionals delivering any treatment, including EECP, 
should adopt a relationship-centred model to develop a supportive relationship with 
the patient.  Professionals should be aware of the importance of using Rogerian 
principles,
 63
 such as empathy, attentive listening and providing reassurance.  
However, it is also important that patients are provided with realistic expectations of 
treatment outcome to ensure realistic illness perceptions.  Patients spend 35 hours 
with the EECP nurses whilst undergoing the treatment.  This time could be used to 
provide information, identify and dispel misconceptions, discuss practical problem-
solving and provide encouragement for patients to break out of the vicious cycle of 
fear-avoidance and increase confidence to increase physical activity.  Cognitive-
behavioural interventions, such as the Angina Plan
11
 aim to dispel misconceptions, 
increase activity and reduce angina frequency.  Research has found that it can 
improve the psychological and physical functioning in patients diagnosed with 
angina.
11
 Clinical psychologists could implement cognitive-behavioural 
interventions, such as the Angina Plan, whilst patients are undergoing the EECP 
treatment to establish an integrated multidisciplinary model of care and service 
delivery.  
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Participants acknowledged the importance of identifying with other patients 
in similar situations.  EECP services need to develop a support network between 
patients that have undergone the treatment.  This could be through regular support 
group meetings, or through producing a contact list of people who would be willing 
to be contacted.    
    
Methodological Limitations  
All participants interviewed in the study were male.  Therefore, the study can only 
make conclusions regarding the experiences of living with refractory angina and 
undergoing the EECP treatment for male patients.  It is unknown whether female 
patients with refractory angina have similar experiences.  However, during the time 
of recruitment, no females completed the EECP treatment.  The majority of patients 
that have undergone this treatment are male.  Research provides evidence for this 
gender bias in treatment availability
80
 and postulates that diagnostic and management 
strategies differ to the disadvantage of women.
81
        
 The study only recruited patients from one hospital, and therefore the 
majority of participants were from Yorkshire.  Tod, Read, Lacey and Abbott 
(2001)
40
 found differences in coping strategies employed based on cultural factors 
and found that South Yorkshire patients were more likely to use stoicism and avoid 
discussing emotions.  Therefore, some of the findings may be specific to the culture 
of the participants interviewed, and may not be applicable to other areas of the UK.  
 Half of the interviews were conducted with a family member present and half 
were conducted with the participant alone.  Having a family member present may 
have altered some participants' answers and responses.  Participants may have felt 
more comfortable with a family member present and therefore been more open and 
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honest, which would have increased the richness of the data.  However, participants 
may also have censored some information to protect their family member from more 
distressing information.  It was interesting to get the perspective of a family member, 
but this was not a research question and may have limited the validity of some of the 
participants' answers.   
 A further limitation of the study is the validity and reliability of qualitative 
research data collection and analysis.
82
  Interpretation of the interview transcripts is 
dependent on the biases and experiences of the researcher and the results can reflect 
the researcher as much as the researched.
83
  However, IPA has been shown to be 
particularly suitable to health psychology research.
84
  The researcher attempted to 
limit the influence of biases through reflection of personal biases and discussion of 
transcripts and themes with three independent researchers.  Quotes were found from 
transcripts to support themes identified.  
 
Future Directions 
It would be important to gain an understanding of female patients' experiences of 
living with refractory angina and undergoing EECP treatment.  This would enable 
comparisons of experiences between genders.  There is a growing evidence base that 
male and female patients with CHD have differing medical and psychological 
profiles.
85
 Therefore it would be important to investigate gender experiences 
separately.  Furthermore, a multi-centre study across multiple hospitals in the UK 
would enable comparison between cultures.   
 The study highlighted the importance of family members in outcomes of 
refractory angina.  Future research should further investigate family members' 
experiences of living with a patient with refractory angina and the impact of EECP 
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treatment on the family system.  It would be interesting to compare the congruence 
between patients' and family members' experiences of this process.  
 It would be important to research the relationship between pain-related fear, 
self-efficacy and chronic pain severity in refractory angina patients using 
quantitative methodology.  Studies have clarified this relationship in the context of 
the adapted FAM
74 
with various chronic pain populations.
73
  However, this has not 
been investigated with refractory angina pain patients.  Future research should also 
investigate the changes in pain-related fear and self-efficacy before and after EECP 
treatment.  It would also be important to investigate the relationship between these 
constructs and outcomes, such as physical and emotional quality of life after the 
treatment.  However, it must be noted that any randomised controlled trials into 
EECP need to account for the level of attention and time patients receive from the 
EECP nurses as this is potentially a confounding factor.  
 
Conclusion 
The current investigation sought to understand the experiences of refractory angina 
patients before, during and after EECP treatment.  Participants described being 
limited in their lives by pain-related fear from themselves and their families.  
However, during the treatment, there was a reduction in pain-related fear and an 
increase in confidence and self-efficacy.  This enabled participants to break free 
from the vicious cycle of fear-avoidance and confront previously avoided activities.  
The present study adds to existing literature by proposing that the process of 
undergoing EECP treatment not only leads to physiological improvement, but also 
effects psychological pathways, through providing hope, establishing a therapeutic 
relationship and increasing confidence and self-efficacy to confront and undertake 
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challenging behaviour changes.  It is recommended that the time spent undergoing 
EECP treatment be used to implement cognitive-behavioural interventions, such as 
the Angina Plan
11
 to provide information, identify and dispel misconceptions and 
discuss practical problem-solving and adaptive coping strategies.        
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Abstract 
Background: The relationship between illness perceptions and outcome has been 
shown to be significant across various chronic illnesses at the beginning and middle 
stages of CHD progression.  However, this relationship has not been investigated for 
refractory angina patients. 
Objectives: To investigate the relationship between illness perceptions, mood and 
quality of life (QoL) in chronic refractory angina patients that have undergone EECP 
treatment.   
Methods:  A consecutive series of refractory angina patients that had undergone 
EECP treatment completed and returned postal questionnaires measuring illness 
perceptions, mood and QoL.   
Results: Spearman's Rho correlations highlighted significant relationships between 
illness perceptions, mood and QoL.  Hierarchical regression analysis found 
emotional representations predicted anxiety, depression and emotional QoL.  
Perceived consequences predicted depression and physical QoL, and personal 
control predicted physical QoL.  Significant differences in specific illness 
perceptions were found to be dependent on age, gender, time since treatment and 
number of treatments completed.      
Conclusions: The current study supports constructs from relevant models; the self-
regulatory model
15
, theory of planned behaviour
62 
and an adapted version of the fear-
avoidance model
64
.  A possible model demonstrating the process between illness 
perceptions and outcomes specific for chronic refractory angina patients is proposed.  
Future research could focus on concomitant interventions to improve physical and 
psychological outcomes, for example the Angina Plan could be delivered in 
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conjunction with EECP to establish an integrated, multidisciplinary model of care 
and service delivery.   
 
Keywords: anxiety; chronic refractory angina; depression; enhanced external 
counterpulsation treatment; illness perceptions; quality of life.   
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Coronary heart disease (CHD) is caused by a build up of atheroma,
xiii
 leading to 
narrowing of the arteries and restricting blood flow to the heart.  CHD is the leading 
cause of mortality in the UK, causing approximately one in five male and one in 
eight female deaths.
1
 The prevalence of CHD is increasing annually,
2
 leading to an 
increase in the number of patients experiencing CHD symptoms, such as angina 
pectoris.
xiv
  This increase has led to a continuing rise of societal burden and cost to 
the NHS.
3
  Allender et al (2008)
4
 estimated that in 2006 the total cost of CHD to the 
UK was approximately £9 billion.  These statistics highlight the importance of 
research to investigate the most effective methods of prevention, diagnosis, treatment 
and recovery in this patient population.     
Although there are widely reported physical determinants in the development 
and outcome of CHD, such as age, obesity, genetics and diabetes,
5, 6
 there is no 
linear relationship between physical severity and outcome.  Patients with similar 
levels of heart disease vary widely in the severity of their experience of angina 
pain.
7, 8
  Thus, psychosocial factors are also important in determining the outcome of 
CHD, such as locus of control (LoC),
9
 self-efficacy,
10
 coping strategies,
11
 social 
support,
12
 mood
13
 and illness perceptions.
14
    
The most widely cited model explaining the association between illness 
perceptions and outcomes is the self-regulatory model.
15
 This model posits that 
patients attempt to make sense of an illness threat by developing parallel cognitive 
and emotional representations.  These representations are organised around five core 
dimensions; beliefs about illness symptoms (Identity), expected duration (Timeline), 
                                                          
xiii
 An accumulation of fat deposits in the artery walls  
xiv
 The most common symptom of CHD, with pain across the chest, shoulders, back, arms 
and jaw.  This pain is due to a lack of blood supply and oxygen to the heart  
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causal factors (Cause), illness effects (Consequences) and the extent to which the 
illness can be controlled or cured (Control/Cure).  Subsequent research has 
highlighted the importance of patients' beliefs that their illness makes sense (Illness 
Coherence), which has become an additional core dimension.
16
  These 
representations provide a conceptual framework for patients to develop coping 
strategies and evaluate outcomes of these approaches (see Figure 1).    
       
Figure 1. The self-regulatory model
15
 
The constructs of the self-regulatory model have been supported by a meta-analytic 
review.
17
  This review included various chronic illnesses, such as chronic fatigue 
syndrome (CFS)
 18
 and chronic obstructive pulmonary disease (COPD).
19
  A range of 
outcomes were also investigated, including psychological wellbeing
20
 and quality of 
life (QoL).
21
  Although CHD patients were not included in the review, subsequent 
research has demonstrated the relationship between illness perceptions and outcomes 
in CHD population, such as mood
22
 and QoL.
23
  As mood and QoL are both strong 
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psychosocial predictors of CHD
24
 and are independently associated with morbidity 
and mortality,
25
 they are important outcome measures to be researched.    
Research has predominantly focused on the relationship between illness 
perceptions, mood and QoL in CHD patients at the beginning and middle stages of 
the disease course.  For example research has been conducted after an initial 
myocardial infarction
xv
 (MI) 
26, 27
 and after pre-planned surgical interventions, such 
as coronary artery bypass graft
xvi
 (CABG) 
28
 and percutaneous transluminal coronary 
angioplasty
xvii
 (PTCA).
29
 No studies, to date, have investigated this relationship in 
patients experiencing chronic, refractory angina pectoris.  Refractory angina occurs 
in patients when CHD chest pain cannot be adequately controlled through 
medication management and revascularisation procedures.
30
   This is more likely to 
occur in patients that have experienced a long history of CHD
31
 and is occasionally 
described as 'end-stage coronary artery disease'.
30 p355
  It is an important area to 
investigate as previous research has shown that refractory angina patients potentially 
hold maladaptive beliefs and misconceptions regarding their illness, which may 
subsequently impact on their health, QoL and mood.
32
   
A systematic literature review (R. Foxwell, unpublished data, 2012) reported 
differences in the strength of the relationship between specific illness perceptions 
with mood and QoL dependent on the stage of disease course and progression.  For 
example, patients' beliefs regarding their degree of illness control was a significant 
determinant of mood and QoL in patients that had experienced an unexpected 
                                                          
xv
 A heart attack 
xvi
 A surgical intervention that involves removing arteries or veins from other parts of the 
body and using them to bypass blocked arteries.   
xvii
 A surgical intervention that involves inflating a balloon within the coronary artery to 
increase blood supply to the heart.  
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medical event, such as a first MI, but not in patients that had lived with CHD for 
longer.  Illness perceptions are thought to be changeable with time and experience.  
Therefore different beliefs at various stages of CHD may be more important 
determinants of mood and QoL outcomes.  As this relationship has not been 
investigated in patients that have experienced CHD for a longer period of time, such 
as patients with refractory angina, it is important to identify the specific illness 
perceptions that may impact on these outcomes.     
Enhanced External Counterpulsation treatment (EECP) is a non-invasive 
treatment for chronic refractory angina.  Although there is limited availability for 
this treatment in the UK, it is widely used in North America on refractory angina 
patients,
30
 and is included in the SIGN guidelines on managing angina symptoms.
33
  
EECP involves wrapping paired compressible cuffs around the calves, lower and 
upper thighs, which are attached to an EEG machine and subsequently inflate and 
deflate in accordance with the cardiac cycle.  Both the inflation and deflation of the 
cuffs reduces cardiac load on the heart.  The inflation of the cuffs during diastole
xviii
 
increases the volume of blood pumped back to the heart, and deflation during 
systole
xix
 decreases the resistance and the cardiac workload.  EECP occurs over 35 
sessions, each lasting one hour over a seven week period.
34
 
Although research has predominantly focused on the physical benefits of 
EECP,
 35
 a number of studies have examined QoL and mood outcomes after the 
treatment.  The Multicenter Study of Enhanced External Counterpulsation trial 
(MUST-EECP)
 36
 found QoL improved in patients that had undergone EECP 
compared to a sham treatment.  This improvement was found across all QoL 
                                                          
xviii
 The period of time when the heart refills with blood after systole 
xix
 Contraction of the heart 
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parameters and was sustained at a 12-month follow-up.
37
  Further research using 
refractory angina patients found this improvement to be sustained for up to two 
years
38
 and five years.
39
  This sustained improvement was not found in heart failure 
patients,
40
 suggesting that it could be specific to refractory angina.  Studies have also 
found improvements in psychological wellbeing and mood.  In a pilot study, 
Fricchione et al (1995)
41
 found an improvement in overall wellbeing, whilst 
Springer, Fife and Lawson (2001)
42
 found an improvement in psychological distress, 
depression and anxiety.  Both studies found these improvements unrelated to 
physical recovery, suggesting an independent psychosocial benefit of EECP.    
No research has examined the illness perceptions of patients that have 
undergone EECP nor investigated the relationship between illness perceptions, mood 
and QoL in patients with chronic refractory angina.  It is important to know which 
illness perceptions have the strongest relationship with mood and QoL to enable the 
development of interventions to address specific maladaptive beliefs.     
 
The primary aim of the present study was to investigate the relationship between 
illness perceptions, mood and QoL in chronic refractory angina patients who had 
undergone EECP treatment.   
 
It was hypothesised that anxiety and depression would positively correlate with 
increased severity of illness perceptions.  With regards to QoL, it was hypothesised 
that physical and emotional QoL would negatively correlate with an increase in 
maladaptive illness perceptions.  Negative illness perceptions may be significant 
predictor variables for mood and QoL, however it was uncertain which beliefs would 
significantly predict these outcomes in this patient population. 
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Method 
Design 
The study employed a cross-sectional, non-experimental design.  Questionnaire data 
were analysed quantitatively.   
 
Participants 
Participants were recruited through the Bradford Teaching Hospitals NHS 
Foundation Trust (BTHFT) Cardiology Department's EECP service at Bradford 
Royal Infirmary (BRI).  All participants who had completed the full EECP treatment 
at least once under the care of the consultant cardiologist were sent postal 
questionnaires (n=137).  All 137 patients met the inclusion criteria (diagnosis of 
refractory angina at the time of treatment
xx
, the cognitive ability to give full consent 
and be able to read fluent English).  A questionnaire completion rate of 81 was 
achieved (59% response rate).  Twelve participants were too ill to complete the 
questionnaire and 44 participants were uncontactable.  See Figure 2 for flow chart of 
recruitment process. 
 
 
 
 
                                                          
xx
 This was a necessary requirement of the treatment.  A diagnosis of refractory angina 
requires the following 1) Presence of stable angina 2) Presence of CHD on a recently 
performed angiogram 3) Experience of severe angina despite optimal conventional anti-
anginal medical therapy 4) Functional class 3-4 according to the Canadian Cardiovascular 
Society classification (CCS) 5) Not accessible for conventional revascularisation procedures.  
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Figure 2. Participant recruitment process.  
Measures 
The postal pack contained a patient information sheet, consent form, bespoke 
demographics form and three measures.  
  
Demographics Form 
Demographic information was age and gender.  Two further questions examined 
whether the participant had visited their GP and/or taken medication more, the same 
or less than before the EECP treatment to obtain a broad overview of cost-benefit of 
EECP.  Details about EECP participants (e.g. number of completed treatment 
sessions and time since completion) were obtained from patient records by clinic 
nurses.   
 
The 12 Item Short-Form Health Survey (SF12v2)
43
 
The SF12v2 is a 12 item scale that measures QoL on two separate domains; physical 
functioning (PCS) and psychological wellbeing (MCS) (Appendix 6.2).  However, 
Total N = 81 
(59%) 
N = 12 too ill (9%) 
N = 44 uncontactable (32%) 
 
170 completed 
EECP treatment 
N = 137 
(100%) 
N = 33 died. 
Inclusion and 
exclusion criteria 
criteria 
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throughout the paper, the physical functioning subscale will be referred to as 
physical QoL (PQoL) and the psychological wellbeing subscale will be referred to as 
emotional QoL (EQoL) for ease of interpretation. The SF12v2 produced norm based 
scores with a mean of 50 (SD=10).  Scores below 50 on both subscales indicate a 
below-average physical or mental health.  The SF12v2 is a shortened version of the 
SF36 and has been found to closely mirror the strong psychometric properties of this 
measure.
43, 44
 Both the PCS and MCS were shown to have high internal reliability, 
with Cronbachs alpha greater than 0.80 for both.
45
 The SF-12v2 has also been widely 
used to assess QoL in other cardiac patients
46
 and the shortened version lessens the 
questionnaire load on participants.  
 
The Hospital Anxiety and Depression Scale (HADS)
 47
  
The HADS is a 14-item self-report questionnaire measuring the symptoms of 
depression and anxiety (Appendix 6.1).  Each question is rated on a 4-point scale 
ranging from an absence of symptoms to frequent symptom experience.  Both HADS 
anxiety and depression scales have good internal consistency, with Cronbach's alpha 
for anxiety ranging from 0.68 to 0.93 and depression from 0.67 to 0.90.
48
 The HADS 
has been used extensively and found to be valid in cardiac populations,
49, 50
 and has 
been recommended as a screening tool for psychological distress in CHD patients by 
the NSF Clinical Guidelines.
51
 
 
The Revised Illness Perception Questionnaires (IPQ-R)
 16
  
The IPQ-R comprises of 70 items assessing the cognitive representations of illness, 
as proposed by the self-regulatory model
15
 (Appendix 6.3).  The IPQ-R measures 
illness perceptions across 9 subscales.  Higher scores on five of these subscales 
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indicates that participants perceive their CHD to be more chronic, severe, variable, 
distressing and identify more symptoms to their illness: identity (14), timeline 
acute/chronic (6), timeline cyclical (4), consequence (6), emotional representations 
(6).  Higher scores on three subscales indicate more positive representations, with the 
participant perceiving more control and understanding of their illness; personal 
control (6), treatment control (5), coherence (5).  The cause subscale (18 items) was 
excluded from analysis due to not reaching the required number for validly analysing 
this subscale (n>85).
16
 
The IPQ-R provides a psychometrically acceptable assessment of patient's 
appraisals of illness and has demonstrated good internal consistency, with 
Cronbach's alpha ranging from 0.79 for timeline cyclical to 0.89 for timeline 
acute/chronic subscale.
16
 The IPQ-R has been widely used to assess illness beliefs in 
chronic illness populations, including CHD groups, and to predict adjustment and 
outcomes after treatment.
52, 53
 
 
Procedure 
Ethical approval was obtained from County Durham and Tees Valley Research 
Ethics Committee (Appendix 2.1).  Research and Development (R&D) approval was 
obtained from Bradford Teaching Hospitals NHS Foundation Trust (BTHFT) 
(Appendix 2.2).  Participants were recruited via BTHFT Cardiology Department's 
EECP nurses and consultant cardiologist who provided the researcher with contact 
details of patients who met the inclusion criteria.  Potential participants were sent the 
questionnaire packs.  Completion of measures and return via a stamped addressed 
envelope was taken as indicative of consent (see Appendix 6.5 and 6.6 for 
information sheets and consent forms).  Potential participants who had not returned 
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packs after 1 month were contacted by telephone to query if they had any questions 
or concerns about the study.  51 participants then returned completed questionnaires.   
 
Data Analysis 
Data was analysed using SPSS 19.0.  Spearman's rho correlations were conducted to 
examine relationships between affect, QoL and illness beliefs due to skewed 
distributions.  Mann Whitney U tests were used to examine differences between 
gender and the number of completed EECP treatments.  Stepwise Hierarchical 
regression was used to examine illness beliefs as predictor variables of QoL and 
affect. 
  
Sample Size Calculation 
Sample size was calculated based on a multiple regression power analysis.  For a 
significant effect when adding in mood, Qol, time since treatment and illness beliefs 
(a total of 10 variables) into a hierarchical regression analysis, a sample size of 59 
was needed to detect an effect size of 0.2, with a 5% significance level and 80% 
power.  However, when affect, time since treatment and illness beliefs were 
separately analysed in a hierarchical regression analysis, a sample size of 81 was 
needed to detect a significant effect size, with a 5% significance level and 80% 
power. 
 
Results 
Variable distributions were tested using Shapiro-Wilk test of normality.  Physical 
QoL, emotional QoL and certain IPQ-R scales (identity, personal and treatment 
control, timeline cyclical and emotional representations) were found to be normally 
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distributed.  However, anxiety, depression and certain IPQ-R scales (timeline 
chronic, consequences and illness coherence) were not normally distributed (see 
Appendix 6.8).  Therefore, non-parametric statistical tests were employed for these 
variables. 
 
Sample Characteristics 
Participants' age ranged from 46 to 87 years, with a mean of 67.7 (SD = 9.4).  This 
was not significantly different to a previous UK CHD sample
54
 (t (415) = 0.192, 
p>.05).  Participant's ages were grouped into five categories (41-50, 51-60, 61-70, 
71-80, 81+).  The highest percentage of participants was aged 71-80 (40%).  No 
significant difference was found between the average age of responders and non-
responders (t (119) = 0.2131, p>.05).   
A high percentage of participants were male (92.6%).  Although this 
proportion is higher than the CHD population in the UK (66.6%),
 54
 it is similar to 
previous studies recruiting EECP patients, suggesting that more males undergo this 
treatment.  The percentage of male and female participants did not differ between 
responders and non-responders (2 (1, N = 137) = 0.00, p = 1.00). 
A high percentage of participants were White British (84%).  The remaining 
participants were from a South Asian culture (16%).  The percentage of South Asian 
and White British participants did not differ between responders and non-responders 
(2 (1, N = 137) = 1.105, p = .293). 
Participants were asked whether they had visited their GP more, less or the 
same amount since the EECP treatment.  The highest percentage of participants 
visited their GP the same amount (49.4%), with the lowest percentage visiting their 
GP more since the treatment (13.6%).  Participants were also asked whether they 
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take more, less or the same amount of medication since the EECP treatment.  The 
highest percentage of participants took the same amount of medication (61.7%), with 
the lowest percentage of participants taking more medication (16%).  See Table 1 for 
frequencies of visiting GP and taking medication.    
Table 1. Frequencies of visiting GP and taking medication 
 Less Same More 
 
Visited GP, % (n) 
 
 
37.0 (30) 
 
49.4 (40) 
 
13.6 (11) 
Taken Medication, % (n) 22.2 (18) 61.7 (50) 16 (13) 
 
The majority of participants had only completed the EECP treatment once (81.5%).  
However, one participant had completed the treatment four times (1.2%).  The length 
of time between finishing the EECP treatment and completing the questionnaire 
packs were calculated based on information provided by the EECP nurses.  The 
number of months ranged from 0-92, with a mean of 32.7 (SD=25.1).  Participants 
were grouped into four categories (0-2 years, 2-4 years, 4-6 years, and 6-8 years).  
The highest percentage of participants had completed the treatment within 0-2 years 
(49.4%).  See Table 2 for frequencies of length of time since completion of EECP. 
Table 2. Time since treatment 
Time since treatment (years) Percentage (n) 
  
0-2 49.4 (39) 
2-4 19.0 (15) 
4-6 24.1 (19) 
6-8 7.6 (6) 
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A one-way ANOVA found no significant difference in the length of time since 
completing EECP between participants rating the frequency of GP visits as more, 
less or the same amount (F (2,73) = 0.432, p=.651) and medication taken (F(2, 73) = 
0.833, p=.439).  
 
Time since CHD Diagnosis 
The EECP nurses searched patient files to obtain information regarding the number 
of years since CHD diagnosis.  This information was available for 53 out of the 81 
participants.  The remaining participants' information was not explicitly stated in the 
medical notes.   
 Number of years since diagnosis ranged from 2-30, with a mean of 16.9 years 
(SD = 7.49).  A one-way ANOVA found no significant difference in the length of 
time since CHD diagnosis for participants rating the frequency of GP visits as more, 
less or the same amount (F (2,50) = 1.381, p=.261) and medication taken (F(2, 50) = 
0.900, p=.413).  
   
Emotional Distress  
Mean score on HADS Anxiety subscale was consistent with the UK CHD population 
(t (415) = 0.211, p>.05).
54
 Mean score on the HADS Depression subscale was 
significantly higher than a previous UK CHD sample (t (415) = 5.484, p<.05).
54
 See 
Table 3 for descriptive statistics of this measure.   
 
Quality of Life  
The mean score on the SF12v2 physical QoL subscale was 28.5 (SD = 10.2).  The 
results ranged from 9.2-49.9.  Scores below 50 on this scale indicate below average 
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physical QoL in the national population, suggesting that all participants reported 
themselves as experiencing lower than the average general population for physical 
QoL.  The mean score on the SF12v2 emotional QoL subscale was 47.7 (SD = 11.1).  
The results ranged from 23.8-74.0.  This suggests that, on average, participants were 
experiencing typical levels of emotional QoL compared to the average score in the 
general population.  See Table 3 for descriptive statistics of this measure.   
 
Illness Perceptions  
Table 3 shows descriptive statistics for the IPQ-R individual subscales.  The number 
of participants decreased to 76 due to missing data; 5 participants did not complete 
the IPQ-R questionnaire section.  Although results cannot be compared to normative 
data (as the general population cannot be assumed to have an illness), mean IPQ-R 
scores are nearer maximum possible scores, suggesting that participants experience 
maladaptive illness perceptions.   
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Table 3. Descriptive statistics of outcome measures. 
 Maximum 
Possible 
Score 
 
Minimum 
 
Maximum 
 
Mean (SD) 
 
N 
 
HADS Anxiety 
 
21 
 
0 
 
17 
 
6.2 (4.7) 
 
81 
HADS Depression 21 0 14 6.7 (3.9) 81 
SF12v2 PCS 100 9.2 49.9 28.5 (10.2) 81 
SF12v2 MCS 100 23.8 74.0 47.7 (11.1) 81 
Identity 14 0 13 5.18 (2.99) 76 
Time (acute/ 
chronic) 
30 9 30 25.68 (4.75) 76 
Consequence 30 11 30 23.01 (4.84) 76 
Personal Control 30 6 30 19.71 (4.24) 76 
Treatment Control 25 5 24 16.26 (3.30) 76 
Coherence 25 5 25 19.79 (4.371) 76 
Time Cycle 20 4 20 12.45 (3.48) 76 
Emotional 
Distress 
30 6 29 17.42 (5.62) 76 
 
IPQ-R scores were compared to other cardiac patient groups; patients that had 
experienced an MI,
 27
 undergone CABG
55
 and diagnosed with acute coronary 
syndrome (ACS).
56
 The results of this comparison are displayed in Table 4.  
Refractory angina patients viewed their illness as significantly more chronic and 
variable in nature compared to other cardiac patients.  They also perceived that their 
illness would have significantly greater consequences and that they have 
significantly lower personal and treatment control compared to patients with MI, 
CABG and ACS.   
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 However, refractory angina patients had significantly greater illness 
coherence than patients experiencing MI, but no significant difference versus 
patients undergoing CABG.  There was no significant difference in scores on 
emotional distress across cardiac populations. 
Table 4. IPQ-R Mean (SD) Scores compared with cardiac populations.  
 Refractory 
Angina (n = 
76) 
Myocardial 
Infarction 
(n = 204) 
CABG 
(n = 56) 
Acute Coronary 
Syndrome (n = 
661) 
 
Time (acute/ 
chronic) 
 
25.68 (4.75) 
 
20.01 (5.39)** 
 
13.31 (5.14)** 
 
18.37 (5.22)** 
Consequence 23.01 (4.84) 18.18 (4.61)** 19.91 (4.35)** 19.88 (4.37)** 
Personal 
Control 
19.71 (4.24) 21.26 (3.94)** 23.50 (3.35)** 24.18 (3.72)** 
Treatment 
Control 
16.26 (3.30) 18.08 (3.22)** 21.11 (3.08)** 19.69 (2.67)** 
Coherence 19.79 (4.37) 17.12 (3.92)* 19.33 (4.19) Not measured 
Time Cycle 12.45 (3.48) 10.80 (2.89)** Not measured 10.98 (3.19)** 
Emotional 
Distress 
17.42 (5.62) 16.65 (4.80) 18.20 (4.45) Not measured 
* p< .05, ** p< .01 
CABG: Coronary Artery Bypass Graft 
Spearman's Rho correlations were used to examine the relationship between illness 
perception variables (see Table 5).  When participants believed that there were 
severe consequences to having CHD and refractory angina, they perceived the illness 
as having more symptoms, to be chronic in nature and experienced the illness as 
more distressing.  In contrast, when participants viewed their illness as having less 
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severe consequences, they perceived their illness to be more controllable (personal 
and treatment control). 
Table 5. IPQ-R Subscale Correlations (p values).  
 
IPQ-R 
 Subscales 
(n = 76) 
 
Identity 
 
Time 
(Acute/ 
Chronic) 
 
Conseq- 
uence 
 
Personal 
Control 
 
Treatment 
Control 
 
Coherence 
 
Time 
Cycle 
 
Emotional 
Distress 
Identity -        
Time (Acute/ 
Chronic) 
.282* 
(.014) 
-       
Consequence 
 
.585** 
(.000) 
.581** 
(.000) 
-      
Personal 
Control 
.238* 
(.039) 
-.243* 
(.034) 
-.400** 
(.000) 
-     
Treatment 
Control 
-.275* 
(.016) 
-.321** 
(.005) 
-.400** 
(.000) 
.256* 
(.026) 
-    
Coherence 
 
-.044 
(.706) 
.376** 
(.001) 
.094 
(.419) 
.017 
(.887) 
.017 
(.884) 
-   
Time Cycle 
 
.141 
(.224) 
-.047 
(.687) 
.261* 
(.023) 
-.043 
(.711) 
.023 
(.846) 
-.144 
(.213) 
-  
Emotional 
Distress 
.237* 
(.039) 
-.022 
(.852) 
.407** 
(.000) 
-.317** 
(.005) 
-.020 
(.862) 
-.218 
(.059) 
.327** 
(.004) 
- 
*p<.05, **p<.01 
 
Emotional Distress and Illness Perceptions 
Spearman's Rho correlations were used to examine the relationship between illness 
perceptions and anxiety and depression.   
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Anxiety 
Participants that had more symptoms of anxiety perceived more symptoms 
associated with their illness (identity), more severe consequences, higher emotional 
distress and lower perceived personal control over their illness.  There were no other 
significant correlations (see Table 6). 
 
 Depression 
Participants that experienced higher levels of depression identified more symptoms 
associated with their illness (identity), more severe consequences and higher 
emotional distress.  Furthermore, participants with more depressive symptoms 
perceived their illness to be less controllable (treatment and personal) and less 
understandable (illness coherence).  There were no other significant correlations (see 
Table 6). 
 
Table 6. Correlations between IPQ-R and HADS anxiety and depression (p values)    
*p<.05, **p<.01 
 
Quality of Life and Illness Perceptions 
Spearman's Rho correlations were used to examine the relationship between illness 
perceptions and physical and emotional quality of life. 
 Identity Time 
acute/ 
chronic 
Conseq- 
uences 
Personal 
control 
Treatment 
control 
Coherence Time 
cycle 
Emotional 
Distress 
HADS 
Anxiety 
.365** 
(.001) 
-.018 
(.880) 
.463** 
(.000) 
-.283* 
(.013) 
-.098 
(.399) 
-.160 
(.167) 
.232* 
(.044) 
.749** 
(.000) 
HADS 
Depression 
.433** 
(.000) 
.154 
(.184) 
.544** 
(.000) 
-.243* 
(.035) 
-.228* 
(.048) 
-.228* 
(.047) 
.144 
(.215) 
.490** 
(.000) 
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Physical QoL   
The better the participants physical QoL, the more control they perceived to have 
over their illness (treatment and personal).  It was also found that participants that 
experienced lower physical QoL identified more symptoms associated with their 
illness, perceived their illness to be chronic in nature and have greater severity of 
consequences.  There were no other significant correlations (see Table 7).  
 
Emotional QoL 
The better the participants emotional QoL, the more personal control they perceived.  
However, treatment control was not significantly correlated.  Participants that 
experienced lower emotional QoL identified more symptoms associated with their 
illness (identity) had greater severity of consequences, perceived their illness to be 
emotional distressing and more cyclical in nature.  There were no other significant 
correlations (see Table 7). 
 
Table 7. Correlations between IPQ-R and Physical and Emotional QoL (p values) 
*p<.05, **p<.01 
 
 
 
 Identity Timeline 
acute/ 
chronic 
Conseq 
uences 
Personal 
control 
Treatment 
control 
Coherence Time 
Cycle 
Emotional 
Distress 
SF12
v2 
PCS 
-.330** 
(.004) 
-.416** 
(.000) 
-.559** 
(.000) 
.449** 
(.000) 
.402** 
(.000) 
-.053 
(.652) 
.017 
(.882) 
-.115 
(.322) 
SF12
v2 
MCS 
-.423** 
(.000) 
-.012 
(.917) 
-.444** 
(.000) 
.273* 
(.017) 
.034 
(.773) 
.127 
(.272) 
-.258* 
(.025) 
-.638** 
(.000) 
128 
 
Age 
Spearman's Rho correlations were used to examine the relationship between 
participants' age and illness perceptions, anxiety and depression.  Significant 
correlations were found for 5 out of the possible 12 variables.  As age increased, 
perceptions of personal and treatment control significantly increased (r = 0.299, p = 
.009; r = 0.253, p=.028).  There were also significant negative correlations between 
age and consequences (r = -0.311, p=.006), emotional representations (r = -0.309, 
p=.007) and timeline chronic (r = -0.313, p=.006).  The older the participants were, 
the better perceptions they had over the consequences and chronicity of their illness 
and their emotional reaction to it.       
 
Time since Treatment 
Spearman's Rho correlations were used to examine the relationship between the time 
since participants completed the EECP treatment and illness perceptions, anxiety and 
depression.  As the time since EECP completion increased, the less variable 
participants perceived their angina symptoms to be (r = -0.242, p=.035).  No other 
significant correlations were found. 
 
Gender 
A series of Mann Whitney U tests were used to determine any differences between 
gender in QoL, emotional distress or illness perceptions.  Significant differences 
were found for the identity subscale (U (75) = 126.5, Z = -2.076, p=.038), with males 
attributing more symptoms to their heart disease than females.  No other significant 
differences were found.  
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Number of Times Completed Treatment 
A series of Mann Whitney U tests were used to determine any differences between 
the number of times participants had completed the EECP treatment in QoL, 
emotional distress or illness perceptions.  Participants were divided into whether 
they had completed the treatment once or more than once.  Significant differences 
were found for the amount of perceived personal control of participants (U (75) = 
301.5, Z = -2.045, p=.041), with those completing the treatment once having higher 
perceptions of personal control.  Significant differences were also found for physical 
QoL (U (80) = 271.0, Z = -2.434, p=.015), with those completing the treatment once 
having a higher perception of physical QoL.  
 
Predictors of Quality of Life and Distress 
Residual plots from all hierarchical multiple regression models were checked to see 
whether the normality regression modelling assumptions were met.  These 
assumptions were met for anxiety, depression and physical QoL.  However, residual 
plots were slightly skewed for emotional QoL.  Therefore it could not be assumed 
that the residuals were normally distributed and a bootstrap analysis was performed 
to get revised p-values for the independent variables 
Age, gender and time since treatment were controlled.  Illness perceptions 
(identity, timeline acute/chronic, consequences, personal control, treatment control, 
illness coherence, timeline cyclical and emotional representations) were entered into 
the regression analyses as predictor variables of distress (anxiety and depression) and 
QoL (physical and emotional QoL).   
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Anxiety 
After adding 8 illness perceptions to the model, 63.1% of HADS anxiety variance 
was accounted for (R² = 0.631, F (11, 64) = 9.95, p<.001).  On examining the tests of 
the individual variables, only emotional representations contributed significantly (β 
= 0.571, SE = 0.082, t = 6.94, p<.001).  When the 8 illness perceptions were added 
into the regression individually, 4 predictors were found to be statistically significant 
(personal control, identity, emotional representations and consequences).  However, 
when the 4 predictors were added together, only emotional representations remained 
statistically significant (β= 0.560, SE = 0.071, t = 7.851, p<.001)  
 
Depression 
After adding 8 illness perceptions to the model, 46.7% of HADS depression variance 
was accounted for (R² = 0.467, F (11, 64) = 5.10, p<.001).  On examining the tests of 
the individual variables, consequences (β = 0.384, SE = 0.127, t = 3.03, p=.004) and 
emotional representations (β = 0.234, SE = 0.083, t = 2.81, p=.007) contributed 
significantly.  When the 8 illness perceptions were added individually, 5 predictors 
were found to be statistically significant (personal control, identity, emotional 
representations, treatment control and consequences).  However, when the 5 
predictors were added into the regression together, both consequences (β=0.284, SE 
= 0.106, t = 2.673, p=.009) and emotional representations (β= 0.257, SE= 0.077, t = 
3.329, p=.001) remained statistically significant.   
 
Physical QoL 
After adding 8 illness perceptions to the model, 42.0% of the Physical QoL variance 
was accounted for (R² = 0.420, F (11, 64) = 5.92, p<.001).  On examining the tests of 
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the individual variables, consequences (β = -1.22, SE = 0.322, t = -3.79, p<.001) and 
personal control (β = 0.702, SE = 0.257, t = 2.75, p=.008) contributed significantly.  
Emotional representations was found to border on significance (β = 0.405, SE = 
0.212, t = 1.92, p=.060).  When the 8 illness perceptions were added into 
individually, 5 predictors were found to be statistically significant (timeline 
acute/chronic, personal control, treatment control, identity and consequences).  
However, when the 5 predictors were analysed together, consequences (β= -0.867, 
SE = 0.296, t = -2.926, p=.005) and personal control (β= 0.614, SE = 0.256, t = 
2.400, p=.019) remained statistically significant.    
 
 Emotional QoL 
After adding 8 illness perceptions to the model, 50.9% of the emotional QoL 
variance was accounted for (R² = 0.509, F (11, 64) = 6.03, p<.001).  On examining 
the tests of the individual variables, emotional representations contributed 
significantly (β = -1.12, SE = 0.224, t = -5.017, p<.001).  Identity was found to 
border on significance (β = -0.822, SE = 0.412, t = -1.99, p=.050).  Residual plots 
were examined and were slightly skewed.  Therefore it could not be assumed that the 
residuals were normally distributed and a bootstrap analysis was performed to get 
revised p-values for the independent variables.  As a result of the bootstrap analysis, 
the variables became weaker in predictive ability (identity: β = -0.822, SE = 0.412, t 
= -1.99, p=.067; emotional representations: β = -1.12, SE = 0.224, t = -5.017, 
p=.001).       
When the 8 illness perceptions were added individually, 4 predictors were 
found to be statistically significant (Personal control, identity, emotional 
representations and consequences).  However, when the 4 predictors were analysed 
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together, identity (β= -0.289, SE = 0.397, t = -2.087, p=.041) and emotional 
representations (β= -1.142, SE = 0.195, t = -5.863, p<.001) were statistically 
significant.  
 
Discussion  
This study investigated the relationship between illness perceptions, mood and QoL 
in chronic refractory angina patients who had undergone EECP treatment.  Results 
confirmed the hypotheses that an increase in negative illness perceptions would 
positively correlate with elevated anxiety and depression symptoms, and poorer 
physical and emotional QoL.  The hypothesis that negative illness perceptions would 
also predict mood and poorer QoL was also confirmed.     
These findings add to existing CHD literature.  The observed relationship 
between illness perceptions, mood and QoL has been reported in CHD patients at the 
beginning and middle stages of disease progression, for example MI
22, 27
 and cardiac 
surgery.
46
   The present study found this association in refractory angina patients at 
'end-stage coronary artery disease', 
30 p355
 suggesting the interaction is significant 
throughout the course of CHD progression.    
The present findings also add to existing literature reviewed by Hagger and 
Orbell (2003),
17
 that demonstrated a relationship between illness perceptions and 
outcome in other chronic illnesses, including CFS and COPD.  The findings from 
this study provide additional evidence that the relationship between illness 
perceptions and outcome is not necessarily disease-specific.  Findings are also 
consistent with the self-regulatory model
15
 that posits a relationship between illness 
perceptions and outcomes.  
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This study also observed differences in the strength of the relationship between 
specific illness perceptions, mood and QoL.   
 
Mood 
Participants' emotional representations, perceived consequences and number of 
symptoms attributed to refractory angina correlated strongly with both anxiety and 
depression.  Emotional representations was a significant predictor variable of mood, 
highlighting the importance of identifying specific emotional representations held by 
refractory angina patients.  However, perceived consequences of angina was only 
predictive of depression, not anxiety.  Perceiving an illness to have negative 
consequences on physical, sexual, social and financial functioning can lead to future 
disability and slower recovery.
57
 Perceptions of worsened disability and limited 
capacity to function in these areas can lead to feelings of loss, which is a common 
trigger for depression
58
 and could explain the findings for EECP patients in this 
study.  Anxiety is more likely to be triggered through different mechanisms, such as 
perceived threat.       
  
QoL 
Illness perceptions related to anxiety and depression (identity, consequences and 
emotional representations) were also found to be related to emotional QoL.  This is 
as expected due to the constructs measuring aspects of psychological wellbeing.  
Patients' negative perceptions of chronicity, perceived consequences, level of 
personal and treatment control and symptoms attributed to angina were all 
significantly correlated with poorer physical QoL.  However, perceived 
consequences and personal control were found to be significant predictors of 
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physical QoL.  Previous research has shown that beliefs regarding negative 
consequences of CHD are associated with future disability and slower recovery.
57
 
Loss of functioning and limited capacity following diagnosis of refractory angina 
could explain the connection between perceived consequences and physical QoL.     
Experiencing a lack of control in the management of refractory angina 
symptoms can lead to a decrease in confidence and self-efficacy in performing 
activities that would have previously been easily undertaken.  Patients with a higher 
sense of control are more likely to undergo positive health-behaviour changes, attend 
self-management training, cardiac rehabilitation
59
 and exercise programmes,
 60
 which 
increase physical QoL.
61, 62
 The theory of planned behaviour
63
 posits that health-
behaviour change is driven by the subjective norms of the behaviour, attitudes 
towards behaviour change (such as the consequences) and perceived self-efficacy of 
accomplishing behaviour change.   
The association between illness perceptions and outcomes in refractory 
angina patients supports the theory of planned behaviour.
63
  Previous qualitative 
research involving chronic refractory angina patients (R. Foxwell, unpublished data, 
2012) has also suggested that an adapted fear-avoidance model
64
 for chronic pain 
patients may explain changes in self-efficacy and health behaviour as a result of 
EECP treatment.  The self-regulatory model
15
 was discussed earlier as a model that 
was supported by the results.  Hypothetically, the specific aspects of each of these 
models that have been described for chronic refractory angina patients could be 
combined to demonstrate a process that these patients may experience and the 
changes that may occur due to the EECP treatment (Figure 3).   
The process in Figure 3 begins with refractory angina patients developing 
perceptions related to their illness, such as beliefs regarding control and 
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consequences of refractory angina.  These illness perceptions impact on patients’ 
decision-making regarding health-behaviour change, such as increased exercise and 
improved diet.  When angina symptoms are experienced, patients’ reactions will be 
dependent on illness perceptions.  For example, negative illness perceptions may 
lead to fear of further heart damage and death.  This link between angina pain and 
fear of death has been documented in a previous qualitative study of refractory 
angina patients, where one patient stated “...cause you just associate heart attacks, 
angina, and people die” (R. Foxwell, unpublished data, 2012, p16).  Fear of 
experiencing angina pain can lead to patients avoiding physical activity, which 
consequently leads to physical de-conditioning, disability and depression.  Poorer 
physical conditioning can increase angina symptoms and worsen illness perceptions.  
This process is a negative vicious cycle, which leads to increasing disability and 
poorer outcomes. 
However, patients that undergo EECP treatment improve physically and 
psychologically.  EECP stimulates the growth of new blood vessels, known as 
collateral formation, which increases blood flow to the heart.  Previous research (R. 
Foxwell, unpublished data, 2012) has found that patients who have undergone EECP 
treatment develop an increase in confidence and self-efficacy and a decrease in fear 
of death.  This leads to refractory angina patients physically pushing themselves 
more.  This increase in confronting fears has been found previously: "Not only did it 
push me to do it, but also by doing it, it showed me that I don't need to worry so 
much about it for the future, so since I've come back I'm pushing myself that much 
more all the time, which is good!"  (R. Foxwell, unpublished data, 2012, p24).  An 
increase in physical activity leads to improved physiological and psychological 
functioning, which, in turn decreases the frequency and intensity of angina and 
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improves illness perceptions.  This process involves a positive cycle of increased 
physical functioning and positive illness perceptions.   
137 
 
 
 
 
 
 
 
  
 
 
 
Figure 3.  Proposed process between illness perceptions and outcome for refractory angina patients. 
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Significant differences in illness perceptions, mood and QoL dependent on age, 
gender and length of time since EECP treatment were found in the study.  Younger 
participants were more likely to experience increased negative illness perceptions 
regarding consequences, chronicity, emotional representations and personal and 
treatment control.  Similar results were found in previous studies.  For example, 
more negative illness perceptions were found in patients that had recently been 
hospitalised for MI that were younger than 57 years
22
 and CHD patients younger 
than 65 perceived more negative consequences.
65
  Older adults are more likely to 
adopt a health-promoting lifestyle through diet, exercise and stress-management.
66
  
Older age is also a protective factor against depression in CHD.
67, 68
  This is pertinent 
as the present study found depression was significantly correlated with illness 
perceptions.  The finding from this study suggests that younger patients are at a 
higher risk of poorer recovery due to worse negative illness perceptions.  Younger 
refractory angina patients may need more support in increasing activity and 
addressing negative illness perceptions.   
 Males were found to significantly attribute more symptoms to their refractory 
angina than females.  It is a common finding that both genders view CHD as more 
frequent in males.
69, 70
 Therefore, women may be less inclined to attribute specific 
symptoms to their heart.  There may also be a greater impact of refractory angina on 
males' identity compared to females.  Previous research has found that males with 
chronic refractory angina can struggle to integrate the illness into their identity (R. 
Foxwell, unpublished data, 2012).  The physical impairments associated with 
refractory angina can lead to role identity difficulties which may contrast to the male 
masculine identity.
71
  The finding from this study suggests that there could be 
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gender-specific interventions, including a focus on discussing challenges to 
masculine identity to increase integration for males. 
Participants that had undergone EECP treatment more recently perceived 
their symptoms to be more cyclical in nature.  During the progression of a chronic 
illness, such as refractory angina, patients are confronted with new situations and 
need to develop new coping strategies to adjust to their altered condition.
72, 73
 This 
process of adjustment can take a long time, as patients need to become accustomed 
to the variability of the condition.  Physiological and psychological changes occur 
due to EECP treatment, which participants may need to adjust to.  Refractory angina 
patients undergoing EECP treatment may need to be provided with realistic 
expectations and information regarding adjustment to these changes.  
 
Cost Effectiveness of EECP 
The majority of participants reported that frequency of GP visits and quantity of 
medication taken was either the same or less than before EECP treatment.  The 
progression of angina and other chronic health conditions usually involves a gradual 
process of increased medical interventions and interactions with health 
professionals.
74
  The results suggest that EECP can maintain patients on lower 
pharmacological treatments and delay the normal progression of chronic illness.  In 
considering the likelihood of co-morbidity in patients with refractory angina, a 
deceleration of progression may also be an important outcome of this treatment.  
Further investigations of this deceleration process are needed.       
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Comparison of Results to Different Populations  
General Population  
Participants reported significantly higher depressive symptoms and poorer physical 
QoL, but average anxiety levels and emotional QoL compared to the general 
population.  It appears that refractory angina patients were experiencing limited 
capacity and increased disability, without an emotional impact.  Previous research 
(R. Foxwell, unpublished data, 2012) reported that refractory angina patients adopted 
emotional-distancing as a coping strategy to avoid experiencing the difficult 
emotions associated with decreasing physical QoL.  Participants may have accepted 
the physical limitations of refractory angina, but not fully accepted or acknowledged 
the emotional impact.   Type D (distressed) personality is associated with negative 
affectivity and social inhibition.
75
  People who have this personality trait are more 
inclined to keep their negative emotions to themselves and not express them to 
others due to fear of being judged.  The present study and previous research (R. 
Foxwell, unpublished data, 2012) has found refractory angina patients to have 
difficulty expressing their emotions, even though they are experiencing high levels 
of depression.  Research has investigated Type D personality with CHD populations, 
and has found that this personality trait is associated with an increased risk of 
morbidity and mortality.
76
 It is, therefore, important that interventions focus on 
encouraging refractory angina patients to share their negative feelings.        
 
Cardiac Populations 
Refractory angina patients held significantly worse illness perceptions compared to 
other cardiac populations.  Patients viewed their illness as significantly more chronic 
and variable, with more negative consequences, and as having lower personal and 
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treatment control.  However, refractory angina patients had a significantly greater 
understanding of their illness, compared to other cardiac populations.  These results 
support the finding that chronic refractory angina patients hold maladaptive illness 
beliefs, which may subsequently impact on their health, QoL and mood.
32
 Although 
interventions to modify maladaptive beliefs are mainly centred on the initial stages 
of CHD or after a significant medical event, the finding from this study suggests that 
refractory angina patients are also in need of these interventions.  However, it must 
be noted that patients with chronic refractory angina may be further along the CHD 
disease course than other patient populations.  Therefore, some of the worsened 
illness perceptions may be realistic, due to the chronic and pervasive nature of the 
condition.  Caution should also be taken when interpreting these findings as illness 
perceptions can vary widely within and between illnesses.
77
   
 
Clinical Implications 
Refractory angina patients hold maladaptive illness perceptions, which are related to 
mood and QoL.  Although identification of these perceptions has been previously 
recommended during the initial stages of CHD and after significant medical 
events,
22, 46
 there is a need for screening of illness perceptions to regularly continue 
throughout CHD progression.  This screening could be completed by healthcare 
professionals using brief screening tools such as the IPQ-R
16
 or the York Angina 
Beliefs Questionnaire (YABG).
78
      
   Interventions to alter maladaptive illness perceptions in refractory angina 
should be made widely available.  Cognitive-behavioural interventions have been 
found to be effective in altering maladaptive illness perceptions in CHD patients.
79
 
The Angina Plan
80
 is a cognitive-behavioural intervention specifically designed to 
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dispel misconceptions, increase activity and reduce angina frequency in refractory 
angina patients.  Research reports an improvement in psychological and physical 
functioning in angina patients that have undergone this treatment.
81
 In the service 
that the current study was conducted, the Angina Plan and EECP treatment were 
offered to refractory angina patients separately, at different times.  However, it could 
be beneficial for patients to improve physically and psychologically in parallel.  
Previous research has supported the effectiveness of collaborative pharmacotherapy 
and psychological interventions to improve outcomes in CHD patients.
82
  Patients 
spend 35 hours with the EECP nurses whilst undergoing the treatment.  Cognitive-
behavioural interventions, such as the Angina Plan, could be implemented whilst 
patients are actively undergoing the EECP treatment to establish an integrated 
multidisciplinary model of care and service delivery.  
Healthcare professionals need to consider differences in illness perceptions 
dependent on age and gender when screening and implementing interventions for 
maladaptive illness perceptions.  For example, they should be aware that younger 
patients are likely to hold more negative illness perceptions, which could impact on 
their mood and QoL.  Furthermore, males attributed more symptoms to their angina; 
although accurate information regarding the symptoms and management of angina 
should be equally shared with both genders.      
 Healthcare professionals also need to consider the effects of patients with 
Type D personality.  It may be beneficial for refractory angina patients to complete a 
Type D personality checklist, such as the Type D Scale (DS14)
75
 to enable 
identification of patients that may need interventions to encourage the expression of 
negative emotions.         
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 Methodological Limitations 
The study utilised correlational analysis.  Therefore the direction of causality 
between illness perceptions, mood and QoL cannot be assumed.  However, 
hierarchical regression analysis was also utilised to demonstrate that certain illness 
perceptions did predict changes in mood and QoL.   
It is possible that sample bias may have occurred, as only participants willing 
to complete and return the questionnaires were included in the study.  Although 
reasons for non-response were not routinely collected, anecdotally, the researcher 
found that some participants declined because they were too ill.  The majority of 
respondents were also male.  However, this discrepancy was found in responders and 
non-responders, suggesting that more males undergo EECP treatment than females.  
Research provides evidence for this gender bias in treatment availability
82
 and 
postulates that diagnostic and management strategies differ to the disadvantage of 
women.
83
   
The present study did not include an objective measure of functional ability.  
The six minute walk test
84
 was routinely used after EECP treatment.  However, the 
study was not longitudinal, and therefore participants completing the questionnaires 
had undergone EECP treatment up to 8 years ago.  Due to the nature of chronic 
conditions, functional ability would have changed during this time.  Furthermore, the 
present study was more interested in participants' perceptions of their physical 
health. 
  The questionnaires did not specifically ask participants to answer solely in 
relation to refractory angina.  Due to the likelihood of co-morbidity in this patient 
population, participants may not have differentiated between conditions when 
answering the questions.  However, investigating solely about patients' refractory 
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angina utilises a reductionist viewpoint.  Even if the questionnaire had specified 
refractory angina, participants would have probably responded in relation to their 
whole self, including any co-morbid illnesses.    
 
Future Directions 
Future research should employ a longitudinal design, investigating changes over 
time in the relationship between illness perceptions and outcomes, such as mood and 
QoL for EECP patients.  Recent qualitative research (R. Foxwell, unpublished data, 
2012) has highlighted the importance of EECP in reducing fear-avoidance and 
promoting self-efficacy in chronic refractory angina patients.  It would, therefore, be 
important to include measures of these in future research of this patient population.   
Comparisons of these measures before and after EECP treatment may demonstrate 
the effects of the treatment in both physiological and psychological domains.  A 
multicentre trial with statistically robust sample size could lead to generalised 
findings across the UK.  
Future research should focus on investigating the effectiveness of parallel 
physiological and psychological interventions for refractory angina patients.  A 
randomised controlled trial (RCT) could be implemented to compare outcomes of 
three separate groups; EECP treatment, Angina Plan
80
 intervention, and a combined 
parallel intervention of EECP and Angina Plan.  Outcomes should include both 
physical and psychological functioning.  This research would have implications for 
implementing an integrated, multidisciplinary, holistic approach for service delivery 
in this patient population.    
The present research found that refractory angina patients may have similar 
personality traits to Type D personality.  Future research should investigate Type D 
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personality in refractory angina patients, as it has been shown to increase risk of 
morbidity and mortality.
76
  To date, this research has focused on CHD patients and 
patients following MI.
85  
This could have implications on the focus of cardiac 
rehabilitations and cognitive-behavioural interventions for refractory angina patients.    
 
Conclusion 
The present study found evidence of a relationship between illness perceptions, 
mood and QoL in chronic refractory angina patients who had undergone EECP 
treatment.  Results from the current study and previous research supports constructs 
from 3 main health models and led to the development of a model illustrating the 
possible process between illness perceptions and outcomes specific for chronic 
refractory angina patients.  The present study also highlights the importance of 
further research into parallel interventions to improve physical and psychological 
outcomes.  Implementing the Angina Plan and EECP treatment in conjunction, to 
establish an integrated, multidisciplinary model of care and service delivery was 
suggested.   
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Appendix 1.1: Reflective Statement 
This reflective statement documents my thoughts throughout the process and upon 
completion of this research project.  I will discuss all aspects of the research process 
and focus particularly on challenges faced and provide insight into what I have 
learnt.  I will also discuss the rationale for choosing specific journals for my research 
papers.  
Beginnings of Research 
At the beginning of this process I was initially interested in the area of chronic pain.  
I had previously worked in a chronic pain service and had found research within this 
area particularly interesting.  However, after extensive literature searches I was 
struggling to formulate and find a gap in the research to focus on.  On reflection, this 
was one of the more difficult times during my research journey and I seemed to 
struggle more with developing an idea than implementing and organising the actual 
research.  Perhaps this reflects my strengths in time-management and organisation 
and my weaknesses in creative thinking.      
The iterative process of formulating research questions and method design 
was a challenge for me.  I have come to realise that I like to be in control, have a 
plan of action and implement that plan.  However the development of research is not 
a straightforward process; I remember my supervisor frequently reminding me that it 
was an iterative process.  Having to stay with that uncertainty has enabled me to 
develop this skill, which, in turn has helped me to use this during my clinical work.      
My supervisor suggested a research project in the Bradford Cardiology 
Department investigating enhanced external counterpulsation treatment (EECP).  At 
this stage I had limited knowledge of cardiology and had never heard of EECP!  
During my regular visits to Bradford to meet the EECP nurses I developed an 
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understanding of this patient population and their positivity and enthusiasm for this 
treatment made me passionate about the importance of this research.   I think the 
positive attitudes from the consultant and the nurses maintained my enthusiasm and 
motivation for this research project throughout.   
Quantitative vs. Qualitative  
During the initial stages of research design I wanted to develop a quantitative 
methodology, as I had only ever completed quantitative research in the past.  
However, due to the lack of research and knowledge of psychological issues related 
to EECP treatment, an exploratory study seemed equally important to implement.  
Therefore, I decided to undergo a mixed method design.  I expected to write them 
into one paper; however, during the data collection stages it was obvious that both 
the quantitative and qualitative sections were too rich in data to combine into one 
paper. 
Throughout the research process, my attitude towards qualitative and 
quantitative research has changed.  I was quite apprehensive of undertaking 
qualitative research, as it was a new experience for me.  I was worried about 'getting 
it right', but came to realise that the results would not only reflect patients' 
experiences, but also my own interpretations.  I found the process of qualitative 
research more rewarding because I met the participants and found that I got a deeper 
understanding of this patient population through doing this.  I found the qualitative 
analysis process more transparent of its strengths and weaknesses than the 
quantitative research.  
I also found it difficult to balance research that derives from two separate 
epistemological assumptions; qualitative adopting a relativist perspective and 
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quantitative adopting a positivist perspective.  It is important to acknowledge that 
there is inevitable contamination from each perspective to the other.  However, by 
doing both, I feel that I understand the epistemological stances and appreciate the 
importance of both types of research complementing each other.  I feel I have 
developed breadth in my research skills, not just depth.    
Write up 
At the initial stages of write up I had decided to write all three papers (literature 
review, empirical paper 1 and paper 2) in parallel.  I think this was initially to lessen 
my anxiety around 'neglecting' an area of my research.  This worked well for the 
method and results sections.  However, when it came to formulation of the results it 
was difficult to hold all three results sections in mind at the same time.  As they were 
all investigating coronary heart disease, it was easy to get confused. I felt slightly 
overwhelmed by the amount of information and the process felt quite disjointed.  In 
supervision, it was reflected upon that these feelings may be similar to how the 
refractory angina patient population may feel about their illness.  It seems that, at 
present, refractory angina patients are offered various treatments, but not an 
integrated multidisciplinary service.    
On several occasions during write up, I thought to myself "why have I 
created more work for myself by doing two research papers instead of just one?" 
However, I feel I have acquired the skills to undergo and develop qualitative and 
quantitative work, which I hope will be useful in the future.  Also, switching from 
one method to the next enabled me to have a 'break' from each study and I really feel 
that the saying 'a change is as good as a rest' encapsulated my strategy for write up.   
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I remember my supervisor frequently telling me that all my reading into the 
chronic pain area that I initially did was "money in the bank".  At the time I felt that I 
had done a lot of work that in the end wasn't needed.  However, during write up, this 
phrase kept coming back to me.  I came to understand that refractory angina is a 
chronic pain condition and that many of the models that I had researched in the 
initial stages fitted well with this patient population.  Looking back, if I had not 
researched chronic pain, I may not have perceived refractory angina in the same way 
and would not have drawn upon the same models.  
Parallel Processes 
Initially, there did not seem any obvious parallel processes occurring in my research.  
However, on further reflection during supervision, control seemed an important issue 
for chronic refractory angina patients, which also seemed to be an important issue for 
me during this research process.  Furthermore, my relationship with the EECP nurses 
and consultant cardiologist reflected a similar relationship to refractory angina 
patients.  I developed a strong relationship with the nurses, who provided a 
supportive space, whereas I spent less time with the consultant cardiologist.  
Although there is limited research into these types of parallel processes, it has been 
documented to be a common experience (Smith, 2012). 
Conclusions 
Although my research was initially an important process to pass my doctoral 
training, the further along the journey I went, it seemed equally important that the 
research I completed was attempted to be published.  There is limited research in this 
field, and funding for EECP treatment seems to be declining.  This research process 
has highlighted the importance of developing a strong working alliance with medical 
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staff when undertaking psychological research in a health setting.   The commitment 
from medical staff will ultimately determine whether your research is successful or 
not.  I will take this valuable lesson with me throughout my career.   
  Throughout the research process I have developed my skills as a researcher.  
I am pleased that I have undergone both qualitative and quantitative research, as I 
have been able to reflect on the differences in methods and epistemological 
assumptions underlying them. I feel that I now have the skills to do both types of 
research again.  On reflection, if I had previously had the capacity to do so, I would 
have completed the qualitative paper before developing the quantitative 
methodology.  The qualitative results would have better informed my quantitative 
paper, for example I would have included a measure of self-efficacy.  Although this 
was not possible, it has highlighted an important research process for the future. 
Choice of Journals 
I chose the Journal of Psychosomatic Research for my systematic literature review.  
Many of the studies included in the review had been published in this journal, so it 
seemed appropriate to continue with this journal to enable consistency.  The impact 
factor of the journal is quite high (2.842), which would mean my research 
disseminated to a wide audience. The main difficulty with this journal was the 
limited word count (5000 words).  It was difficult to write concisely, however, I feel 
I have developed my skills in succinct writing. 
I chose the Journal of Cardiovascular Nursing for my two empirical papers.  
It seemed important to disseminate the findings to medical staff, as the clinical 
recommendations made were directed to nursing staff.  The Journal of 
Cardiovascular Nursing also publishes psychological papers, demonstrating that their 
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demographic is more likely to be psychologically minded medical staff.  Finally, the 
Journal seems to accept both qualitative and quantitative studies.    
References 
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Appendix 1.2: Epistemological Statement. 
Epistemology is the theory of how we come to know things and believe they are true 
and real.  All research methods derive from an epistemological position, which can 
vary widely depending on the methods adopted.  I have utilised qualitative 
(empirical paper 1) and quantitative methods (systematic literature review and 
empirical paper 2) and will discuss the underlying epistemological assumptions for 
these.  
Quantitative research adopts a positivist and realist epistemology.  A 
positivist stance suggests that reality does exist independently of human perceptions 
(Fade, 2004) and that it can be objectively measured independently of the researcher.  
The idea of an independent reality allows for theories, models and hypotheses to be 
tested using statistical analysis (Yates, 2004).  Research into the relationship 
between illness perceptions, mood and quality of life allowed for testing and 
supporting various theories and models, such as the self-regulatory model 
(Leventhal, Meyer & Nerenz, 1980). 
Qualitative research focuses on 'knowledge', which differs from 'evidence' in 
quantitative methods (Scott-Findlay & Pollock, 2004).  Qualitative research adopts a 
relativist perspective, suggesting there is no absolute truth because reality is an 
individual, subjective experience of human perception.  This epistemological stance 
appeared to match the exploratory aims of the qualitative paper, which were to 
explore the experiences of refractory angina patients before, during and after EECP 
treatment. 
Interpretative Phenomenological Analysis (IPA) was chosen by the 
researcher as the most appropriate qualitative analysis method.  IPA explores how 
164 
 
people experience the world and how they place meaning on these experiences 
(Smith, Jarman & Osborne, 1999).  There are 3 main theoretical underpinnings of 
IPA; phenomenology, hermeneutics and idiography.  Phenomenology involves the 
study of experience, whereas hermeneutics is the theory of interpretation.  People are 
constantly interpreting and placing meaning on their experiences.  I became involved 
in a double hermeneutic, as a dual interpretation process occurred, where I was 
trying to make sense of a person who was trying to understand their own 
experiences.  Finally, idiography is the focus on an individual's experiences in 
contrast to a whole population or a universal experience.  Through interviewing each 
participant separately I focused on their individual experience of EECP and living 
with angina.   
Although quantitative and qualitative research methods are derived from 
distinct philosophical assumptions, research suggests that these methods can 
complement each other (Patton, 2002).  However, throughout this research process, a 
relativist perspective seems to fit better with my outlook and my clinical training, 
which has encouraged a person-centred, individual approach.   
 References 
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outcome (for example drugs, surgical procedures, devices, behavioural treatments, dietary interventions, and 
process-of-care changes). Health outcomes include any biomedical or health-related measures obtained in patients 
or participants, including pharmacokinetic measures and adverse events. Further information can be found at 
http://www.icmje.org.  
 
Reporting on other types of research studies  
 
It is also recommended that authors submitting other types of articles (non-trials) follow the appropriate reporting 
guidelines for the type of study being reported (  http://www.equator-network.org/resource-
centre/library-of-health-research-reporting/reporting-guidelines/).  
 Systematic reviews and meta-analyses of randomized trials and other evaluation studies: PRISMA  
 Systematic reviews and meta-analyses of observational studies: MOOSE  
 Studies of diagnostic accuracy: STARD  
 Observational studies: STROBE  
 
 
Copyright  
 
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more 
information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the 
agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding 
author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the 
online version of this agreement.  
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation 
within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and 
for all other derivative works, including compilations and translations (please consult 
http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the 
author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier 
has preprinted forms for use by authors in these cases: please consult 
http://www.elsevier.com/permissions.  
 
Retained author rights  
 
As an author you (or your employer or institution) retain certain rights; for details you are referred to: 
http://www.elsevier.com/authorsrights.  
 
Role of the funding source  
 
You are requested to identify who provided financial support for the conduct of the research and/or preparation of 
the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and 
interpretation of data; in the writing of the report; and in the decision to submit the article for publication. If the 
funding source(s) had no such involvement then this should be stated. Please see 
http://www.elsevier.com/funding.  
 
Funding body agreements and policies  
 
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals 
published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their 
grant awards. To learn more about existing agreements and policies please visit 
http://www.elsevier.com/fundingbodies.  
 
Language and language services  
 
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors 
who require information about language editing and copyediting services pre- and post-submission please visit 
http://webshop.elsevier.com/languageservices or our customer support site at 
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http://support.elsevier.com for more information.  
 
Submissions  
 
The Journal of Psychosomatic Research utilizes a web-based submission and peer review system. Authors should 
submit their manuscripts, with figures and tables, electronically at the journal Web site:  
http://ees.elsevier.com/jpsychores. Complete instructions are available on the Web site. 
 
 
The journal reviews all material that it receives. Approximately 50% of manuscripts are rejected after pre-review by 
an editor, typically after consultation with another member of the editorial staff or an external peer reviewer. This is 
done so as to allow authors whose manuscripts would almost certainly be rejected after peer review to submit the 
work elsewhere with as little delay as possible. Common reasons for rejection at this stage are insufficient 
originality, low priority of interest to the journal and clear quality deficits. We attempt to reach an initial decision on 
all articles that go through full peer review within 90 days of submission. Approximately 25% of submitted 
manuscripts are ultimately accepted for publication.  
 
 
 
 
Manuscripts should conform to the uniform requirements known as the 'Vancouver style' (International Committee 
of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals. N Engl J Med 
1997; 336:309-315). The Editors and Referees attach considerable importance to a succinct and lucid prose style 
and well organized tables. Authors whose native language is not English are advised to seek help before 
submission. Statistical procedures should be clearly explained.Manuscripts should conform to the uniform 
requirements known as the 'Vancouver style' (International Committee of Medical Journal Editors. Uniform 
requirements for manuscripts submitted to biomedical journals. N Engl J Med 1997; 336:309-315). The Editors and 
Referees attach considerable importance to a succinct and lucid prose style and well organized tables. Authors 
whose native language is not English are advised to seek help before submission. Statistical procedures should be 
clearly explained.  
 
Use of wordprocessing software  
 
It is important that the file be saved in the native format of the wordprocessor used. The text should be in single-
column format. Keep the layout of the text as simple as possible. Most formatting codes will be removed and 
replaced on processing the article. In particular, do not use the wordprocessor's options to justify text or to 
hyphenate words. However, do use bold face, italics, subscripts, superscripts etc. When preparing tables, if you are 
using a table grid, use only one grid for each individual table and not a grid for each row. If no grid is used, use 
tabs, not spaces, to align columns. The electronic text should be prepared in a way very similar to that of 
conventional manuscripts (see also the Guide to Publishing with Elsevier: 
http://www.elsevier.com/guidepublication). Note that source files of figures, tables and text graphics 
will be required whether or not you embed your figures in the text. See also the section on Electronic artwork.  
To avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' functions of 
your wordprocessor.  
 
Cover letter  
 
Each manuscript should be accompanied by a Cover Letter. In addition to a brief description of the article being 
submitted and its relevance to likely readers of the journal, the Cover Letter should include a statement that 
(1)authors of this article had access to all study data, are responsible for all contents of the article, and had 
authority over manuscript preparation and the decision to submit the manuscript for publication, (2) that all listed 
authors have approved of the submission of the manuscript to the journal, and (3) an explanation of the relationship 
of the submitted paper to any other published, submitted or proposed papers reporting the same or overlapping 
data. You may submit the completed letter online.  
 
Title Page  
 
This should contain (a) the title of the article; (b) a short running head; (c) name of department where the work was 
conducted; (d) names of the each author with highest academic degree; (e) name, address, phone and fax of 
author responsible for correspondence and to whom requests for reprints should be addressed.  
 
Structured Abstract  
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This should be subdivided under the headings Objective, Methods, Results, and Conclusion and should not 
exceed 250 words.  
 
Keywords  
 
Up to six keywords should be listed in alphabetical order after the abstract. These terms should optimally 
characterize the paper to facilitate choice of peer reviewers.  
 
Article Structure  
 
The text should be divided into sections with main headings: Introduction, Method, Results and Discussion and, in 
total, these sections should not normally be greater than 4000 words in length.  
 
Acknowledments  
 
Collate acknowledgements in a separate section at the end of the article before the references and do not, 
therefore, include them on the title page, as a footnote to the title or otherwise. Acknowledgements must include 
mention of any source of funding outside the basic funding of the host institution (see Role of the funding source 
above). List here those individuals who provided help during the research (e.g., providing language help, writing 
assistance or proof reading the article, etc.).  
 
Tables  
 
Number tables consecutively in accordance with their appearance in the text. Place footnotes to tables below the 
table body and indicate them with superscript lowercase letters. Avoid vertical rules. Be sparing in the use of tables 
and ensure that the data presented in tables do not duplicate results described elsewhere in the article.Each should 
be on a separate sheet, numbered consecutively in Roman numerals.  
 
Figures  
 
Each should be on a separate sheet, and numbered consecutively. Captions should be on a separate sheet. The 
number of illustrations should be kept to a minimum. Colour illustrations are not normally acceptable. Authors may 
be asked to support the costs of colour reproduction.  
 
Competing Interest Statement  
 
All manuscripts should include a competing interests declaration that should be in the following format: 
 
 
'All authors have completed the Unified Competing Interest form at 
http://www.icmje.org/coi_disclosure.pdf and declare that(1)[authors] received support from [name of 
company or other competing interest] for the submitted work;(2)[authors] have [specify relationships] with [name of 
companies or other competing interests] in the past three years that could be perceived to constitute a conflict of 
interest;(3)spouses, partners, or children of [authors] have [specified] financial relationships that may be relevant to 
the submitted work; and(4)[authors] have [specify type of relationship] non-financial interests that may be relevant 
to the submitted work. 'If there are no competing interests to report, the authors should state, 'The authors have no 
competing interests to report'.  
 
Appendices  
 
If there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in appendices 
should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent appendix, Eq. (B.1) and so on. 
Similarly for tables and figures: Table A.1; Fig. A.1, etc.  
 
Abbreviations  
 
Keep abbreviations to a minimum and avoid their use in the abstract. Spell out each abbreviation in the text the first 
time that it is used. Ensure consistency of abbreviations throughout the article.  
 
Footnotes  
 
Footnotes should be used sparingly. Number them consecutively throughout the article, using superscript Arabic 
numbers. Many wordprocessors build footnotes into the text, and this feature may be used. Should this not be the 
case, indicate the position of footnotes in the text and present the footnotes themselves separately at the end of the 
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article. Do not include footnotes in the Reference list.  
Table footnotes  
Indicate each footnote in a table with a superscript lowercase letter.  
 
Electronic artwork  
 
General points  
• Make sure you use uniform lettering and sizing of your original artwork.  
• Save text in illustrations as 'graphics' or enclose the font.  
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  
• Number the illustrations according to their sequence in the text.  
• Use a logical naming convention for your artwork files.  
• Provide captions to illustrations separately.  
• Produce images near to the desired size of the printed version.  
• Submit each figure as a separate file.  
 
A detailed guide on electronic artwork is available on our website:  
http://www.elsevier.com/artworkinstructions  
You are urged to visit this site; some excerpts from the detailed information are given here.  
Formats  
Regardless of the application used, when your electronic artwork is finalised, please 'save as' or convert the images 
to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone 
combinations given below):  
EPS: Vector drawings. Embed the font or save the text as 'graphics'.  
TIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.  
If your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) then please supply 
'as is'.  
Please do not:  
• Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too low;  
• Supply files that are too low in resolution;  
• Submit graphics that are disproportionately large for the content.  
 
Color artwork  
 
Submit color illustrations as original photographs, high-quality computer prints or transparencies, close to the size 
expected in publication, or as 35 mm slides. Please make sure that artwork files are in an acceptable format (TIFF, 
EPS or MS Office files) and with the correct resolution. If, together with your accepted article, you submit usable 
color figures then Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web 
(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced in color in the 
printed version. For color reproduction in print, you will receive information regarding the costs from 
Elsevier after receipt of your accepted article. Please indicate your preference for color: in print or on the Web 
only. For further information on the preparation of electronic artwork, please see 
http://www.elsevier.com/artworkinstructions.  
Please note: Because of technical complications which can arise by converting color figures to 'gray scale'(for the 
printed version should you not opt for color in print) please submit in addition usable black and white versions of all 
the color illustrations.  
 
Figure captions  
 
Ensure that each illustration has a caption. Supply captions separately, not attached to the figure. A caption should 
comprise a brief title (not on the figure itself) and a description of the illustration. Keep text in the illustrations 
themselves to a minimum but explain all symbols and abbreviations used.  
 
References  
 
These should be numbered consecutively in the text in the order in which they are first mentioned and be so 
denoted in the list. Their form should be that adopted by the US National Library of Medicine, as used in the Index 
Medicus and as recommended in Huth EJ, Medical Style and Format.  
 
Web references  
 
As a minimum, the full URL should be given and the date when the reference was last accessed. Any further 
information, if known (DOI, author names, dates, reference to a source publication, etc.), should also be given. Web 
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references can be listed separately (e.g., after the reference list) under a different heading if desired, or can be 
included in the reference list.  
 
Reference style  
 
Text: Indicate references by number(s) in square brackets in line with the text. The actual authors can be referred 
to, but the reference number(s) must always be given.  
List: Number the references (numbers in square brackets) in the list in the order in which they appear in the text.  
Examples:  
Reference to a journal publication:  
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2010;163:51–9.  
Reference to a book:  
[2] Strunk Jr W, White EB. The elements of style. 4th ed. New York: Longman; 2000.  
Reference to a chapter in an edited book:  
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith RZ, editors. 
Introduction to the electronic age, New York: E-Publishing Inc; 2009, p. 281–304.  
Note shortened form for last page number. e.g., 51–9, and that for more than 6 authors the first 6 should be listed 
followed by 'et al.' For further details you are referred to 'Uniform Requirements for Manuscripts submitted to 
Biomedical Journals' (J Am Med Assoc 1997;277:927–34) (see also 
http://www.nlm.nih.gov/bsd/uniform_requirements.html).  
 
Journal abbreviations source  
 
Journal names should be abbreviated according to  
Index Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;  
List of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;  
CAS (Chemical Abstracts Service): http://www.cas.org/sent.html.  
 
Video data  
 
Elsevier accepts video material and animation sequences to support and enhance your scientific research. Authors 
who have video or animation files that they wish to submit with their article are strongly encouraged to include these 
within the body of the article. This can be done in the same way as a figure or table by referring to the video or 
animation content and noting in the body text where it should be placed. All submitted files should be properly 
labeled so that they directly relate to the video file's content. In order to ensure that your video or animation material 
is directly usable, please provide the files in one of our recommended file formats with a preferred maximum size of 
50 MB. Video and animation files supplied will be published online in the electronic version of your article in Elsevier 
Web products, including ScienceDirect: http://www.sciencedirect.com. Please supply 'stills' with your 
files: you can choose any frame from the video or animation or make a separate image. These will be used instead 
of standard icons and will personalize the link to your video data. For more detailed instructions please visit our 
video instruction pages at http://www.elsevier.com/artworkinstructions. Note: since video and 
animation cannot be embedded in the print version of the journal, please provide text for both the electronic and the 
print version for the portions of the article that refer to this content.  
 
Supplementary data  
 
Elsevier accepts electronic supplementary material to support and enhance your scientific research. Supplementary 
files offer the author additional possibilities to publish supporting applications, high-resolution images, background 
datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic 
version of your article in Elsevier Web products, including ScienceDirect: 
http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please 
provide the data in one of our recommended file formats. Authors should submit the material in electronic format 
together with the article and supply a concise and descriptive caption for each file. For more detailed instructions 
please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.  
 
Submission Checklist  
 
The following list will be useful during the final checking of an article prior to sending it to the journal for review. 
Please consult this Guide for Authors for further details of any item.  
Ensure that the following items are present:  
One Author designated as corresponding Author:  
• E-mail address  
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• Full postal address  
• Telephone and fax numbers  
•All necessary files have been uploaded, including appropriate checklists for relevant reporting guidelines(e.g., 
CONSORT, PRISMA)  
• Line spacing 
• Please ensure to use double line spacing in your paper 
• Keywords  
• All figure captions  
• All tables (including title, description, footnotes)  
Further considerations  
• Manuscript has been 'spellchecked' and 'grammar-checked'  
• References are in the correct format for this journal  
• All references mentioned in the Reference list are cited in the text, and vice versa  
• Permission has been obtained for use of copyrighted material from other sources (including the Web)  
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print 
or to be reproduced in color on the Web (free of charge) and in black-and-white in print  
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes  
For any further information please visit our customer support site at http://support.elsevier.com.  
 
 
 
 
Use of the Digital Object Identifier  
 
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a 
unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic 
publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 
'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing 
a DOI is shown as follows (example taken from a document in the journal Physics Letters B):  
doi:10.1016/j.physletb.2010.09.059  
When you use the DOI to create URL hyperlinks to documents on the web, the DOIs are guaranteed never to 
change.  
 
Proofs  
 
One set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do not have an e-mail 
address then paper proofs will be sent by post) or, a link will be provided in the e-mail so that authors can download 
the files themselves. Elsevier now provides authors with PDF proofs which can be annotated; for this you will need 
to download Adobe Reader version 7 (or higher) available free from http://get.adobe.com/reader. 
Instructions on how to annotate PDF files will accompany the proofs (also given online). The exact system 
requirements are given at the Adobe site: http://www.adobe.com/products/reader/tech-
specs.html.  
If you do not wish to use the PDF annotations function, you may list the corrections (including replies to the Query 
Form) and return them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any reason, 
this is not possible, then mark the corrections and any other comments (including replies to the Query Form) on a 
printout of your proof and return by fax, or scan the pages and e-mail, or by post. Please use this proof only for 
checking the typesetting, editing, completeness and correctness of the text, tables and figures. Significant changes 
to the article as accepted for publication will only be considered at this stage with permission from the Editor. We 
will do everything possible to get your article published quickly and accurately – please let us have all your 
corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication: 
please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. 
Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no 
response is received.  
 
Offprints  
 
The corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For an extra charge, 
paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. 
The PDF file is a watermarked version of the published article and includes a cover sheet with the journal cover 
image and a disclaimer outlining the terms and conditions of use.  
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Cardiovascular Nursing 
Author Guide 
 
Author Guide (this page) 
Copyright Transfer (PDF) 
Reprint Ordering 
Permissions Requests 
Permissions Form (.doc) 
 
Purpose of the Journal  
The primary objective of The Journal of Cardiovascular Nursing (JCN) is to foster expert clinical 
practice of cardiovascular nurses. Issues address the physiological, psychological, and social 
responses of cardiovascular patients and families in a variety of environments.  
Publication Policy 
JCN publishes both unsolicited articles (research reports, literature reviews, articles on innovations in 
practice, and clinical questions) on any cardiovascular topic, and invited articles on planned topics. 
Authors are encouraged to submit (1) original research articles; (2) analytical reviews that codify 
existing knowledge; (3) clinical articles that synthesize information in a specific area or guide the 
practice of specialists in the field; and (4) articles describing innovations in practice. The decision to 
accept or reject an article will be based on the judgment of peer reviewers and the editors.  
Manuscript Submission  
Online manuscript submission: All manuscripts must be submitted online through the Web site at 
http://jcn.edmgr.com/. The manuscript preparation guidelines below must be followed.  
First-time users: Please click the Register button from the menu on the Web site and enter the 
requested information. After successful registration, you will be sent an e-mail indicating your user 
name and password. Note: If you have received an e-mail from us with an assigned user ID and 
password, or if you are a repeat user, do not register again, just log in. Once you have an assigned 
ID and password, you do not have to reregister, even if your status changes (ie, author or reviewer).  
Authors: Please click the Log-In button from the menu at the top of the page and log in to the 
system as an author. Submit your manuscript according to the author instructions. You will be able 
to track the progress of your manuscript through the system. If you experience any problems, please 
contact the JCN Editorial Manager, Jeanine Vezie at jdvezi2@email.uky.edu.  
AUTHOR'S MANUSCRIPT CHECKLIST FOR SUBMISSION TO JCN 
Authors should pay particular attention to the following items before submitting their manuscripts.  
Manuscript Preparation  
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 Manuscripts should be prepared in accordance with the style guidelines of the 10th edition 
of the AMA Manual of Style. 
 Please take care to prepare your references in the correct format (examples shown below). 
 Please be sure to number each page of the manuscript. 
 Manuscripts must be created on IBM-compatible (PC) equipment using Windows 95 or 
higher operating system. Our preferred software is Microsoft Word. 
 Manuscripts should be entirely double spaced (including quotations, abstract, lists, and 
references, footnotes, figure captions, and all parts of tables). Leave 1" margins 
throughout. Minimize creative formatting and avoid varying spacing between headings and 
paragraphs. 
 Manuscripts should be ordered as follows: title page, abstract, text, references, summary 
and implications (see below for description of this element), tables, figure legends and any 
figures.  
 If English is not your first language, has this manuscript been reviewed by a native English 
speaker? If not, you may want to use ScienceDocs (www.sciencedocs.com) and/or 
the editing-only site the Scientific-Editor at www.scientific-editor.com.  
Manuscript Contents  
Each manuscript must include the following:  
 Title page including (1) title of the article, (2) author names (with highest academic 
degrees) and affiliations (including titles, departments, and name and location of 
institutions of primary employment), (3) corresponding author’s name and complete 
address including email, phone and FAX numbers, (4) any acknowledgments, credits, 
or disclaimers, including funding sources and conflicts of interest, and (5) number of tables 
and figures. 
 Please do not use abbreviations in the title or any headers on your manuscript.  
 Abstract of 300 words or fewer describing the main points of the article. If it is a research 
article, prepare a structured abstract with the following headings: (1) background; (2) 
objective; (3) methods; (4) results; and (5) conclusions. If the article is not a research 
article, please prepare a structured abstract with the following headings: (1) background; 
(2) purpose; (3) conclusions; and (4) clinical implications.  
 Keywords: Also include 3 to 5 key words that describe the contents of the article. To 
identify key words that help readers find your article, look in the National Library of 
Medicine's Medical Subject Headings (MeSH). It is essential that your keywords are 
compatible with MeSH.  
 Each research article or review of the literature must include a table entitled, “What’s New?” 
that includes in bullet point form (2-3 bullets only) a summary of the findings with 
implications for practice. Place this section on a separate page after the references. Use this 
section to address the “so what?” of your findings. All other types of articles must include a 
table entitled “Clinical Pearls” that that includes in bullet point form (2-3 bullets only) a 
summary of the important clinical points of the article.  
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 COPYRIGHT TRANSFER FORM: (Authorship responsibility, disclosure and 
copyright transfer form.) Each person listed as an author must complete each 
section entirely and sign the Authorship Responsibility, Disclosure, and Copyright 
Transfer Form. THE FORM FOR EACH AUTHOR MUST BE SUBMITTED 
ELECTRONICALLY WITH YOUR SUBMISSION TO AVOID DELAYS IN PROCESSING 
YOUR MANUSCRIPT. Failure to submit a completed and signed form for each 
author listed will result in having your manuscript returned to you.  
 Each person listed as an author should be thoroughly familiar with the substance 
of the final manuscript and be able to defend its conclusions.  
 ACKNOWLEDGEMENTS: Persons who make subsidiary contributions may be listed 
in an "Acknowledgments" on the Title Page only.  
 KEY WORDS: It is essential that you visit Medline and be certain that your 
keywords are compatible with MeSH headings.  
 Word limit: There is no word limit  
 Written permission, including complete source, for any borrowed text, tables, or figures 
submitted by mail or fax (form attached to the end of this file).  
Conflicts of Interest  
Authors must state all possible conflicts of interest in the manuscript, including financial, consultant, 
institutional and other relationships that might lead to bias or a conflict of interest. If there is no 
conflict of interest, this should also be explicitly stated as none declared.  All sources of funding 
should be acknowledged in the manuscript. All relevant conflicts of interest and sources of funding 
should be included on the title page of the manuscript with the heading “Conflicts of Interest and 
Source of Funding:”. For example:  
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is currently 
receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for Organization X – 
the CME organizers for Company A. For the remaining authors none were declared.  
In addition, each author must complete and submit the journal’s copyright transfer agreement, 
which includes a section on the disclosure of potential conflicts of interest based on the 
recommendations of the International Committee of Medical Journal Editors, “Uniform Requirements 
for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html). The 
form is readily available on the manuscript submission page 
http://www.editorialmanager.com/jcn/ and can be completed and submitted 
electronically. Please note that authors may sign the copyright transfer agreement form 
electronically. For additional information about electronically signing this form, go to 
http://links.lww.com/ZUAT/A106.  
References  
 References must be cited in text and styled in the reference list according to the American 
Medical Association Manual of Style, Ed. 10. 
 If references are created using EndNote or similar reference creation software, 
the “field codes” or other internal codes must be removed or “unlinked” prior to 
submission of the manuscript. References should not be created using Microsoft Word's 
automatic footnote/endnote feature. 
 References should be included on a separate page at the end of the article and should be 
completely double-spaced.  
 References should be numbered consecutively in the order they are cited; if a reference is 
cited more than once, use the original reference number. Cite personal communications in 
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text only and give source, date, and type of communication. Do not use footnotes, except in 
tables.  
 Page numbers should appear with the text citation following a specific quote. 
 Examples of correctly styled reference entries:  
Journals: Using the punctuation indicated below, include the following items: author, 
article title, journal, year, volume, issue number in parentheses following the volume 
number (this element is new with the 10th edition of the AMA guidelines), and inclusive 
pages. Always give the volume number and the issue number. Abbreviate journal titles 
per the List of Journals Indexed for Medline, which can be found on the National Library 
of Medicine website or here: 
ftp://nlmpubs.nlm.nih.gov/online/journals/ljiweb.pdf  
For six or fewer authors, list all authors. 
     Doe JS, Lister FG, Lise JK, Kellert JL. Allied medical education. JAMA. 1975; 23(3):170–184.  
For more than six authors, list the first three followed by et al. 
     Doe JS, Justin MN, Gum KL, et al. Drug use during high school. Am J Public Health. 
1976;64(1):12–22.  
Reference to an Entire Book: Author, book title, place of publication, publisher, year. 
     Farber SD, Ball WD. Neurorehabilitation: A Multisensory Approach. Philadelphia, Pa: Saunders; 
1982.  
Chapter in an Edited Book: 
     Winawar S, Lipkin M. Proliferative abnormalities in the gastrointestinal tract. In: Card WI, 
Creamer B, eds. Modern Trends in Gastroenterology. 4th ed. London, England: Butterworth & Co; 
1970.  
Figures:  
 Cite each figure in the text in consecutive order. If a figure has been previously published, 
in part or in total, acknowledge the original source and submit written permission from the 
copyright holder to reproduce or adapt the material. Include a source line. Type "Source: 
Author" on figures that you created. This will help LWW identify the need for permissions for 
each figure.  
 Supply a caption for each figure, typed double spaced on a separate sheet (Figure 
Legends). Captions should include the figure number and title, definitions for all 
abbreviations used, explanatory statements, notes, or keys; and source and permission 
lines if borrowed.  
A) Four Steps for Submitting Artwork  
1. Please reference “5 Steps to Creating Digital Artwork (pdf)” available at 
http://edmgr.ovid.com/lww-
final/accounts/5StepsforArt.pdf, specifically steps 2 and 3, when 
creating figures for submission.  
2. Create, Scan, and Save your artwork according to the “5 Steps to Creating Digital 
Artwork (pdf).”  
3. Compare your final figure to the Target Digital-Imaging Results listed below.  
4. Upload each figure to Editorial Manager in conjunction with your manuscript text 
and tables.  
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B) Digital Artwork Guideline Checklist  
Here are the basics to have in place before submitting your digital art.  
 Artwork saved as TIFF and EPS files. Do not save TIFFs as compressed files. 
Powerpoints are also acceptable.  
 Artwork created as the actual size (or slightly larger) it will appear in the journal. (To 
get an idea of the size images should be when they print, study a copy of the journal to 
which you wish to submit. Measure the artwork typically shown and scale your image to 
match.)  
 Crop out any white or black space surrounding the image.  
 Text and fonts in any figure are one of the acceptable fonts: Helvetica, Times Roman, 
Symbol, Mathematical PI, and European PI.  
 Color images are created/scanned and saved and submitted as CMYK only. Do not 
submit any figures in RGB mode because RGB is the color mode used for screens/monitors 
and CMYK is the color mode used for print.  
 Line art saved at a resolution of at least 1200 dpi.  
 Images saved at a resolution of at least 300 dpi.  
 Each figure saved as a separate file and saved separately from the accompanying text 
file.  
o For multi-panel or composite figures only: Any figure with multiple parts should be 
sent as one file with each part labeled the way it is to appear in print  
 
Remember:  
 Artwork generated from office suite programs such as CorelDRAW, MS Word, Excel, and 
artwork downloaded from the Internet (JPEG or GIF files) cannot be used because the 
quality is poor when printed.  
 Cite figures consecutively in your manuscript.  
 Number figures in the figure legend in the order in which they are discussed.  
 Upload figures consecutively to the Editorial Manager Web site and number figures 
consecutively the Description box during upload  
Supplemental Digital Content 
Authors may submit Supplemental Digital Content (SDC) via Editorial Manager to LWW journals that 
enhance their article's text to be considered for online posting. SDC may include standard media 
such as text documents, graphs, audio, video, and the like. On the Attach Files page of the 
submission process, please select Supplemental Audio, Video, or Data for your uploaded file as 
the Submission Item. If an article with SDC is accepted, our production staff will create a URL with 
the SDC file. The URL will be placed in the call-out within the article. SDC files are not copy-edited by 
LWW staff, they will be presented digitally as submitted. For a list of all available file types and 
detailed instructions, please visit http://links.lww.com/A142.  
SDC Call-Outs 
Supplemental Digital Content must be cited consecutively in the text of the submitted manuscript. 
Citations should include the type of material submitted (Audio, Figure, Table, etc.), be clearly labeled 
as "Supplemental Digital Content," include the sequential list number, and provide a description of 
the supplemental content. All descriptive text should be included in the call-out as it will not appear 
elsewhere in the article.  
Example:  
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We performed many tests on the degrees of flexibility in the elbow (see Video, Supplemental Digital 
Content 1, which demonstrates elbow flexibility) and found our results inconclusive.  
List of SDC 
A listing of SDC must be submitted at the end of the manuscript file. Include the SDC number and 
file type of the SDC. This text will be removed by our production staff and not be published. 
Example: 
Supplemental Digital Content 1.wmv  
SDC File Requirements 
All acceptable file types are permissible up to 10 MBs. For audio or video files greater than 10 MBs, 
authors should first query the journal office for approval. For a list of all available file types and 
detailed instructions, please visit http://links.lww.com/A142.  
Tables  
 Tables should be on separate pages placed after the references.  
 Number tables consecutively and supply a brief title for each. Always define abbreviations in 
a legend at the bottom even if they have already been defined in the text.  
 For footnotes to appear in the legend, use roman superscript alphabets. Abbreviations 
should be defined in a legend at the bottom of the table. List abbreviations in alphabetical 
order; do not include the word "and" before the last abbreviation.  
 Cite each table in the text in consecutive order.  
 If you use data from another published or unpublished source, obtain permission and 
acknowledge fully.  
Permissions 
Authors are responsible for obtaining signed letters from copyright holders granting permission to 
reprint material being borrowed or adapted from other sources, including previously published 
material of your own or from Lippincott Williams & Wilkins. This includes forms, checklists, cartoons, 
text, tables, figures, exhibits, glossaries, and pamphlets; concepts, theories, or formulas used 
exclusively in a chapter or section; direct quotes from a book or journal that are over 30% of a 
printed page; and all excerpts from newspapers or other short articles. Without written permission 
from the copyright holder, these items may not be used. Authors are responsible for any permission 
fees to borrow reprinted material.  
Drug Names  
The generic (nonproprietary) name of a drug should be used throughout a manuscript. Use the 
complete name of a drug, including the salt or ester (eg, tetracycline hydrochloride) at first mention 
and elsewhere in contents involving dosage. When no generic name exists for a drug, give the 
chemical name or formula or description of the names of the active ingredients. 
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Appendix 4.1: Quality Checklist 
A modified version of Down and Black (1998) checklist, incorporating questions from the CONSORT 2010 statement (Schulz, Altman & 
Moher, 2010).  The first number represents the number given by the researcher and the second number given by an independent researcher. 
 Quality Checklist 
Question                                                                                                   
(Y =1, N=0) 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Total 
Abstract Was there a structured 
summary of trial 
design, methods, 
results and 
conclusions? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
Introduction Was the scientific 
background and 
rationale for the 
research explained? 
1/1 1/1 1/1 1/0 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
20 
 Are the 
hypotheses/aims/objec
tives of the study 
clearly described? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/0 21/ 
20 
Method 
 
Participant 
Are the characteristics 
of the patients 
included in the study 
clearly described?  
1/1 1/1 1/1 1/1 0/0 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 20/ 
20 
 Inclusion and 
exclusion criteria? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 0/0 1/1 1/1 0/0 1/0 1/1 0/0 1/1 1/1 0/0 1/1 1/0 17/ 
15 
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 Were there 
explanations/reasons 
given for 1) losses 2) 
exclusion 3) dropped 
out participants?  
1/1 1/1 1/1 0/0 1/1 1/1 0/0 1/1 1/1 0/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 0/0 0/0 1/1 1/1 16/ 
17 
 Were the subjects 
asked to participate in 
the study 
representative of the 
entire population from 
which they were 
recruited? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
 Were those subjects 
who were prepared to 
participate 
representative of the 
entire population from 
which they were 
recruited? 
0/0 0/0 0/0 0/0 0/0 1/1 1/1 1/0 0/1 0/0 0/0 0/0 0/0 0/1 0/0 1/1 0/1 1/1 0/1 1/0 0/1 6/9 
Design Was the trial design 
clearly described? 
1/1 1/1 1/1 1/0 1/1 1/1 0/0 1/1 1/1 1/1 1/1 1/1 1/0 1/0 1/1 1/1 1/1 1/0 0/0 1/1 1/1 19/ 
15 
 Were the statistical 
methods clearly 
described? 
1/1 1/1 1/1 1/1 0/0 1/1 1/0 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 0/1 0/1 1/1 1/1 18/ 
19 
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 Are the main 
outcomes to be 
measured clearly 
described in the 
introduction or 
method section? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
Results Are the main findings 
of the study clearly 
described? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
 Have actual 
probability values 
been reported( e.g. 
0.035 rather than 
<0.05) for the main 
outcomes except 
where the probability 
value is less than 
0.001?  
1/1 1/1 0/0 1/1 0/0 1/1 1/1 0/1 1/0 1/1 1/1 1/0 0/0 0/0 0/1 0/1 1/1 1/1 0/0 1/1 0/1 12/ 
14 
 Does the study 
provide estimates of 
the random variability 
in the data for the 
main outcomes? 
0/0 1/1 1/1 1/1 0/0 0/0 1/1 1/1 0/0 0/0 1/1 0/0 0/0 0/0 0/0 0/0 1/1 0/0 0/0 1/1 0/0 8/8 
 Were the statistical 
tests used to assess the 
main outcomes 
appropriate? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
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Discussion Did the study 
summarise key results 
with reference to the 
study objectives? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 0/0 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 20/ 
20 
 Did the discussion 
address limitations to 
the study? 
1/1 1/1 1/1 1/1 1/0 1/0 1/1 1/1 1/1 0/0 1/1 1/1 1/1 1/1 1/0 0/0 1/1 1/1 1/0 1/1 1/1 19/ 
15 
 Did the discussion 
address the 
generalizability of the 
study and clinical 
relevance? 
1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 21/ 
21 
 Did the study discuss 
implications of 
results? 
1/1 1/1 1/1 0/1 1/1 0/1 1/1 1/1 1/1 1/1 1/1 0/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 1/1 18/ 
21 
Total  
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17 
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17 
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15 
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16 
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15
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Appendix 4.2: Data Extraction Form 
Data Extraction Form 
 
Study Number  
Title of Study  
Author / Publication Date / 
Country 
 
Journal Source  
Details of Sample N  
 
 
 Age Range  
 
 
 Gender  
 
 
 Ethnicity  
 
 
 Population  
 
 
Response Rate  
 
 
Research Aims  
 
 
Study design and basic 
methodology 
 
 
 
 
Statistical tests used  
 
 
 
 
Psychological Factors under 
consideration 
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Outcome measures used to 
assess these? 
(method of measurement, 
direct/indirect, who 
completed it, when it was 
measured – baseline/post) 
 
 
Main results/findings  
 
 
 
 
Conclusions 
 
 
 
 
 
 
Main limitations identified  
 
 
 
 
Quality Rating  
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Appendix 5: Supplementary Information for Empirical Paper One 
 
Appendix 5.1: Interview Schedule 
Appendix 5.2: Patient Information Sheet 
Appendix 5.3: Patient Consent Form 
Appendix 5.4: Advertisement 
Appendix 5.5: Worked example of IPA 
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Appendix 5.1: Interview Schedule 
Interview Schedule 
 Can you tell me the symptoms that you experience that you attribute to your heart 
difficulties? 
 In your own words, how would you describe the EECP treatment you have 
recently had? Can you tell me what that means to you? 
 What was good/bad about the treatment? 
 In what ways has the EECP treatment made your life better/worse? 
 Has any aspect of your life changed since the treatment? 
 In what ways does angina/heart disease affect your life? 
 What type of things do you do now that you may not have done before the EECP 
treatment? 
 What do your family/friends think about these changes? 
 When you think about your angina/heart condition, how do you feel? 
 What do you think about the future, with regards to your heart condition? 
 What do you think were the main causes for developing heart disease?  
 In what ways is this different to the opinions of the doctors?  
 How do people get angina? What causes it? 
 What do you think is the main cause for bringing on your angina symptoms? 
 How has angina/heart disease affected/changed your relationships? 
 In what ways do you feel in control of your life? 
 How in control of your symptoms do you feel? 
 What does angina/heart disease mean to you? 
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Appendix 5.2: Patient Information Sheet 
Patient Information Sheet 
 
We would like you to take part in our research study.  Before you decide, we would like you 
to understand why the research is being done and what it would involve for you.  Please 
take time to read the following information carefully and discuss it with other if you wish.  
Please ask us if there is anything that is not cleat or if you would like more information. 
Thank you for taking the time to read this. 
Study Title: The outcomes of patients that have previously undergone Enhanced External 
Counterpulsation Treatment (EECP) 
What is the purpose of the study? 
Although there is a lot of research into the medical benefits of EECP, there are limited 
studies into other outcomes of EECP, such a quality of life and mood, which are equally 
important in recovery after treatment.  There has also been no research which has asked 
the patients directly what they think of the procedure.  We want to investigate these 
aspects of recovery, to see whether EECP is not only medically beneficial, but also whether 
it helps with recovery by improving quality of life and mood.   
We would like to invite you to meet with us to discuss your experiences of the treatment 
and in what ways it has affected your quality of life, your mood and your views about your 
angina symptoms.   
Why have I been invited? 
You have been invited to take part in our study because you have recently completed the 
EECP treatment at Bradford Royal Infirmary.  We are hoping to meet with ten patients who 
have also, like you, recently completed the treatment.   
Do I have to take part? 
No, taking part in the study is voluntary; it is up to you to decide whether or not to take 
part.  If you do decide to take part, you will be given this information sheet to keep and be 
asked to sign a consent form when you come to the first meeting.  You can decide to 
withdraw from the study at any time, without giving a reason.  This would not affect the 
standard of care you receive. 
What will happen if I decide to take part? 
If you agree to take part, we will contact you to arrange a time and place that is suitable to 
meet.  When we meet you will be given the opportunity to ask any questions and obtain 
more information about the study.  At this time you will be given a consent form to sign.  
Once you have signed this consent form, you will be given the opportunity to discuss with 
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us your experiences of the EECP treatment, your views on the impact of this treatment, and 
your attitudes towards your symptoms.  This meeting will last for approximately one hour. 
What are the possible disadvantages and risks of taking part? 
The research study consists of a one off, one hour interview.  Therefore, we do not expect 
any disadvantages or risks.  However, discussing your angina symptoms and how it has 
affected your life may be upsetting.  If you do become upset during the interview, you have 
the right to stop at any time.  
What are the possible benefits of taking part? 
Whilst there are no immediate benefits for participants taking part in the study, hopefully 
the information you give us will improve the understanding of the benefits of this 
treatment and help future patients gain better access to this service. 
However, taking part may give you a chance to discuss how you have been coping since the 
treatment finished, which some people may find helpful. 
What will happen if I decide I no longer wish to take part? 
At any point during the interview, you can decide to withdraw from the study.  Your data 
would then be erased and not be used in future analysis.   
What if there is a problem? 
If you have a concern about any aspect of this study, you should contact the main 
researcher, Rachel Foxwell, on the contact details below, and she will do her best to 
answer your questions.  If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure. Details can be obtained from the main 
reception desk of Bradford Royal Infirmary. 
Will my taking part in this study be kept confidential? 
All data will be handled according to ethical and legal practice. All information which is 
collected about you during the course of the research will be anonymous. Your completed 
questionnaires will be given an identification number which will be used throughout the 
analysis of the results. The data will be stored securely on University Departmental 
premises for five years after completion of the study. 
However, it is important to note that should you disclose anything which the researcher 
feels puts yourself or others at risk, then confidentiality would have to be broken. 
 
What will happen to the results of the study? 
The results will be written up as part of a doctoral qualification and are intended to be 
published in a scientific journal. You will not be personally identified in any of the results. If 
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you wish to obtain information about the results, they will be available in the Cardiology 
Department upon completion in summer 2012.  
Who is organising and funding the research? 
This research is being undertaken as part of a doctoral research project in Clinical 
Psychology. The research is funded through the University of Hull and through the Bradford 
Cardiology Department. 
Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by the Research Ethics Proportionate Review Sub-Committee. 
Further information and contact details 
If you have any further questions or queries, please contact Rachel Foxwell on 
07702807574 or email r.foxwell@2009.hull.ac.uk. 
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Appendix 5.3: Patient Consent Form 
Participant Identification number for this study: 
CONSENT FORM 
Title of project: The outcomes of patients that have previously undergone Enhanced 
External Counterpulsation Treatment (EECP) (Version 1.0) 
Name of Researcher: Rachel Foxwell 
1. I confirm that I have read and understand the information 
sheet dated 06/01/2011. Version 1.1 (Part1), for the above 
study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
 
2. I understand that my participation is voluntary and that I 
am free to withdraw at any time without giving any reason, 
without any medical care or legal rights being affected. 
 
 
3. I understand that relevant sections of my medical notes 
and data collection during the study may be looked at by 
individuals from the regulatory authorities or NHS trust, 
where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my 
records. 
 
 
4. I am aware of the potential risks and benefits of taking 
part. 
  
5. I agree to the interview being audio recorded  
6. I agree to the use of anonymised quotes in publications  
7. I agree to take part in the above study  
__________________   ______________ ______________________ 
Name of participant    Date    Signature 
___________________    ______________ ______________________ 
Person taking consent Date    Signature 
Please place 
initials in the box 
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Appendix 5.4: Advertisement 
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Appendix 5.5. Worked Example of IPA 
A section of transcript from one of the participants is used to illustrate each stage of 
the IPA process from participant 7, a 62 year-old male.  In this extract, participant 7 
is describing his experiences of life after the EECP treatment.  
Participant 7 Interview Extract 
R: So I wasn't really able to put any.. great... measure on how I was, other than, as I 
said to you a few moments ago, having come back from Keswick, and those walks 
are incredible.  There is now way that I would have do.. that I would have even 
attempted to do them 5 years ago, and no way I would have wanted to do them 10 
years ago without having pains and the rest of it.  And, the fact that I did meant that 
the whole experience was fantastic.  And I, well I go round telling.. singing the songs 
of EECP without a shadow of a doubt now to anybody and everybody 
I: That's great 
R: No question 
I: Especially seeing as you came in a bit sceptical 
R: Absolutely 
I; So would you say, like, the confidence of the team, as well, helped with it? 
R: I think that has a great deal to do with it, yeah. Um.. you're not just lying on a bed 
receiving treatment, like you are invariably, if you go into hospital for anything else, 
nine times out of ten they've got some other, other things to do and so forth.  You 
don't get a lot of talk, of time to talk to them.  But when you're lying on that bed for 
an hour you've got things to talk about and be talked through.  There.. it .. it is 
important that you have got that enthusiasm... uh.. in the team.. uh.. and Pat and Dr. 
Morley and the rest of them, yeah definitely, without a shadow of a doubt. 
I: Yeah.. and it seems like you noticed, um.. the improvement when you had to 
push yourself a bit more, like when you went on those walks and you thought, 
it's like in day to day life that you not [pushing yourself... 
R: One of the...] One of the complications of angina.. and this is the thing that the, 
the, the nurses were keen to stress, is that one of the problems with angina is you 
tend to not do things because you know full well it's going to subsequently hurt or be 
painful or, or you going to get pains deedaadeedaa... and so therefore, you tend to 
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become a little bit of a couch monkey, um.. and, and , and not take on the 
opportunities... 
I: Yeah 
R: And to a degree, that is still true now, because after ten years of being in that sort 
of situation, it's really difficult to get yourself out of it, but equally so it's really 
important that you do get out of it, and that's why, yes, when I went up to Keswick 
and pushed to ... umm...do the walking, that, that helped, unquestionably. But more 
to the point, not only did it push me to do it, but also by doing it, it showed me that I 
don't need to worry so much about it for the future. 
I: Yeah 
R: So since I've come back, I'm now pushing myself that much more all the time, 
which is, which is good! 
I: So every time you push yourself you get a bit more confidence [to push 
yourself that bit further... 
R: Absolutely right.. absolutely right.. yeah] so it's a case of improving those 
confidence levels or raising those confidence levels  
 
 
Stage one analysis.  The transcripts were re-read and anything of significance and 
interest noted in the left hand margin. At this stage comments were separated into 
descriptive, linguistic and conceptual comments.  Descriptive comments focused on 
the content of the participants' comments, linguistic comments explored the specific 
use of language used and conceptual comments were at a further interrogative level.  
At this stage three other independent researchers read extracts of interview 
transcripts and made initial comments according to descriptive, linguistic and 
conceptual domains.  Discussion between the researchers took place to facilitate and 
formulate a consensus of main themes emerging from transcripts.  
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Wouldn't have attempted 
 
Wouldn't have wanted to 
attempt 
 
The experience of pushing 
himself was fantastic 
 
EECP seen a special / 
religious? 
 
 
 
Negative illness perception 
at the start.  
 
 
 
 
 
Comparison to other 
medical treatments 
 
 
 
Talking is important to him 
The enthusiasm of the team 
was important 
 
 
 
 
 
 
Nurses talk about how fear 
of pain can be limiting  
 
 
Couch monkey – 
dehumanised? De-
masculinised? 
 
 
 
 
Hard to break that vicious 
cycle 
 
 
Knows rationally that he 
has to break the cycle 
 
 
By confronting fears, 
R: So I wasn't really able to put any.. great... measure on 
how I was, other than, as I said to you a few moments 
ago, having come back from Keswick, and those walks 
are incredible.  There is now way that I would have do.. 
that I would have even attempted to do them 5 years ago, 
and no way I would have wanted to do them 10 years ago 
without having pains and the rest of it.  And, the fact that 
I did meant that the whole experience was fantastic.  And 
I, well I go round telling.. singing the songs of EECP 
without a shadow of a doubt now to anybody and 
everybody 
I: That's great 
R: No question 
I: Especially seeing as you came in a bit sceptical 
R: Absolutely 
I; So would you say, like, the confidence of the team, 
as well, helped with it? 
R: I think that has a great deal to do with it, yeah. Um.. 
you're not just lying on a bed receiving treatment, like 
you are invariably, if you go into hospital for anything 
else, nine times out of ten they've got some other, other 
things to do and so forth.  You don't get a lot of talk, of 
time to talk to them.  But when you're lying on that bed 
for an hour you've got things to talk about and be talked 
through.  There.. it .. it is important that you have got that 
enthusiasm... uh.. in the team.. uh.. and Pat and Dr. 
Morley and the rest of them, yeah definitely, without a 
shadow of a doubt. 
I: Yeah.. and it seems like you noticed, um.. the 
improvement when you had to push yourself a bit 
more, like when you went on those walks and you 
thought, it's like in day to day life that you not 
[pushing yourself... 
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gained an increase in 
confidence to confront 
more fears. 
 
 
 
Understands that it is 
important to improve 
confidence levels 
R: One of the...] One of the complications of angina.. and 
this is the thing that the, the, the nurses were keen to 
stress, is that one of the problems with angina is you tend 
to not do things because you know full well it's going to 
subsequently hurt or be painful or, or you going to get 
pains deedaadeedaa... and so therefore, you tend to 
become a little bit of a couch monkey, um.. and, and , 
and not take on the opportunities... 
I: Yeah 
R: And to a degree, that is still true now, because after 
ten years of being in that sort of situation, it's really 
difficult to get yourself out of it, but equally so it's really 
important that you do get out of it, and that's why, yes, 
when I went up to Keswick and pushed to ... umm...do 
the walking, that, that helped, unquestionably. But more 
to the point, not only did it push me to do it, but also by 
doing it, it showed me that I don't need to worry so much 
about it for the future. 
I: Yeah 
R: So since I've come back, I'm now pushing myself that 
much more all the time, which is, which is good! 
I: So every time you push yourself you get a bit more 
confidence [to push yourself that bit further... 
R: Absolutely right...absolutely right.. yeah] so it's a case 
of improving those confidence levels or raising those 
confidence levels 
 
 
Stage two analysis.  Transcripts were re-read and emerging themes were documented 
on the transcripts.  Emerging themes were discussed with three other independent 
researchers.  
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Wouldn't have 
attempted 
 
Wouldn't have 
wanted to attempt 
 
The experience of 
pushing himself 
was fantastic 
 
EECP seen a 
special / 
religious? 
 
 
Negative illness 
perception at the 
start.  
 
 
 
 
 
Comparison to 
other medical 
treatments 
 
 
 
Talking is 
important to him 
The enthusiasm 
of the team was 
important 
 
 
 
 
 
 
 
 
 
Nurses talk about 
how fear of pain 
can be limiting  
 
 
Couch monkey – 
dehumanised? 
De-masculinised? 
 
 
 
R: So I wasn't really able to put any.. great... 
measure on how I was, other than, as I said to 
you a few moments ago, having come back 
from Keswick, and those walks are incredible.  
There is now way that I would have do.. that I 
would have even attempted to do them 5 
years ago, and no way I would have wanted to 
do them 10 years ago without having pains 
and the rest of it.  And, the fact that I did 
meant that the whole experience was 
fantastic.  And I, well I go round telling.. 
singing the songs of EECP without a shadow 
of a doubt now to anybody and everybody 
I: That's great 
R: No question 
I: Especially seeing as you came in a bit 
sceptical 
R: Absolutely 
I; So would you say, like, the confidence of 
the team, as well, helped with it? 
R: I think that has a great deal to do with it, 
yeah. Um.. you're not just lying on a bed 
receiving treatment, like you are invariably, if 
you go into hospital for anything else, nine 
times out of ten they've got some other, other 
things to do and so forth.  You don't get a lot 
of talk, of time to talk to them.  But when 
you're lying on that bed for an hour you've got 
things to talk about and be talked through.  
There.. it .. it is important that you have got 
that enthusiasm... uh.. in the team.. uh.. and 
Pat and Dr. Morley and the rest of them, yeah 
definitely, without a shadow of a doubt. 
 
 
 
 
 
 
Increase in QoL  
 
 
 
 
 
 
Fear as a limiting 
factor 
 
 
Special 
relationship with 
EECP nurses 
 
 
 
 
 
 
 
Change in illness 
perceptions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Developing a 
therapeutic 
relationship 
 
 
Dialogic 
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Hard to break 
that vicious cycle 
 
 
Knows rationally 
that he has to 
break the cycle 
 
 
 
By confronting 
fears, gained an 
increase in 
confidence to 
confront more 
fears. 
 
 
 
Understands that 
it is important to 
improve 
confidence levels 
I: Yeah.. and it seems like you noticed, um.. 
the improvement when you had to push 
yourself a bit more, like when you went on 
those walks and you thought, it's like in 
day to day life that you not [pushing 
yourself... 
R: One of the...] One of the complications of 
angina.. and this is the thing that the, the, the 
nurses were keen to stress, is that one of the 
problems with angina is you tend to not do 
things because you know full well it's going 
to subsequently hurt or be painful or, or you 
going to get pains deedaadeedaa... and so 
therefore, you tend to become a little bit of a 
couch monkey, um.. and, and , and not take 
on the opportunities... 
I: Yeah 
R: And to a degree, that is still true now, 
because after ten years of being in that sort of 
situation, it's really difficult to get yourself 
out of it, but equally so it's really important 
that you do get out of it, and that's why, yes, 
when I went up to Keswick and pushed to ... 
umm...do the walking, that, that helped, 
unquestionably. But more to the point, not 
only did it push me to do it, but also by doing 
it, it showed me that I don't need to worry so 
much about it for the future. 
I: Yeah 
R: So since I've come back, I'm now pushing 
myself that much more all the time, which is, 
which is good! 
I: So every time you push yourself you get 
relationship 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Increase in 
knowledge of 
angina 
 
 
 
 
 
 
 
Change in identity 
 
 
 
 
 
 
 
Fear limiting cycle 
Less anxiety 
 
 
 
 
Confronting fears 
 
 
 
 
 
 
 
 
 
 
 
 
211 
 
a bit more confidence [to push yourself that 
bit further... 
R: Absolutely right...absolutely right.. yeah] 
so it's a case of improving those confidence 
levels or raising those confidence levels 
 
 
 
 
Increase in 
confidence 
 
Stage three analysis.  The researcher then looked for patterns in these themes and 
across different participant's themes.  Quotes from the transcripts were extracted to 
support identified themes. 
 
Emerging Theme Supporting Quotes 
 
The EECP treatment being 
special and important 
 
 
The EECP being a very different 
experience to normal medical 
professionals   
 
 
The limiting effect of fear 
 
 
 
 
Increase in freedom 
 
 
 
 
 
 
Increase in Confidence 
 
 
 
 
 
A last hope 
 
 
Fear of negative evaluation from 
 
"well I go round telling, singing the songs of 
EECP without a shadow of a doubt now to 
anybody and everybody" 
 
"She's concentrating on the one person all the 
time, that's gotta be advantageous, both for the 
treatment, the person on the bed and of course 
her as well" 
 
"and you think to yourself why? Why should I do 
that cause I know full well that it's gonna hurt, 
so then you don't do it and as I said before, you 
then retreat, you then become introverted" 
 
"if you can imagine like a bud that's closed 
tight, like I'm in a cocoon, I can't do anything, 
but then, I've had the... uh... EECP and I feel as 
though it's open and there's daylight there, and I 
feel as though it helps so much, I feel as though 
I could do anything" 
 
"not only did it push me to do it, but also by 
doing it, it showed me that I don't need to worry 
so much about it for the future, so since I've 
come back, i'm pushing myself that much more 
all the time, which is good!" 
 
"So EECP were the last thing for me to go for 
really" 
 
"Stresses you a little bit I suppose. Cause you 
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other people 
 
Coping: Stoicism  
 
 
do, you do want to work" 
 
"This is the way, you have to keep going going 
going" 
 
Stage four analysis. The most relevant themes from across all 10 participants were 
synthesised and re-organised to form super-ordinate and subordinate themes.  
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Appendix 6.1: Hospital Anxiety and Depression Scale (HADS) 
Removed for hard binding 
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Appendix 6.2: Short-Form 12 version2 (SF12v2). Page 1 
Removed for hard binding. 
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Appendix 6.2: Short-Form 12 version2 (SF12v2). Page 2 
Removed for hard binding. 
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Appendix 6.3: Illness Perceptions Questionnaire-Revised (IPQ-R). Page 1 
Removed for hard binding 
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Appendix 6.3: Illness Perceptions Questionnaire-Revised (IPQ-R). Page 2 
Removed for hard binding 
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Appendix 6.3: Illness Perceptions Questionnaire-Revised (IPQ-R). Page 3 
Removed for hard binding 
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Appendix 6.4: Demographics Questionnaires 
Participant Demographics Sheet. 
 
Could you please answer the following questions: 
 
What is your age? 
o 30 or under 
o 31-40 
o 41-50 
o 51-60 
o 61-70 
o 71-80 
o 81 or older 
 
 
What is your gender? 
o Female 
o Male 
 
 
Have you visited your local GP...? 
o More than before the EECP treatment 
o Approximately the same 
o Less than before the EECP treatment 
 
 
Have you needed medication...? 
o More than before the EECP treatment 
o Approximately the same 
o Less than before the EECP treatment 
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Appendix 6.5: Patient Information Sheet 
Patient Information Sheet 
We would like you to take part in our research study.  Before you decide, we would like you 
to understand why the research is being done and what it would involve for you.  Please 
take time to read the following information carefully and discuss it with others if you wish.  
Please contact us if there is anything that is not clear or if you would like more information. 
Thank you for taking the time to read this. 
Study Title: The outcomes of patients that have previously undergone Enhanced External 
Counterpulsation Treatment (EECP). 
What is the purpose of the study? 
Although there is a lot of research into the medical benefits of EECP, there are limited 
studies into other outcomes of the treatment, such a quality of life and mood, which are 
equally important in the recovery after treatment.  We would like to investigate these 
aspects of recovery, to see whether EECP is not only medically beneficial, but also whether 
it aids recovery by improving quality of life and mood.   
We will ask you to complete the questionnaires attached and return them using the 
stamped addressed envelope provided. 
Why have I been invited? 
You have been invited to take part in our study because you have previously completed the 
EECP treatment at Bradford Royal Infirmary.  We are inviting all patients, like you, that have 
previously completed this treatment to take part.  We hope to find 100 patients who would 
be willing to take part. 
Do I have to take part? 
No, taking part in the study is voluntary; it is up to you to decide whether or not to take 
part.  If you do decide to take part, you will be given this information sheet to keep (and be 
asked to sign the consent form attached).  You can decide to withdraw from the study at 
any time, without giving a reason.  However, once you have completed the questionnaires 
and sent them off they will be anonymised.  This would mean that your data could not be 
removed from the study. This would not affect the standard of care you receive. 
What will happen if I decide to take part? 
You will be asked to complete the package of questionnaires attached.  The package 
contains three questionnaires; two of which are regularly sent out by the EECP service and 
the third questionnaire is about your symptoms and what you think about them.  There are 
no right or wrong answers. 
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What are the possible disadvantages and risks of taking part? 
The research study consists of completing only one package of questionnaires.  Therefore, 
we do not expect any disadvantages or risks. 
What are the possible benefits of taking part? 
Whilst there are no immediate benefits for participants taking part in the study, hopefully 
the information you give us will improve the understanding of the benefits of this 
treatment and help future patients gain better access to this service. 
What will happen if I decide I no longer wish to take part? 
You will be able to withdraw from the study at any point before sending your 
questionnaires back.  However, once you have sent your questionnaires back they will be 
anonymised.  Therefore, it would not be possible to withdraw your data from the study at 
this point. 
What if there is a problem? 
If you have a concern about any aspect of this study, you should contact the main 
researcher, Rachel Foxwell, on the contact details below, and she will do her best to 
answer your questions.  If you remain unhappy and wish to complain formally, you can do 
this through the NHS Complaints Procedure. Details can be obtained from the main 
reception desk of Bradford Royal Infirmary. 
Will my taking part in this study be kept confidential? 
All data will be handled according to ethical and legal practice. All information which is 
collected about you during the course of the research will be anonymous. Your completed 
questionnaires will be given an identification number which will be used throughout the 
analysis of the results. The data will be stored securely on University Departmental 
premises for five years after completion of the study. 
What will happen to the results of the study? 
The results will be written up as part of a doctoral qualification and are intended to be 
published in a scientific journal. You will not be personally identified in any of the results. If 
you wish to obtain information about the results, they will be available in the Cardiology 
Department upon completion in summer 2012.  
Who is organising and funding the research? 
This research is being undertaken as part of a doctoral research project in Clinical 
Psychology. The research is funded through the University of Hull and through the Bradford 
Cardiology Department. 
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Who has reviewed the study? 
All research in the NHS is looked at by an independent group of people, called a Research 
Ethics Committee, to protect your interests. This study has been reviewed and given 
favourable opinion by the Research Ethics Proportionate Review Sub-Committee. 
Further information and contact details 
If you have any further questions or queries, please contact Rachel Foxwell on 
07702807574 or email r.foxwell@2009.hull.ac.uk. 
Helpful Resources 
The British Heart Foundation: www.bhf.org.uk Telephone number: 0300 330 3311 
NHS website: www.nhs.uk  
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Appendix 6.6: Patient Consent Form 
Participant Identification number for this study: 
CONSENT FORM 
Title of project: The outcomes of patients that have previously undergone Enhanced 
External Counterpulsation Treatment (EECP) (Version 1.0) 
Name of Researcher: Rachel Foxwell 
1. I confirm that I have read and understand the information 
sheet dated 06/01/2011. Version 1.1 (Part1), for the above 
study. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
 
2. I understand that my participation is voluntary and that I 
am free to withdraw at any time without giving any reason, 
without any medical care or legal rights being affected. 
 
 
3. I understand that relevant sections of my medical notes 
and data collection during the study may be looked at by 
individuals from the regulatory authorities or NHS trust, 
where it is relevant to my taking part in this research. I give 
permission for these individuals to have access to my 
records. 
 
 
4. I am aware of the potential risks and benefits of taking 
part. 
  
5. I agree to take part in the above study  
____________________     ______________ ___________________ 
Name of participant     Date    Signature 
____________________     ______________ ___________________ 
Name of person      Date    Signature 
taking consent 
 
 
Please place 
initials in the box 
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Appendix 6.7: Advertisement 
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Appendix 6.8: Tests of Normality 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shapiro-Wilk 
Statistic df Sig. 
HADS Anxiety .932 76 .001 
HADS Depression .937 76 .001 
SF12v2 PCS .987 76 .641 
SF12v2 MCS .967 76 .044 
Identity .977 76 .174 
Time (acute/chronic) .773 76 .000 
Consequences .892 76 .000 
Personal Control .929 76 .000 
Treatment Control .915 76 .000 
Coherence .874 76 .000 
Time Cycle .985 76 .523 
Emotional Distress .969 76 .060 
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Appendix 6.9: Examples of Correlation Analysis 
 
 HADS 
Anxiety 
HADS 
Depression Identity 
Timeline 
(acute/ 
chronic) Consequence 
Personal 
Control 
Treatment 
Control Coherence 
Time 
Cycle 
Emotional 
Distress 
Spearman'
s rho 
HADS Anxiety Correlation  1.000 .709
**
 .365
**
 .018 .463
**
 -.283
*
 -.098 -.160 .232
*
 .749
**
 
Sig. (2-tailed) . .000 .001 .880 .000 .013 .399 .167 .044 .000 
N 76 76 76 76 76 76 76 76 76 76 
HADS 
Depression 
Correlation  .709
**
 1.000 .433
**
 .154 .544
**
 -.243
*
 -.228
*
 -.228
*
 .144 .490
**
 
Sig. (2-tailed) .000 . .000 .184 .000 .035 .048 .047 .215 .000 
N 76 76 76 76 76 76 76 76 76 76 
Identity Correlation  .365
**
 .433
**
 1.000 .282
*
 .585
**
 -.238
*
 -.275
*
 -.044 .141 .237
*
 
Sig. (2-tailed) .001 .000 . .014 .000 .039 .016 .706 .224 .039 
N 76 76 76 76 76 76 76 76 76 76 
Time(acute/ 
chronic) 
Correlation  .018 .154 .282
*
 1.000 .581
**
 -.243
*
 -.321
**
 .376
**
 .047 -.022 
Sig. (2-tailed) .880 .184 .014 . .000 .034 .005 .001 .687 .852 
N 76 76 76 76 76 76 76 76 76 76 
Consequence Correlation  .463
**
 .544
**
 .585
**
 .581
**
 1.000 -.400
**
 -.400
**
 .094 .261
*
 .407
**
 
Sig. (2-tailed) .000 .000 .000 .000 . .000 .000 .419 .023 .000 
N 76 76 76 76 76 76 76 76 76 76 
Personal Correlation  -.283
*
 -.243
*
 -.238
*
 -.243
*
 -.400
**
 1.000 .256
*
 .017 -.043 -.317
**
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Control Sig. (2-tailed) .013 .035 .039 .034 .000 . .026 .887 .711 .005 
N 76 76 76 76 76 76 76 76 76 76 
Treatment 
Control 
Correlation  -.098 -.228
*
 -.275
*
 -.321
**
 -.400
**
 .256
*
 1.000 .017 .023 -.020 
Sig. (2-tailed) .399 .048 .016 .005 .000 .026 . .884 .846 .862 
N 76 76 76 76 76 76 76 76 76 76 
Coherence Correlation  -.160 -.228
*
 -.044 .376
**
 .094 .017 .017 1.000 -.144 -.218 
Sig. (2-tailed) .167 .047 .706 .001 .419 .887 .884 . .213 .059 
N 76 76 76 76 76 76 76 76 76 76 
Time Cycle Correlation  .232
*
 .144 .141 .047 .261
*
 -.043 .023 -.144 1.000 .327
**
 
Sig. (2-tailed) .044 .215 .224 .687 .023 .711 .846 .213 . .004 
N 76 76 76 76 76 76 76 76 76 76 
Emotional 
Distress 
Correlation  .749
**
 .490
**
 .237
*
 -.022 .407
**
 -.317
**
 -.020 -.218 .327
**
 1.000 
Sig. (2-tailed) .000 .000 .039 .852 .000 .005 .862 .059 .004 . 
N 76 76 76 76 76 76 76 76 76 76 
**. Correlation is significant at the 0.01 level (2-tailed). 
*. Correlation is significant at the 0.05 level (2-tailed). 
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Appendix 7.0: Examples of Regression Analysis 
 
 
 
 
 
Model Summary
c
 
Model R R Square 
Adjusted R 
Square 
Std. Error of the 
Estimate 
1 .208
a
 .043 .003 4.702 
2 .794
b
 .631 .567 3.098 
a. Predictors: (Constant), Time in Months, Age in years, Gender Code 
b. Predictors: (Constant), Time in Months, Age in years, Gender Code, 
Timeline (acute/chronic), Emotional Representations, Illness Coherence, 
Personal Control, Identity, Timeline Cyclical, Treatment Control, 
Consequences 
c. Dependent Variable: HADS Anxiety 
 
 
 
Variables Entered/Removed
b
 
Model Variables Entered 
Variables 
Removed Method 
1 Time in Months, 
Age in years, 
Gender Code 
. Enter 
2 Timeline 
(acute/chronic), 
Emotional 
Representations, 
Illness 
Coherence, 
Personal Control, 
Identity, Timeline 
Cyclical, 
Treatment 
Control, 
Consequences 
. Enter 
a. All requested variables entered. 
b. Dependent Variable: HADS Anxiety 
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ANOVA
c
 
Model Sum of Squares df Mean Square F Sig. 
1 Regression 71.932 3 23.977 1.084 .361
a
 
Residual 1591.858 72 22.109   
Total 1663.789 75    
2 Regression 1049.723 11 95.429 9.946 .000
b
 
Residual 614.066 64 9.595   
Total 1663.789 75    
a. Predictors: (Constant), Time in Months, Age in years, Gender Code 
b. Predictors: (Constant), Time in Months, Age in years, Gender Code, Timeline (acute/chronic), Emotional 
Representations, Illness Coherence, Personal Control, Identity, Timeline Cyclical, Treatment Control, 
Consequences 
c. Dependent Variable: HADS Anxiety 
 
Coefficients
a
 
Model 
Unstandardized 
Coefficients 
Standardized 
Coefficients 
t Sig. B 
Std. 
Error Beta 
1 (Constant) 13.012 3.931  3.310 .001 
Gender Code -.076 1.879 -.005 -.041 .968 
Age in years -.103 .057 -.208 -1.798 .076 
Time in Months -.001 .021 -.003 -.030 .976 
2 (Constant) -8.468 5.292  -1.600 .115 
Gender Code 1.818 1.306 .112 1.392 .169 
Age in years .033 .042 .067 .785 .435 
Time in Months .011 .016 .061 .700 .486 
Identity .172 .152 .109 1.135 .261 
Timeline (acute/chronic) -.042 .100 -.042 -.419 .677 
Consequences .189 .125 .195 1.511 .136 
Personal Control -.070 .100 -.063 -.705 .483 
Treatment Control .006 .136 .004 .044 .965 
Illness Coherence .014 .090 .013 .154 .878 
Timeline Cyclical -.109 .121 -.081 -.902 .370 
Emotional Representations .571 .082 .681 6.935 .000 
 
